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I. Introduction: The Technological Society'
The disruptive propensity of new technologies on existing
social, economic, moral, and cultural milieus is no less sacrosanct
than it is ancient and topical.2 For example, the technique of
metallurgy, which involves the extraction of metals from naturally
occurring ores, is an ancient technological feat, which the
apocryphal book of Enoch dated back to at least 3300 B.C.E.3
However, the advent of metallurgy was greatly disruptive of a
tranquil way of life, as metallurgical technology was
simultaneously pressed into worthwhile agricultural pursuits and
the service of disruptive warfare and strife.4 Moreover, the advent
of omaments and bracelets, which were, of course, by-products of
I The Technological Society is the title of Jacques Ellul's 1954 seminal work on
the downsides of society's increasing dependency on technology. Since the book's
publication in 1954, we have become ever more dependent on technology, and the title is
used in this article to highlight and contextualise the dual use dilemmas posed by our
continuing dependency on technology generally and transgenic plant technology
especially. For further discussion, see generally JACQUES ELLUL, THE TECHNOLOGICAL
SOCIETY (1973).
2 See Charles Harding, Threadbearers: The Disseminators of Technology, 6 INT'L
J. TECH. KNOWLEDGE & Soc'y, no. 2, 2010, at 141, 141-49 (citing the account in the
apocryphal book of Enoch).
3 Id. at 143.
4 Id. at 143-44.
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metallurgy, led to undue fixation on personal grooming at the
expense of divine pursuits, and very much to the displeasure of
God.' The apocryphal account of the origin of metallurgy in the
book of Enoch in chapter 8, verses 1 and 2, aptly notes the
disruptive effects of metallurgical technology on existing socio-
cultural milieus:
And Azazel taught men to make swords, and knives, and
shields, and breastplates, and taught them about metals of the
earth and the art of working them, and bracelets, and ornaments,
and the use of antimony, and the beautifying of the eyelids, and
all kinds of precious stones, and all coloring and dyes .... And
there was a great impiety, they turned away from God, and
committed fornication, and they were led astray, and became
6corrupt in all their ways.
However, in retrospect, metallurgy would not be the only
technology with inherent propensity for unpredictable
disruptiveness,7 and while most readers might readily, and perhaps
rightly, dismiss Enoch's apocryphal account of the origin of
metallurgy as a myth,' the moral of the story remains palpably
tangent and topical with uncanny resonance in contemporary
technologies with dual-use potentials, capabilities, and
unpredictable tendencies.' After all, the technologies that
5 Id. at 144.
6 Id. (citing JOSEPH LUMPKIN, THE FIRST AND SECOND BOOKS OF ENOCH: THE
ETHIOPIC AND SLAVONIC TEXTS 28 (2009)).
7 See Braden R. Allenby, Governance and Technology Systems: The Challenge of
Emerging Technologies, in THE GROWING GAP BETWEEN EMERGING TECHNOLOGIES AND
LEGAL-ETHICAL OVERSIGHT: THE PACING PROBLEM 3, 3-7 (Gary E. Marchant, Braden R.
Allenby & Joseph R. Herkert eds., 2011) (citing the revolutionary impacts of railways on
the social, cultural, and economic institutions of the United States in the early 17th
century).
8 In fact, there are more rational historical accounts of the origin and use of
metallurgy over the centuries dating from the Neolithic Iron Age, a third principal period
of the three-age system, which was characterised by the manufacture of iron implements
such as weapons and agricultural tools. See RONALD FRANK TYLECOTE, A HISTORY OF
METALLURGY (2d ed. 2002).
9 The dual-use research dilemma deals with managing technologies that are
capable of hostile and positive uses, such as nuclear installations. The dual use research
dilemma is especially prevalent in biotechnological products, which could be used for
terrorist activities. See Taiwo A. Oriola, Against the Plague: Exemption of
Pharmaceutical Patent Rights as a Biosecurity Strategy, 2007 U. ILL. J.L. TECH. &
POL'Y, 287, 289-93 (2007) (discussing the challenges posed by hostile use of biological
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facilitated the industrial revolution, the Green Revolution,
penicillin, and the computer, amongst others, also heralded the age
of environmental pollution, sundry high technological risks,
chemical, germ, biological, and nuclear warfare.'o These
technologies are mostly high-profiled and ubiquitous, and include
a broad array of diverse fields including, for instance, nuclear
technology, nanotechnology, biotechnology, robotics, information
technology, and communication technology." A notable high
profile technology with far-reaching implications for public health
and safety, and which is often a target of public anxiety,
opposition, and intense regulation, is nuclear technology. 2 It is a
technology that is perhaps loathed and loved almost in equal
measure, due to its ability to harness the awesome power of
uranium simultaneously for useful nuclear energy and destructive
nuclear weaponry, with concomitant nuclear waste disposal
challenges." Yet another high profile technology, which is the
subject of discourse in this article, is the product of agricultural
biotechnology or recombinant DNA in plant agriculture, otherwise
known as genetically modified organisms, or transgenic plant or
inventions for bioterrorism). The National Science Advisory Board for Biosecurity is
routinely convened in the United States by the Office of Biotechnology Activities to
advise on dual use potentials of biotechnological inventions. See Dual Use Research,
NATIONAL INSTITUTES OF HEALTH-OFFICE OF SCIENCE POLICY, http://oba.od.nih.gov/
biosecurity/biosecurity.html.
10 See David Beckmann, Foreword to PER PINSTRUP-ANDERSEN & EBBE SCHIOLER,
SEEDS OF CONTENTION: WORLD HUNGER AND THE GLOBAL CONTROVERSY OVER GM
CROPS viii (John Hopkins Univ. Press 2001).
11 Nanotechnology, biotechnology, robotics, information technology, and
communication technology were described as "the five horsemen of emerging
technologies." See Allenby, supra note 7, at 7-11.
12 See Koos Van Der Bruggen, Nuclear Ethics, in A COMPANION To THE
PHILOSOPHY OF TECHNOLOGY 462, 462-65 (Jan Kyrre Berg Olsen, Stig Andur Pedersen
& Vincent F. Hendricks eds., 2009) (discussing the United States' deployment of nuclear
weapons twice against Japan in 1945, and the polarised opinions on the propriety and
ethics of nuclear weapons).
13 See Helen Caldicott, Prof Gordon Edwards on the Perils of Nuclear
Technology, Uranium Mining, and Weapons Prolhferations, COTO REPORT (Mar. 17,
2011), http://coto2.wordpress.com/2011/03/17/prof-gordon-edwards-on-the-perils-of-
nuclear-technology-uranium-mining-and-weapons-proliferation/ (providing an interview
on the perils of nuclear technology, in which Professor Gordon Edwards was quoted as
follows: "[y]ou get electricity for maybe 20 or 30 years if you're lucky, then you have
plutonium forever").
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crops.14  Like nuclear technology, it has been a subject of
relentless public anxiety, intense scrutiny, regulation, and
opposition, since its commercial debut in 1996," amidst
continuing, often acrimonious, conflicting scientific data on its
susceptibility to new toxins and allergens, and its full ramifications
for public health and the environment.16
However, it is sacrosanct that, for better or worse, ours is a
"technological society," 7 to which we are irrevocably bound and
dependent, and as Martin Heidegger rightly noted, "[e]verywhere
we remain unfree and chained to technology, whether we
passionately affirm or deny it." Most significantly, the growing
ascendancy of technology, and our growing technological
dependency over the past century, were largely facilitated by
strategic governmental interventions in the forms of promotions
and regulations of new technologies." For example, most cutting-
14 Transgenic plants or crops are those that have been genetically modified to host
and express certain desirable characteristics, such as pest and drought resistance.
Examples include transgenic Bt cotton, corn, soybeans, and canola. See MICHAEL J.
REISS & ROGER STRAUGHAN, IMPROVING NATURE? THE SCIENCE AND ETHICS OF GENETIC
ENGINEERING 131-64 (1996).
15 Calgene's "Flavr Savr" tomato was the first transgenic plant to reach the market
in 1994, but it was quickly withdrawn because its "anti-sense" gene for delayed ripening
did not confer any on-field or market advantage on the tomato. Several varieties of
transgenic corn incorporating Bt toxins were subsequently commercialised in 1996.
These were followed by transgenic soy, cotton, and canola. See JACK RALPH
KLOPPENBURG JR., FIRST THE SEED: THE POLITICAL ECONOMY OF PLANT BIOTECHNOLOGY
296 (Univ. of Wisconsin Press, 2d ed. 2004).
16 Scientific research into the safety of transgenic crops for public health and the
environment tends to be divisive and acrimonious. For example, research completed in
1999 by a laboratory in the United States finding that monarch caterpillars died
following consumption of pollen from a new variety of genetically modified corn was
subsequently discredited by new research, which showed that monarch caterpillars and
butterflies did not suffer any harm in their natural habitat See PER PINSTRUP-ANDERSEN
& SCHIOLER, SEEDS OF CONTENTION: WORLD HUNGER AND THE GLOBAL CONTROVERSY
OVER GM CROPS 47-48 (Johns Hopkins Univ. Press 2001).
17 Our society is arguably more dependent and reliant on technology than Jacques
Ellul feared in the 1950s, when he published his seminal work on the impacts of
technology on the society in 1954. See Ellul, supra note 1.
18 See Martin Heidegger, THE QUESTION CONCERNING TECHNOLOGY AND OTHER
ESSAYS 4 (1977).
19 See Oliver Todt, Regulating Agricultural Biotechnology Under Uncertainty, 42
SAFETY SCIENCE 143, 144 (2004) (noting regulation and promotion as two fundamental
governmental interventionist activities for technology development and describing the
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edge technologies are rooted in research conducted at publicly
funded universities in Europe and North America,2 0 whilst the
intellectual property regime, which is openly promoted by
governments of industrialized countries, is primarily designed to
safeguard investments in applied research and innovations.2'
Thus, there is a symbiotic relationship between governmental
technology regulation and promotion that range from laws
safeguarding property rights, tax breaks, and government
subsidies, to direct public funding for start-up and established
firms.2 2
However, while governments around the world are keen to
promote new technologies as part of national strategic social and
economic development policies,23 they often struggle to keep
challenges of balancing the two activities).
20 See Taiwo A. Oriola, Strong Medicine: Patents, Markets, and Policy Challenges
for Managing Neglected Diseases and Affordable Prescription Drug, 7 CANADIAN J.L. &
TECH. 57, 72-78 (2009) (discussing how pioneering and breakthrough prescription drugs
are often rooted in basic research conducted at publicly funded universities and research
institutes in the United States, Canada, United Kingdom, and Europe, and arguing for the
reflection of taxpayers' investments in the pricing of privately owned pharmaceuticals);
see also Mark Henderson, THE GEEK MANIFESTO: WHY SCIENCE MATTERS 114-17 (2012)
(discussing science's serendipity and how important inventions such as fibre optic cable
technology were borne out of publicly funded university research); see also
KLOPPENBURG, supra note 15, at 195-96 (noting how new genetic technologies were
developed by publicly funded research at universities and institutes).
21 The quid pro quo for the legal protection of intellectual property rights is
primarily to incentivise innovation and technology developments by the grant of a
limited monopoly to rights owners, which in turn allows for the recoupment of
investments in new technologies. See generally David I. Bainbridge, INTELLECTUAL
PROPERTY 17-19 (6th ed. 2007) (discussing the rationale and justifications for intellectual
property rights protection).
22 In the United Kingdom, for example, tax advantages for start-up or new
businesses set up in one of the twenty-one new enterprise zones could amount to one
hundred percent business rates discounts for five years. The discounts could be worth up
to E275,000 over a five year period. See Tom Bawden, Budget 2011: Selected
Enterprise Zones Designed to Encourage New Investment, THE GUARDIAN (Mar. 23,
2011), http://www.theguardian.com/uk/201 1/mar/23/budget-20 11 -enterprise-zones-
designed-to-encourage-new-investment.
23 For example, the administration of Prime Minister Atal Bihari Vajpayee in India
perceived and promoted biotechnology as a pro-poor national development 'precision'
tool with which to create wealth, "fight obdurate diseases, increase agricultural
production, combat nutritional deficiencies and protect the environment." See Ronald J.
Herring, The Genomics Revolution and Development Studies: Science, Poverty and
Politics, 43 J. DEV. STUD. 3 (2007) [hereinafter Genomics Revolution] (discussing the
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technology policy and regulatory framework abreast of new
technological developments,24 fueling concerns on the propriety,
adequacy, or efficacy of regulatory and governance regimes for
new technologies. 25  Thus, while technological regulation is
sacrosanct, 26  there is a risk that governmental technology
promotional policy could obfuscate an effective technological
regulatory regime in the absence of a proper balance between
technology promotion and regulation.2 7 For example, a
government that is overly enthused by the endearing promise of
transgenic plant agricultural technology could, in all probability,
have a more favourable promotional policy regime than a
government less enthused due to national developmental policy
objectives or social, economic, cultural, or political imperatives.29
There is arguably a parallel between this hypothesis and the
dichotomies in transgenic plant agricultural regulatory and policy
frameworks in the United States, with its proactive and laissez-
faire regulatory and policy regime,30 as exemplified by its official
economic, political, and social forces that were driving innovations in life-sciences-
related technologies).
24 See Lyria Bennett Moses, Recurring Dilemmas: The Law's Race to Keep Up
with Technological Change, 2007 U. ILL. J.L. TECH. & POL'Y 239, 239-85 (2007).
25 See Gary E. Marchant, The Growing Gap Between Emerging Technologies and
the Law, in THE GROWING GAP BETWEEN EMERGING TECHNOLOGIES AND LEGAL-ETHICAL
OVERSIGHT: THE PACING PROBLEM 19-33 (Gary E. Marchant, Braden R. Alleaby &
Joseph R. Herkent eds. 2011).
26 See Allenby, supra note 7, at 7-11.
27 See Todt, supra note 19, at 144 (discussing how governments have to balance
their promotional and regulatory interests in technology governance regimes).
28 Agricultural biotechnology is routinely touted as a panacea to food scarcity and
world hunger by its adherents. See PER PINSTRUP-ANDERSOEN & EBBE SCHIOLER, supra
note 15, at 86-105 (discussing the potential of transgenic crops to solve world hunger,
especially in Africa).
29 Some analysts believe that the continuing European public resistance to
transgenic crops, which stemmed from mistrust of environmental and safety agencies,
largely informed the precautionary principle that currently predominates the regulatory
framework for transgenic crops in Europe. See Ambuj Sagar, Arthur Daemmrich, &
Mona Ashiya, The Tragedy of the Commoners: Biotechnology and Its Publics, 18
NATURE BIOTECHNOLOGY 2, 2-4 (2000); Robert Lee, GM Resistant: Europe and the
WTO Panel Dispute on Biotech, in I ETHICS, LAW & SOCIETY 131, 131-39 (Jennifer
Gunning & Soren Holm eds., 2005).
30 See George Gaskell et al., Transatlantic Tensions over GM Crops and Food, in
GENOMICS & SOCIETY: LEGAL, ETHICAL & SOCIAL DIMENSIONS 197, 197-211 (George
Gaskell & Martin W. Bauer, eds., 2006).
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aversion for labeling transgenic plant food products,"1 and
countries of the European Union, where popular resistance to
transgenic plant agricultural technology endures and defines its
relatively stringent policies that regulate the technology.32
Yet, while transgenic plant agriculture is perhaps one of the
most regulated technologies of our time, its regulatory framework,
characterized in this Article as "regulatory science"33 is arguably
molded almost entirely by evolutionary or evolving "science"34 on
31 Despite overwhelming support for the labeling of transgenic plant products as
exemplified by a 2003 survey and the aborted states' legislative initiatives such as that of
Oregon, the FDA has refused to endorse labeling of transgenic plant food products. This
policy starkly contrasts with that of the countries of the European Union, where labeling
of transgenic food products is mandatory. See ROBERT PAARLBERG, STARVED FOR
SCIENCE: How BIOTECHNOLOGY IS BEING KEPT OUT OF AFRICA 17 (2009) (noting how
domestic pressure forced the European Union to introduce a compulsory labeling rule for
all transgenic crops products sold within the European Union).
32 In contradistinction to the United States, regulators in the European Union took
the view that transgenic plant agriculture and products posed uncertain risks that
warranted special regulation, such as the Directive 90/220 on Deliberate Release of
Genetically Modified Organisms into the Environment, which was designed to prevent
"adverse effects on human health or the environment." See Les Levidow, Joseph
Murphy & Susan Carr, Recasting "Substantial Equivalence": Transatlantic Governance
of GM Food, 32 Sc!., TECH. & HUM. VALUES at 26, 36 (Jan. 2007); see also Sheila
Jasanoff, DESIGNS ON NATURE: SCIENCE AND DEMOCRACY IN EUROPE AND THE UNITED
STATES 274-80 (2007) (discussing how the differing framing of biotechnological risks
led to policy differences between the United States and the European Union. While the
United States' "product-based" approach drew heavily on scientific accounts, extolling
the merits and promises of genetic engineering "as a highly specific intervention,
grounded in molecular biology" with untold benefits and minimal risks to public health
and the environment, the European Union and Member states adopted a "process-based"
approach, which took cognizance of ecological implications and inherent uncertainties of
the technology as exemplified by their normative precautionary regulatory approach).
33 For a discussion on the concept of regulatory science and various definitions,
see YEONwOO LEBOVITZ ET AL., BUILDING A NATIONAL FRAMEWORK FOR THE
ESTABLISHMENT OF REGULATORY SCIENCE FOR DRUG DEVELOPMENT: WORKSHOP
SUMMARY 5-11 (2011). Also it is worthwhile to consult regulatory decisions for the best
scientific knowledge available.
34 The word "science" is defined by the Oxford Dictionary as "an organised body
of knowledge on a subject." See THE OXFORD DICTIONARY AND THESAURUS 1350
(American ed. 1996). The term "evolutionary science" is used contextually in this essay
to denote an evolving body of knowledge as opposed to an exact, evolved, standardised,
or established knowledge. For example, while the knowledge that water, iron, gold, and
copper are electricity conductors is sacrosanct, the science on the full implications of
transgenic agriculture for public health and the environment is arguably evolutionary and
not as well established, due to innumerable unknowns that range from horizontal gene
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issues that range from transgenic plant food allergens and toxins,
to the coexistence of transgenic and non-transgenic plants, to the
safety of transgenic plant agriculture and food respectively for the
environment and public health.35 In general terms, regulatory
science connotes science-based regulation, policy, or decision-
making processes3 6 and has been defined as "a unique application
of science, at all levels, to the societal decision process[,]"3 7 or as
"[t]he development and use of new tools, standards and
approaches to more efficiently develop products and to more
effectively evaluate product safety, efficacy and quality.""
Significantly, a distinction is often made between "regulatory
science" and "research science," with the latter being regarded as
qualitatively superior to the former.3 9  According to Sheila
Jasanoff: "[w]hereas, research science places greatest value on
published papers, certified by peers as true, original, and
significant, science conducted for policy is rarely innovative and
may never be submitted to the discipline of peer review and
publication."40
Whilst it is beyond the remit of this article to join the fray on
the contested theoretical and empirical distinctions between
"regulatory" and "research" science,4 ' it would suffice to argue
flow, to new allergens, to new toxins from novel proteins. See Genomics
Revolution, supra note 23, at 2.
35 It is axiomatic that scientists are divided on what the full implications of
transgenic agriculture could be for the public health and the environment. See MAE-
WAN Ho, GMO FREE: EXPOSING THE HAZARDS OF BIOTECHNOLOGY TO ENSURE THE
INTEGRITY OF OUR FOOD SUPPLY 21-25 (2004) (branding the "substantial equivalence"
doctrine on which the safety of transgenic crops was premised as "unscientific," and
noting how the contrarian findings of Professor Puszai on the dangers posed by
transgenic crops to public health and the environment were attacked within the scientific
establishment).
36 See Alan Irwin et al., Regulatory Science: Towards a Sociological Framework,
29 FUTURES 17, 17-31 (1997).
37 See LEBOVITZ ET AL., supra note 33, at 6 (citing Alan Moghissi). While there is
no official definition of regulatory science, there are numerous contextual definitions,
especially in the context of biopharmaceutical products governance.
38 Id. (citing NIH-FDA definition).
39 See SHEILA JASANOFF, THE FIFTH BRANCH: SCIENCE ADVISERS AS
POLICYMAKERS 76-83 (1994).
40 Id. at 77.
41 For example, no distinction was made between research and regulatory science
by Alan Irwin et al., in their paper on the role of regulatory science in the governance of
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that there is no evidence to suggest that "research science" is
either infallible4 2 or sacrosanct as such,43 or that the current crop of
regulatory and policy framework for national and transnational
governance of transgenic plant agricultural technology is premised
entirely on inferior or un-refereed science.44 Rather, an audit of
scientific literature on transgenic plant technology, which was
commissioned by the United Kingdom Department of
Environment Food and Rural Affairs (DEFRA) and published by
the GM Science Review Panel in 2004, showed that most of the
literature by both academic and industry researchers was in peer-
toxic chemicals in the European Union, which relied on works of university-based
researchers, private laboratories conducting large-scale regulatory compliance texts,
industrial scientists assessing health and environmental benefits of chemical products,
and government institutions tasked with assessing scientific evidence submitted by
industry. See Irwin et al., supra note 36, at 17-31; see also LEBOVITZ ET AL., supra note
33, at 1-78 (discussing the role of regulatory science in the context of drug development,
as inclusive of assessment of laboratory data, review and assessment of animal and
human clinical data, methods of drug development, development of technical and
scientific standards for preclinical assessment, product development, post market
surveillance manufacturing, food safety standards, and food processing technologies, all
of which would mostly require peer review work).
42 For example, between 1975 and 2012, a total of 2,047 research articles in life-
sciences and biomedical research indexed by PubMed were retracted. A detailed review
of the reasons underlying retractions showed that 21.3% were attributable to errors,
while a whopping 67.4% were attributable to misconduct including fraud or suspected
fraud. See Ferric C. Fang, R. Grant Steen & Arturo Casadevall, Misconduct Accounts
for the Majority of Retracted Scientific Publications, 149 PROC. NAT'L ACAD. ScI.
17028, 17028-33 (2012).
43 In a corporate sense, "research science," even if superior, is arguably organic,
cumulative, dynamic, and progressive. The state of the art of a technology is inherently
variable depending on the underlying scientific discoveries and understanding of new
materials such as nano-materials for example. See Bernard d'Espagnat, Is Science
Cumulative? A Physicist Viewpoint, 255 BOsTON STUD. IN PHIL. & HIST. SCI. 145, 145-51
(2008). Moreover, many "research science" results that are borne out of rigorous peer-
review systems are known to lack replicability and tend to generate conflicting results.
For discussion, see Jonah Lehrer, The Truth Wears Off Is There Something Wrong with
the Scientific Method?, THE NEW YORKER (Dec. 13, 2010), http://www.newyorker.com/
reporting/2010/12/13/101213fa fact lehrer.
44 For example, the Second Report of GM Science Review Panel, commissioned
by DEFRA UK, was premised on a review of academic (research) and industry scientific
literature on issues of public concerns ranging from GM food safety to gene flow. See
GM Science Review (Second Report): An Open Review of the Science Relevant to GM
Crops and Food Based on Interests and Concerns of the Public, Jan. 2004, available at
http://www.bis.gov.uk/files/filel4992.pdf.
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reviewed and refereed journals. 45 Furthermore, in October 2001,
the Research Directorate of the European Union released an
eighty-one page review of scientific studies published on
transgenic crops over a fifteen-year period and concluded that
"[r]esearch on GM plants and derived products so far developed
and marketed, following usual risk assessment procedures, has not
shown any new risks to human health or the environment." 4 6 It is
instructive to note that the report released by the European Union
Research Directorate had no reason to qualify the quality of the
scientific publications and research audited, which was a mixture
of academic and industry research. 47  Thus, the hypothesis that
regulatory science is inferior to research science ostensibly smacks
of an arbitrary distinction and categorization because, invariably,
regulatory science is premised on an amalgam of scientific
knowledge from industry and academia. This is so irrespective of
publication medium or the quality of publication outlet.
Regulatory science differs as much from country to country as it
does from one type of technology to the other, with concomitant
variations in its fundamental constituents, a point well adumbrated
by Alan Irwin et al., who state:
[T]he literature on science and policy-making suggests that the
institutional culture of regulatory science changes from country
to country so that cross-national comparison suggests significant
variation. Thus, it can be implied from the work of several
authors that in Europe regulatory science shows greater
similarities to academic science than is the case in the USA.48
Thus, in the context of transgenic plant agricultural technology
policy, for example, cross-country variations in the regulatory and
policy science framework are exemplified by the European Union
precautionary principle, 49 which arguably informed legislation
45 See id.
46 Press Release, European Union Research Directorate, GMOs: Are There Any
Risks? (Oct. 9, 2001) (available at http://ec.europa.eu/research/biosociety/pdf/
gmo_press release.pdf) (noting on page I that it was meant "to raise the voice of science
in the GMO debate by establishing an ongoing discussion forum on the research results
relating to benefits and risks of GMOs").
47 See id.
48 The term "academic science" as used in this context, connotes "research
science." See Irwin et al., supra note 36, at 20.
49 The precautionary principle involves applying provisional risk management
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such as the transgenic food products labeling rules, to which the
United States did not subscribe,so despite a survey suggesting that
ninety-four percent of Americans in 2003 preferred the labeling of
transgenic plant food products."' A fortiori, in this Article, the
term "regulatory science" will, ipso facto, be employed in a
generic, comprehensive, and utilitarian sense to denote all science-
based regulation and policy regimes for transgenic plant
agricultural technology governance (whether peer-reviewed or
otherwise) and irrespective of the nature or quality of the
publication medium.5 2
Most significantly, it is arguable that the regulatory and policy
framework for transgenic plant agricultural technology is largely
underpinned by science.5 3 This is exemplified by the European
Food and Safety Authority's guidance document on the
environmental risk assessment of genetically modified plants,
which, inter alia, enjoins the conduct of risk assessment as
follows: "in a scientifically sound manner based on available
scientific and technical data and on common methodology for
identification, gathering and interpretation of the relevant
measures where there is a high probability of harm to public health, in the face of
scientific uncertainties. The precautionary principle is premised on a range of scientific
research highlighting the uncertainties surrounding transgenic plant agriculture and food
respectively for the environment and public health. See Communication from the
Commission on the Precautionary Principle, COM (2000) 14 final (Feb. 2, 2000).
50 For example, while the European Union has a law mandating the labelling of
transgenic agricultural food products, the United States has no national labelling policy,
and attempts by states such as Oregon to enact labelling legislations were scuppered in
the mid 2000's. See Margaret Rosso Grossman, European Community Legislation for
Traceability and Labeling of Genetically Modified Food, in LABELING GENETICALLY
MODIFIED FOOD: THE PHILOSOPHICAL AND LEGAL DEBATE 32, 32-62 (Paul Weirich ed.,
2007).
51 See Paarlberg, supra note 31, at 23.
52 However, while no distinction is made between research and regulatory science,
the quality of the science on which regulatory science is premised will be subject to
scrutiny in Parts III and IV of this essay, in order to ascertain the limits and propriety of
regulatory science vis-a-vis ethical, cultural, and religious frameworks in the governance
of transgenic plant agricultural technology.
53 According to Sheldon Krimsky et al., the United States' regulatory agencies in
the 1990s "adopted the concept of science-based policy to emphasize that science alone,
not politics or values, would be the basis of their decisions . .. to ensure that there are
not unacceptable human health and environmental risks." See Sheldon Krimsky & Nora
K. Murphy, Biotechnology at the Dinner Table: FDA's Oversight of Transgenic Food,
584 ANNALS AM. ACAD. POL. & SOC. ScI. 80, 82 (2002).
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data .... Sufficient scientific data must be available in order to
arrive at qualitative/quantitative risk estimates."54 Furthermore,
Articles 5(1) and 5(2) of the Agreement on the Application of
Sanitary and Phytosanitary Measures of the Uruguay Round (SPS
Agreement), require that all food safety measures must be based
on risk assessment and scientific evidence.
However, while the ostensible science-centric policy
disposition of regulatory science might invoke a vista of a
tyrannical or deterministic science, regulatory science is by no
means peculiar to the governance of transgenic plant agricultural
technology.56 Regulatory science is an arguably putative and
interpretive policy tool for defining, delimiting, and
deconstructing the relationship between virtually all forms of
technology and nature, a point aptly adumbrated by Robert G. Lee
as follows: "[w]hile nature is inevitably interpreted and technically
constructed through science, it is now also shaped by its
deliberative intrusion."57 Notably, regulatory science and the
policy framework through which science's "deliberative intrusion"
in, or deconstruction of, nature is often accomplished could either
be legislative or judicial." The juridical element of regulatory
science is arguably exemplified by the landmark United States
Supreme Court decision in Diamond v. Chakrabarty,59 in which
Justice Warren E. Burger, while delivering the Court's five-four
judgment held, inter alia, that a genetically modified live micro-
organism was patentable subject matter, a "manufacture or
54 See EFSA Panel on Genetically Modified Organisms, Scientific Opinion:
Guidance on the Environmental Risk Assessment of Genetically Modified Plants, 8
EFSA J, Nov. 2010, at 1, 3.
55 See Agreement on the Application of Sanitary and Phytosanitary Measures, Apr.
15, 1994, Final Act Embodying the Results of the Uruguay Round of Multilateral Trade
negotiations, Annex IA, Legal Instruments-Results of the Uruguay Round vol. 27,
available at http://www.wto.org/english/tratop e/spse/spsagr-e.htm.
56 Regulatory science is routinely employed in the governance of pharmaceuticals
and new drug development. See LEBOVITZ ET AL., supra note 33, at 5-11.
57 See Robert G. Lee, Look at Mother Nature on the Run in the 21' Century:
Responsibility, Research and Innovation, 1 Transnat'l Envtl. L. 105, 107 (2012).
58 See Taiwo A. Oriola, Ethical and Legal Issues in Singapore Biomedical
Research, II PAC. RIM L. & POL'Y J. 497, 497-529 (2002) (discussing legislative and
juridical examples of pro-biotechnology research policies).
59 See Diamond v. Chakrabarty, 447 U.S. 303 (1980).
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composition of matter" under United States patent legislation.60
The micro-organism in question was a bacterium, which had been
genetically modified to break down crude oil as a means to clean
up oil spills.6' The Office of the United States Patents
Commissioner, Sidney Diamond, had rejected a patent application
for the bacterium on grounds that living things, such as a live
bacterium, could not be patented under United States patent law.62
While rejecting the Patents Commissioner's arguments, the United
States Supreme Court held the U.S. Congress had intended
patentable subject matter to "include anything under the sun that is
made by man,"63 and that the genetically altered bacterium was "a
nonnaturally occurring manufacture or composition of matter-a
product of human ingenuity having a distinctive name, character[,
and] use."64
However, even with our ingenuity, prowess, and current
cutting-edge technological sophistication, we have yet to create
life from scratch, notwithstanding the Craig Venter Institute's
synthetic bacteria.6 5 Yet, due mainly to the pioneering
Chakrabarty decision, scientists have secured proprietary rights in
micro-organisms merely for the discovering, isolating, shuffling,
60 See id. at 309. The provision of the Patent Act that the Court was interpreting
was § 101, which provides that "[w]hoever invents or discovers any new useful process,
machine, or manufacture, or composition of matter, or any new or useful improvement
thereof, may obtain a patent therefore, subject to the conditions and requirement of this
title." 35 U.S.C. § 101 (1952).
61 See Chakrabarty, 447 U.S. at 303.
62 See id. at 306.
63 Id. at 309.
64 Id. at 309-10 (internal quotation marks omitted).
65 For example, in July 2010, Dr. Craig Venter, a synthetic biologist, and his
colleagues published a research article in Science magazine, reporting that they had
created a synthetic life, by replacing the genome of a natural cell with a different genome
created by gene synthesis, resulting in a new bacterial, which Venter and colleagues
described as "Mycoplasma laboratorium." See Daniel G. Gibson et al., Creation of a
Bacterial Cell Controlled by a Chemically Synthesized Genome, 329 SCIENCE 52, 52-56
(2010). Following the publication of the experiment, the J. Craig Venter Institute refuted
the media's suggestion that the Institute was playing God, and that the experiment was
not tantamount to "creating life from scratch." They also maintained that they had
merely created "new life out of already existing life using synthetic DNA." See First
Self-replicating Bacterial Cell: Frequently Asked Questions, J. CRAIG VENTER
INSTITUTE, http://www.jcvi.org/cms/research/projects/first-self-replicating-synthetic-
bacterial-cell/faq (last visited Oct. 1, 2013).
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and transferring of useful genes from one organism into another,
as exemplified by the Myriad Genetics' controversial patents for
isolated human breast and ovarian cancer genes.66 The
significance of the Chakrabarty decision was that it, arguably
single-handedly, opened the floodgates for patents on life, as
exemplified by subsequent proliferation of patents for mere gene
shuffling and gene transfer.6 Thus, albeit juridical, the
Chakrabarty decision exemplifies science's "deliberative
intrusion" into nature, typically via the tendentious regulatory
science and policy regime that often exhibits pro-science leanings
and biases, a stance ostensibly necessitated by the policy
imperatives for promotion of innovations and new technologies on
grounds of public interest and technological progress.68
66 Myriad Genetics and the University of Utah discovered, isolated, and patented
breast and ovarian cancer genes, which they christened BRCAl and BRCA2. They
subsequently developed diagnostic tests for which they charged over $3,000, to examine
extracted DNA from the genes for mutations that could be indicative of high
predisposition to ovarian or breast cancer. However, because the monopoly conferred by
Myriad's patents prevented other laboratories from performing similar tests, the patents
were challenged by the American Civil Liberties Union and Public Patent Foundation on
behalf of numerous medical groups, researchers and laboratories, on grounds that human
genes could not be patented because they were products of nature, and that the
consequential monopoly on diagnostic tests for breast and ovarian cancer aggravated
medical costs. In 2010, the patents were invalidated by the United States District Court,
Southern District of New York. See Ass'n for Molecular Pathology v. U.S. Patent &
Trademark Office, 702 F. Supp. 2d 181 (S.D.N.Y. 2010). However, in a subsequent
appeal filed by Myriad Genetics, the Court of Appeals for the Federal Circuit reversed
the District Court's ruling on grounds that an isolated DNA from the human body could
be patented because it was "markedly different" from the DNA inside the body. See
Ass'n for Molecular Pathology v. U.S. Patent & Trademark Office, 653 F.3d 1329 (Fed.
Cir. 2011). In a subsequent appeal to the United States Supreme Court, the Supreme
Court remanded the case to the Court of Appeals with instructions to review its decision
validating the patents in light of the new Supreme Court ruling invalidating medical
diagnostic patents in Mayo Collaborative Servs. v. Prometheus Labs., Inc., 132 S. Ct.
1289, 182 L. Ed. 2d 321 (2012). See Ass'n for Molecular Pathology v. Myriad Genetics,
Inc., 132 S. Ct. 1794, 182 L. Ed. 2d 613 (2012). For discussion, see Samantak Ghosh,
Gene Patents: Balancing the Myriad Issues Concerning the Patenting of Natural
Products, 27 BERKELEY TECH. L.J. 241, 241-72 (2012).
67 See Taiwo A. Oriola, Genes for Sale: Ethical Reflections on Donors Proprietary
Rights in Human Genetic Derivatives, in 3 ETHICS, LAW & SOCIETY 159, 166-67
(Jennifer Gunning & Soren Holm, eds., 2007).
68 Albeit juridical in nature, the Chakrabarty decision was actually premised on
the Supreme Court's interpretation of § 101 of the U.S. Patent Act, which of course is a
regulatory instrument enacted by the U.S. Congress. In the Chakrabarty decision for
example, the argument that the "invented" bacterium and similar genetic research could
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However, barring any unsavoury or blatant instrumental uses
of regulatory science for political ends, there is nothing
intrinsically wrong with regulatory science and policy as such,
primarily because it is ostensibly predicated on "science," which
has been defined as "the systematized observation of an
experiment with phenomena, [especially] concerned with the
material and functions of the physical universe,"69 or as "an
organized body of knowledge on a subject.""7 According to
Francis Bacon, experimental observation of materials and the
concomitant inductions or deductions thereof are the hallmarks of
science." Thus, observable, verifiable, and replicable scientific
knowledge arguably should be preferable to ethical, religious,
conscientious, cultural, whimsical, subjective, or idiosyncratic
rationales for regulating technological inventions,72 precisely
because of science's perceived neutrality, objectivity, rationality,
agnosticism, and relative certitude.73  This point is aptly summed
"spread pollution and disease" or "result in a loss of genetic diversity" or "depreciate the
value of human life" was dismissed by the court on grounds that only the U.S. Congress
had the legislative oversight to do so. For discussion, see Chakrabarty, 447 U.S. 303,
316-17 (1980). Thus, the Chakrabarty case demonstrates how policy objectives for
promotion of new technologies for the common good could shape the outcome of a
judicial decision. Similarly, in the Harvard Onco-mouse case, patents examiners drew
on the public benefits inherent in the advancement of cancer research, to find that the
Harvard Onco-mouse invention did not contravene the provisions of Article 53(a) of the
European Patent Convention, which excluded inventions that were contrary to public
policy, public order, or morality from being patentable. See Decision on Onco-
mouse/Harvard, 1992 O.J. EPO (10) 593; see also Oriola, supra note 58, at 497-529
(discussing deliberative and public policy-induced legislative and juridical examples of
pro-biotechnology research policies).
69 See THE OXFORD DICTIONARY AND THESAURUS, supra note 34, at 1350.
70 See id.
71 See CLAUDE BERNARD, AN INTRODUCTION TO THE STUDY OF EXPERIMENTAL
MEDICINE 6 (1957). Sir Francis Bacon, who lived between 1561 and 1626, was widely
regarded as the original philosopher of science, who "proposed a scientific method that
suspended most traditional belief in favour of a project of establishing a comprehensive
new understanding of the world." See DAVID PAPINEAU, PHILOSOPHY 96 (2009).
72 See, e.g., Case C-165/08, Comm'n v. Poland, 2009 E.C.R. 1-6843 [hereinafter
Poland]. Polish anti-transgenic seeds legislation, which prohibited the marketing of
seeds derived from genetically modified varieties and the registration of such varieties in
the national catalogue of seed varieties on ethical and religious grounds was challenged
by the European Commission. The Polish law was held violative of the provisions of
Articles 22 and 23 of the Deliberate Release Directive 2001/18/EC.
73 See Hans Radder, Science and Technology: Positivism and Critique, in A
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up by David Papineau as follows:
The uniqueness of scientific knowledge seems to derive from
two factors. First, scientific theories are not wild speculations.
Unlike theological or metaphysical claims, scientific theories are
grounded in careful observation and controlled experiment.
Second, scientific theories are very abstract. They use concepts
that are not found in common sense and explain familiar events
in terms of things we cannot see. This combination of the
observable and the theoretical is unprecedented in human
thought.74
But then the pertinent recurring question, which is at the core
of this Article, is the extent to which "science" is ultimately
reliable, objective, agnostic, or neutral in its pivotal role as the
fulcrum anchoring the regulatory and governance systems of
transgenic plant agricultural technology." After all, if the general
public were to rely on "science" to the exclusion of ethical,
religious, or cultural imperatives for regulating technologies both
76 thold and new, then the general public certainly should have
legitimate expectations of "science" to deliver a relative degree of
reliability, neutrality, and certitude in the governance of transgenic
plant agriculture and foods.n Otherwise, what would be the
COMPANION TO THE PHILOSOPHY OF TECHNOLOGY 61-65 (Jan Kyrre Berg Olsen et al.
eds., 2009) (discussing how "[s]cience and technology are seen as yielding universally
valid knowledge and objectively working tools that are normatively neutral and acquire
value only when applied for specific social purposes"). However, the author also noted
recent studies, which question science neutrality and universal validity. See id. at 61-62.
74 See PAPINEAU, supra note 71, at 98; see also ROGER A. PIELKE, JR., THE HONEST
BROKER: MAKING SENSE OF SCIENCE IN POLICY AND POLITICS 43-44 (2007) (discussing
how society tends to ascribe high value to scientific information and regard it as
authoritative, while non-scientific information is perceived negatively).
75 Even the uncertainties, which scientists acknowledge signify more than one
outcome, and which routinely dog science and scientific claims, could be framed or
measured objectively and subjectively. According to Roger A. Pielke, "[s]o long as
there exist . . . different, valid scientific perspectives, some degree of uncertainty will
always exist." Pielke, supra note 74, at 61.
76 For example, the ethical, religious, and cultural oppositional grounds to
transgenic plant agriculture and foods were discountenanced by the court in the U.S. case
of Alliance for Bio-Integrity v. Donna Shalala, 116 F. Supp. 2d 166 (2000). See also
Poland, supra note 72.
77 Indeed, it has been proven that many scientific ideas generate conflicting results,
and that not all scientific studies are replicable. See Lehrer, supra note 43; see also John
P.A. loannidis, Why Most Published Research Findings Are False, 2 PLOS MEDICINE
0696, 0696-701 (2005).
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justifications for excluding or denying those with legitimate claims
to alternative or parallel technological governance systems in
ethics, religion, or culture, which arguably are notoriously
heterogeneous and ostensibly lacking in neutrality, objectivity, and
predictability? 78 This question is particularly tangent and relevant
to any general academic inquiry into the limits and propriety of
regulatory science in the governance of transgenic plant
agricultural technology in light of the hotly contested safety
science of transgenic plant agriculture, 79 and the recent assertion
by approximately 250 members of the United States National
Academy of Sciences, in a letter published in the Science journal,
that there was always some uncertainty associated with scientific
conclusions, and that "science never absolutely proves anything."so
But then, perhaps, the hypothesis that "science never
absolutely proves anything" is explainable or justifiable by the
axiom that most published research findings, especially in the field
of genetics, are irreplicable or false.i Yet, replicability of
scientific results is crucial to the validation or affirmation of their
reliability, as aptly expressed by Jonah Lehrer as follows:
The test of replicability, as it's known, is the foundation of
modem research. Replicability is how the community enforces
itself. It's a safeguard for the creep of subjectivity. Most of the
time, scientists know what results they want, and that can
influence the results they get. The premise of replicability is
that the scientific community can correct for these flaws.82
However, aside from replicability problems inherent in most
scientific research results, the claim that "science never absolutely
78 See Papineau, supra note 71, at 98.
79 There is a plethora of literature on the dangers and promise of transgenic plant
agricultural technology. For a quintessential view on the danger of the technology, see
F. WILLIAM ENGDAHL, SEEDS OF DESTRUCTION: THE HIDDEN AGENDA OF GENETIC
MANIPULATION 22-24 (2007). For a contrarian account on the promise of the
technology, see Paarlberg, supra note 3 1, at 1-80.
80 See Peter H. Gleick et al., Letter to the Editor, Climate Change and the Integrity
of Science, 328 SCIENCE 689, 689 (2010).
81 See Lehrer, supra note 43; see also loannidis, supra note 77, at 0696-0701; see
also Ramal Moonesinghe, Muin J. Khoury & A. Cecile J.W. Janssens, Most Published
Research Findings Are False: But a Little Replication Goes a Long Way, 4 PLOS
MEDICINE 0218, 0218-21 (2007) (noting how a lack of replication in research findings
especially in the field of genetics, was due mostly to publication and selection bias).
82 See Lehrer, supra note 43.
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proves anything"8 3 could also be justified partly by the theory that
science, which typically underpins regulatory policy for
technologies, could either be "proven" science or "evolving"
science.84 For example, the science that underpins aerodynamics
technology, 5 and the constitution of human genetic material,8 6
would appear relatively settled. However, the underlying science
on the safety, toxicity, and allergenicity of transgenic plant food
products is arguably neither precise nor exact, and is at best
evolutionary, in light of pervasive scientific uncertainties,
conflicting scientific research results, contested and unresolved
scientific questions, and as yet unknown ramifications of the
advent of transgenic plant agriculture and food respectively for the
environment and public health."
Significantly, the central hypothesis in this Article, which
posits that the current underlying science on the full ramifications
of transgenic plant agriculture and food products respectively for
the environment and public health is evolutionary, is not entirely
unfounded, as scientific knowledge is arguably generally organic
and tends to be incremental and cumulative over time, despite
contrarian claims." Arguably, current scientific knowledge is
invariably built on past or cumulative scientific studies, as aptly
exemplified by the famous statement of "the greatest and most
83 See Gleick et al., supra note 80, at 689.
84 Science is generally classified into two categories: proven and evolving science.
See A. Alan Moghisi, Best Available Science: Metrics for Evaluation of Scientific
Claims, INSTITUTE FOR REGULATORY SCIENCE, http://www.nars.org/bas.html (last visited
Oct. 2, 2013).
85 Aerodynamics deals with the study of the interaction of air with solid objects,
and knowledge is crucial for designing and calculating the speed of aircrafts relative to
their weights and sizes. See JOHN D. ANDERSON, FUNDAMENTALS OF AERODYNAMICS II-
14 (5th ed. 2011).
86 It is well established that human genetic material comprises DNA, which
includes two complementary strands and undergoes transcription and translation. For
discussion, see GEORGE WEI, AN INTRODUCTION To GENETIC ENGINEERING, LIFE
SCIENCES AND THE LAW 1-53 (2001).
87 For example, with regards to allergenicity of transgenic plant foods, it is
difficult to ascertain with absolute certainty, whether a transgene protein is a potential
allergen. See Robert B. Buchanan, Genetic Engineering and the Allergy Issue, 126
PLANT PHYSIOLOGY 5, 5-7 (2001).
88 See d'Espagnat, supra note 43, at 145-51 (dismissing Kuhn's theory or its
interpretation thereof to the effect that science is not cumulative).
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influential scientist who ever lived," 9 Isaac Newton, who wrote
that "[i]f I have seen further, it is by standing on the shoulders of
the giants." 90  Moreover, the cumulative nature of scientific
knowledge is mirrored by the broad categorisation of scientific
information or knowledge into two classes: "proven science" and
"evolving science." For example, whilst the science of
aerodynamics technology facilitated the flight of the first powered
aircraft by the Wright brothers in 1903, the scientific knowledge
that underpinned their work was arguably largely predicated on
the accumulated body of knowledge garnered over time from
numerous earlier abortive experimental powered flights.92 Even
so, the science of aerodynamics technology has since progressed
considerably, as exemplified by subsequent emergence of crucial
knowledge on the interactive dynamics of aircraft designs, weight,
and speeds that inevitably impacted flight safety and performance
in the latter part of the 20th Century. 93 Thus, arguably, the science
that underpinned the supersonic Concorde airplane was far
superior to that of the first powered-aircraft flown by the Wright
brothers. But then, there is no denying that the Concorde airplane
and all modern jets incorporated and built on the basic science that
powered the Wright brothers' maiden flight. Thus, over time, the
evolving or evolutionary science that underpins aerodynamics
technology has become relatively proven or standardized, in light
of the current state of the art in civilian and military aircrafts, vis-
a-vis the state of the art of the science that underpinned
aerodynamics technology in the formative years leading up to the
epochal first powered-flight by the Wright brothers.94
89 See DANIEL S. BURT, THE BIOGRAPHY BOOK: A READER'S GUIDE TO NON-
FICTION, FICTIONAL AND FILM BIOGRAPHIES OF MORE THAN 500 OF THE MOST
FASCINATING INDIVIDUALS OF ALL TIME 315 (2001).
90 See JEAN-PIERRE MAURY, NEWTON: UNDERSTANDING THE COSMOS, NEW
HORIZON SERIES 117 (1992).
91 See Moghisi, supra note 84.
92 For discussion on the history of aviation see OCTAVE CHANUTE, PROGRESS IN
FLYING MACHINES 308 (Dover 2003).
93 See Anderson, supra note 85, at 10-37.
94 This is not to suggest that there is no scope for further improvements or
possibility for future breakthroughs in aerodynamics science, especially with regards to
hypersonic flights, aerospace technology, and safer and more efficient flights. The
aerodynamics technology example is meant to demonstrate the relative advancements of
aviation science since the Wright brothers, and to underscore the general evolutionary
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Indeed, the generally progressive and cumulative nature of the
science underlying most technological advancements is
transcendental of technology types, and not in any way peculiar to
either aerodynamics or transgenic plant technology. Moreover,
and most crucially, the central hypothesis in this article-that the
science of transgenic plant agricultural technology is cumulative,
evolving, or evolutionary, especially on its safety implications for
public health and the environment-is arguably buttressed and
exemplified by a 2012 publication on the impact of transgenic
Bacillus thuringiensis maize on non-target soil organisms." The
research revealed that transgenic Bt. maize, which was designed to
curb traditional maize foes such as the European corn borer, could
be deleterious to the populations of non-target soil organisms such
as arbuscular mycorrhizal fungi.96 Notably, the revelatory findings
were the first ever demonstration of a probable link between the
possible reduction in arbuscular mycorrhizal fungi populations and
the cultivation of transgenic Bt. maize, and contributed to the
growing and evolutionary body of knowledge on the
"unanticipated effects of Bt. crop cultivation on non-target soil
organisms."9 7
Therefore, within the context of the evolutionary or evolving
nature of the safety science underpinning transgenic plant
agricultural technology, as well as the current scientific
uncertainties pervading its full ramifications for public health and
the environment, what follows are pertinent questions, central to
the theme of this article. First, could the current contested,
unsettled, and arguably evolutionary science on the implications of
transgenic plant agriculture and new transgenic plant food toxins
and allergens respectively for the environment and public health
definitively change overtime? In other words, could future
scientific breakthroughs reveal as yet unknown adverse effects of
transgenic plant agriculture and food respectively on the
environment and public health, which could be as dramatic as the
nature of science and its resultant technology.
95 See Tanya E. Cheeke, Todd N. Rosentiel & Mitchell B. Cruzan, Evidence of
Reduced Arbuscular Mycorrhizal Fungal Colonization in Multiple Lines of Bt Maize, 99
AM. J. BOTANY 700, 700-707 (2012).
96 See id.
97 See id. at 700.
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recent findings on the probable debilitating impacts of transgenic
Bt crops on arbuscular mycorrhizal fungi populations? Second, in
light of the pervasive uncertainties dogging the long-term safety
science of transgenic plant agriculture and food respectively for
the environment and public health, should science continue to
trump alternative, albeit non-scientific, premises or rationales for
transgenic plant technology governance, including, among others,
ethical, religious, cultural, and conscientious considerations, when
the said science is notoriously susceptible to irreplicability, and
arguably neither precise nor exact, and no more than an
evolutionary work in progress? Third, assuming arguendo that the
central hypothesis in this article, which posits that the underlying
"science" of regulatory science is overly tendentious and
deterministic in its putative oversight of transgenic plant
agricultural technology is grossly exaggerated, flawed, or
unfounded, to what extent is the "science" that underpins
transgenic plant agricultural technology governance inclusive of
extraneous non-scientific values, considerations, and socio-
cultural influences? Answering these questions could arguably
highlight the strengths, weaknesses, and limits of regulatory
science, and aid policy makers to better understand the propriety
of regulatory science in the governance of transgenic plant
agriculture.
The article is divided into five parts. Part I is the introduction,
which defines and reviews the literature on the central problems.
It discusses the dilemmas inherent in regulatory science oversight
of transgenic plant agriculture focusing on the uncertainty of its
underlying science within the broader context of "the
technological society," as well as the concomitant challenges
posed by regulatory science oversight of new technologies. Part II
reviews the literature on the theory of science and the symbiotic
relationship between science and technology, with a view to
underscoring the intimate nexus between science, technology, and
policy, and, particularly, how the science of transgenic plant
agriculture ultimately informs the regulation and policy
framework for the technology. Part III examines the limits of
regulatory science for transgenic plant agriculture governance,
with specific focus on the propriety of the substantial equivalence
doctrine, the validity and reliability of the science that underpins
transgenic plant allergens and toxins, and the validity of the
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science that underpins in situ gene flow and adventitious
commingling of transgenic and non-transgenic plant materials.
The primary aim is to join issues on the propriety and limits of
regulatory science in transgenic plant agriculture governance, by
highlighting the frailty and uncertainty of its underlying science.
Part IV discusses selected case law to highlight what the Article
characterizes as science determinism or centralism, and the
ostensibly visceral grip of science over transgenic plant agriculture
policy, at the expense of alternative, albeit non-scientific
governance systems including ethical, religious, to cultural values.
Part V concludes the Article, by urging for a more inclusive
regulatory regime that takes cognizance of non-scientific
externalities and considerations in the governance of transgenic
plant agricultural technology.
II. The Science and Technology of Transgenic Plant
Agriculture
Arguably, there is no technology without an underlying
science. But then, while it may seem that modem science is
separable from its resultant technology, modern science is indeed
"instrumentally embodied" or technologically dependent.98
Therefore, in order to grasp the full ramifications of the limits of
regulatory science in transgenic plant agricultural technology
governance, it is important to review the literature on the
distinctions and dynamics between science and technology
generally. In particular, it is imperative to consider how the
underlying science of transgenic plant agricultural technology
ultimately informs the concomitant regulatory and policy regimes
for transgenic plant technology. This analysis is crucial to
understanding the role and limits of regulatory science in national
and transnational transgenic plant agricultural technology
governance.
A. Definitional, Conceptual, and Theoretical Framework for
Transgenic Plant Agriculture
Every organism, including bacteria, fungi, plants, animals, and
humans, is imbued by nature with genes, which are no more than
98 See Don Ihde, Technology and Science, in A COMPANION To THE PHILOSOPHY
OF TECHNOLOGY, supra note 12, at 52.
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"codes or messages," programmed by nature to instruct organisms
about which chemicals or proteins are needed for survival,
reproduction, and growth." Perhaps, the most ground-breaking
twentieth century scientific innovation in the field of biology, with
the most profound implications for medical and agricultural
technologies, is the ability of scientists to move genes from one
species or organism to another, across natural structural barriers
that separate, define, and distinguish species or organisms.oo The
procedure or technique for moving, recombining, or shuffling of
genes from one organism into another organism is known as
"genetic engineering,"o' and it is typically undertaken to confer a
desirable trait from one organism unto another organism. The
recipient organism typically is able to manifest the desirable trait
via the chemical produced by the transferred genes.'0 2 This
procedure is exemplified by the StarLinkTM transgenic corn
produced by Aventis CropScience Corporation, which was a
progeny of the convergence of genes between Bacillus
thuringiensis, a bacterium micro-organism, and corn, which is of
course a plant organism.o3 Bacillus thuringiensis is naturally
imbued with insecticide properties, and it is routinely used to
eliminate unwanted insects in agriculture, forests, and urban
areas.'04  Thus, scientists at Aventis CropScience Corporation
inserted proteins from Bacillus thuringiensis into the corn genome,
which imbued the corn with immunity against its traditional insect
foes, such as the European corn borer and corn earthworm, thus
99 See Reiss & Straughan, supra note 14, at 1-2.
100 See Mark L. Winston, Travels in the Genetically Modified Zone 1 (2002); see
also KLOPPENBURG, supra note 15, at 2-4 (discussing the superiority of recombinant
DNA technology over conventional plant breeding techniques, and how the new
technology was tantamount to "outdoing evolution").
101 See REISS & STRAUGHAN, supra note 14, at 1; see also Mae-Wan Ho & Lim Li
Ching, GMO Free: Exposing the Hazards of Biotechnology to Ensure the Integrity of
Our Food Supply 15 (2004).
102 REISS & STRAUGHAN, supra note 14, at 1-2.
103 For discussion on Aventis CropScience StarLinkTM corn, which was approved
by the United States Environmental Protection Agency on May 22, 1998, see Bacillus
Thuringiensis Subspecies Tolworthi Cry9C Protein and the Genetic Material Necessary
for its Production in Corn; Exemption from the Requirement of a Tolerance, 63 Fed.
Reg. 28258 (May 22, 1998).
104 For discussion on Bacillus thuringiensis, see Carrie Swadener, Bacillus
Thuringiensis (Bt), 14 J. PESTICIDE REFORM, FALL 1994, 13, 13-20.
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obviating the need for the use of insecticide.'o
Technically, genetic engineering techniques for intra and trans-
species genes transfer as typified by the process for making
StarLinkTM transgenic corn, is broadly defined as "a technique of
altering an organism's genotype by inserting genes from another
organism into its DNA."' 6  The resultant product, as in
StarLinkTM corn, is known technically as transgenic organisms,10 7
or in general parlance, as genetically modified organisms or
(GMOs).' 8 A GMO is defined by Article 2(2) of the European
Community Deliberate Release Directive 2001/18/EC as "an
organism, with the exception of human beings, in which the
genetic material has been altered in a way that does not occur
naturally by mating and/or natural recombination."'109
The European Community and similar international official
documents, such as the Food and Agriculture Organization of the
United Nations, routinely use the phrase genetically modified
organisms (GMOs) to describe transgenic plant organisms that are
products of intra and trans-species genes transfer."o However, the
term has been described as no more than a political construct, and
a variant of the strategic, systematic, subjective, and hostile
framing of transgenic plant agriculture by oppositional "epistemic
brokers" or "intermediaries of knowledge" allegedly bent on
undermining transgenic plant agriculture and stifling its
105 See Madhuri Kota, Henry Daniell, Sam Varma, Stephen F. Garczynski, Fred
Gould & William J. Major, Over Expression of the Bacillus Thuringiensis (Bt) Cry2Aa2
Protein in Chloroplasts Confers Resistance to Plants Against Susceptible and Bt-
resistant Insects, 96 PROC. NAT'L ACAD. SCI. 1840, 1840-45 (1999).
106 CHRIS PRESCOTT, OXFORD SCIENCE STUDY DICTIONARY 101 (1999).
107 See Ronald J. Herring, Epistemic Brokerage in the Bio-property Narrative:
Contributions to Explaining Opposition to Transgenic Technologies in Agriculture, 27
NEW BIOTECHNOLOGY 614, 614-22 (2010) (expressing preference for transgenic
technology for its neutrality in describing products of Recombinant DNA technologies,
rather than GMOs, which is a "political terminology").
108 The term GMOs is used by Article 2(2) of Directive 2001/18/EC of the
European Parliament and of the Council, of 12 March 2001, on the deliberate release into
the environment, of genetically modified organisms. See Council Directive 2001/18/EC,
art. 2(2), 2001 O.J. (L 106) 1, 4.
109 See id.
110 See id.; see also Food and Agriculture Organization of the United Nations,
Weighing the GMO Arguments, FAONEWSROOM (Mar. 2003), http://www.fao.org/
english/newsroom/focus/2003/gmo8.htm.
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concomitant promise and potential contribution to human
development."' For instance, while affirming preference for the
term "transgenic organisms," due to its supposedly neutral and
apolitical connotations,'1 2 Ronald J. Herring decried what he
considered as negative, inflammatory, or discriminatory political
connotations inherent in the use of the terms "genetically modified
organisms" or "GMOs":
The GMO is political shorthand for any agricultural product
involving recombinant DNA (rDNA) techniques; its success as a
cognitive frame is such that even proponents of genetic
engineering in agriculture accept this political terminology. The
frame does not apply to rDNA techniques in pharmaceuticals,
medicine or industry, where transgenics have been globally
accepted."13
In this article, the term "transgenic" plant agriculture is
preferred to "genetically modified organism" or "GMOs,"
precisely in order to transcend the alleged political and negative
connotations attributed to these terms, and the increasingly deeply
partisan nature of the debates that have come to characterize recent
scholarship on the legal, ethical, and scientific proprieties of the
use of recombinant rDNA technology in plant agriculture.1'
Indeed, as Ronald J. Herring rightly noted, genetic engineering is
widely used and unquestioningly accepted in medicine,
pharmaceuticals, and numerous industrial applications,"' and it
remains the arrowhead of modem biotechnology, which the
Cartagena Protocol on Biosafety defines as the application of:
[i]n vitro nucleic acid techniques, including recombinant
deoxyribonucleic acid (DNA) and direct injection of nucleic
acid into cells, or [. . .] [fjusion of cells beyond the taxonomic
family, that overcome natural physiological reproductive or
I One of the prominent critics of opponents of transgenic plant agriculture is
Ronald J. Herring, a resolute believer in the promise and potentials of transgenic plant
agriculture to eradicate hunger in poor and developing countries, who strongly believes
that anti-transgenic plant agriculture activists are undermining the technology and its
potentials by disseminating exaggerative and inflammatory knowledge, which invoke
negative connotations. For discussion, see Herring, supra note 107, at 614-15.
112 See id. at 614-15, 618.
113 Id. at 614-15.
114 See id.
115 See id.
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recombination barriers and that are not techniques used in
traditional breeding and selection." 6
In the same vein, a 1984 definition by the United States
Congressional Office of Technology conceptualises modem
biotechnology as "any technique that uses living organisms (or
part of organisms) to make or modify products, to improve plants
or animals, or to develop microorganisms for specific uses."' 17
Historically, modem biotechnology, as opposed to traditional
biotechnology," 8 dates from the mid-1970's and involves the use
of genetic engineering techniques'' 9 to shuffle or transfer genes
between and among plant and animal species, with the aim of
passing on certain desirable hereditary traits to the host plants or
animals.'2 0 in plant agriculture, for example, such hereditable
desirable traits range from delayed fruits-ripening,121 drought
116 Cartagena Protocol on Biosafety to the Convention on Biological Diversity art.
3(i), Jan. 29, 2000, 2226 U.N.T.S. 208. The Protocol was made pursuant to Articles
8(g), 17, and 19, paragraphs 3 and 4, of the 1992 Rio Convention on Biological
Diversity. See Convention on Biological Diversity arts. 8(g), 17, 19, June 9, 1992, 1760
U.N.T.S. 79.
117 See CONGRESSIONAL OFFICE OF TECHNOLOGY ASSESSMENT, COMMERCIAL
BIOTECHNOLOGY: AN INTERNATIONAL ANALYSIS 3 (1984).
118 Traditional biotechnology comprises centuries' old practices of plant and animal
domestication, selection, breeding, and the use of microorganisms in the production of
beer, wine, bread, yogurt, and cheese. See REISS & STRAUGHAN, supra note 14, at 2-5.
For example, traditional plants breeding dates from over 10,000 years ago, and
precipitated the evolution of thousands of land races in several plants species. Land
races have been defined as "genetically variable populations that exhibit different
responses to pests, diseases, and fluctuations in environmental conditions." Genetic
diversity in land races, which emanated from the complex interactions between artificial
selection, natural selection, and plants cultivation outside of their centre of origin, was to
become the very foundation of modern agriculture. See KLOPPENBURG, supra note 15, at
46. See STEPHEN NOTTINGHAM, EAT YOUR GENES, How GENETICALLY MODIFIED FOOD
Is ENTERING OUR DIET 10-26 (2d ed. 2003); see also CARY FOWLER, UNNATURAL
SELECTION: TECHNOLOGY, POLITICS, AND PLANT EVOLUTION 3 (1994).
119 See REISs & STRAUGHAN, supra note 14, at 2.
120 See NOTTINGHAM, supra note 118, at 10-26.
121 In 1994, the United States Food and Drug Administration approved the first
transgenic plant food, which was a transgenic tomato with the trade name of "Flavr
Savr." The DNA sequence of the key gene: the polygalacturonase enzyme, which is
responsible for "the degradation of pectin and the initiation of ripening" in the tomato
had been reversed via a process known as "antisense technology" in order to slow down
the rate of ripening. For discussion, see Krimsky & Murphy, supra note 53, at 81.
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tolerance, 122 to pest and herbicide resistance properties. 123  The
technique of genetic engineering or modem biotechnology was
first successfully pioneered in 1973, when Stanley Cohen of
Stanford University and Herbert Boyer of the University of
California, San Francisco, used restriction enzymes,12 4  to
successfully splice "a DNA sequence from one organism into
bacteria plasmid DNA, and then [used] the properties of the
plasmid to insert the gene into an Escherichia coli bacterium,
where [the transferred gene] was successfully expressed."l 25 The
feat earned the duo a U.S. patent in 1980 and precipitated a genetic
engineering revolution and patent gold rush, as industry and
university laboratories became embroiled in the highly
competitive and lucrative race to discover and shuffle useful and
desirable hereditable genetic information between higher and
lower organisms into microbes and vice versa.126  Indeed, the
genetic engineering technique pioneered by Cohen and Boyer was
first used commercially in the field of medicine in 1982, when the
United States Food and Drug Administration (FDA) gave approval
for the use of human insulin, produced by a genetically modified
bacterium.127 This was swiftly followed by genetically engineered
animals, such as Dolly the sheep,128 and genetically engineered
agricultural crops, such as Bt maize, soybeans, and canola, which,
122 See PAARLBERG, supra note 31, at 149-77 (discussing the usefulness of drought-
tolerant transgenic plant crops especially in Africa).
123 Examples of pest-resistant transgenic food crops include Bt. maize, Bt.
soybeans, and Bt. canola, all of which had nucleic acid proteins from Bacillus
thuringiensis, a bacterium that is naturally toxic to pests, grafted into their genome. See
Taiwo A Oriola, Consumer Dilemmas: The Right to Know, Safety, Ethics, and Policy of
Genetically Modified Food, 2002 SING. J. LEGAL STUD. 514, 516 (2002).
124 Restriction enzymes are culled from bacteria and are used by bacteria as a
natural defence mechanism against invading viruses. Scientists employ restriction
enzymes as "molecular scissors" to cut out DNA strands with accuracy and precision.
See Wei, supra note 86, at 28.
125 KLOPPENBURG, supra note 15, at 193-94.
126 See id.
127 See PAARLBERG, supra note 31, at 10-11.
128 Dolly the sheep was a domestic sheep, and the first mammal to be cloned from
an adult somatic cell, using the genetic engineering technique of nuclear transfer. For
discussion, see I. Wilmut, A. E. Schnieke, J. McWhir, A. J. Kind & K. H. S. Campbell,
Viable Offspring Derived from Fetal and Adult Mammalian Cells, 385 NATURE 810,
810-13 (1997).
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first debuted commercially in 1996 in North America, Argentina,
and Europe. 129
Perhaps the most significant difference between traditional
plant breeding technique and plant genetic engineering technique
is the latter's capability for trans-species genes transfer, a feat that
is patently beyond conventional plant breeding technique. 3 0 Thus,
due mainly to its inherent capability to breach "the walls of
speciation," plant genetic engineering breeding technique
surpasses, and is qualitatively superior to conventional plant
breeding methodology, which is inherently limited by sexual
compatibility constraints.13 ' This superiority is two-dimensional.
First, genetic engineering operates at the cellular and molecular
levels. 3 2  Second, genetic engineering technique dispenses with
sexual reproduction and allows for the transfer of genes between
totally unrelated organisms.'33 A typical example of trans-species
gene transfer is the transgenic Bt maize, which was genetically
modified to carry genes from Bacillus thuringiensis bacterium, in
order to avoid the use of "synthetic pesticides for the control of
certain caterpillars."l 34
Thus, in the context of transgenic plant agricultural
technology, the underlying science covers not only the production
process for the technology in accordance with the technique
pioneered by Cohen and Bayer or any of its modem variants,3 3 but
129 See PAARLBERG, supra note 31, at 12; see also KLOPPENBURG, supra note 15, at
296.
130 Norman W. Thorson, International Trade in Genetically Altered Agricultural
Products: Impact of the Biosafety Protocol, in AGRICULTURE AND INTERNATIONAL TRADE
LAW, POLICY AND THE WTO 239, 240 (Michael N. Cardwell, Margret R. Crossman &
Christopher P. Rogers eds., 2003).
131 See KLOPPENBURG, supra note 15, at 2-3, 192.
132 Id. at 3.
'33 Id.
134 Id. at 315.
135 See id. at 193-94. In plant genetic engineering, for example, at least two
different methods are used to transfer DNA into plants. Alan McHughen, Learning from
Mistakes: Missteps in Public Acceptance Issues with GMOs, in WHAT CAN
NANOTECHNOLOGY LEARN FROM BIOTECHNOLOGY: SOCIAL AND ETHICAL LESSONS FOR
NANOSCIENCE FROM THE DEBATE OVER AGRIFOOD BIOTECHNOLOGY AND GMOs 38
(Kenneth David & Paul B. Thompson eds., 2008). The first is a biological method that
uses a bacterium known as Agrobacterium tumefaciens as a naturally occurring genetic
engineering agent. Id The second possible method comprises "a purely physical
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includes the safety science governing the use of the technology to
protect public health and the environment, which ranges from
allergen and toxin reduction to combating in situ gene flow
between transgenic and non-transgenic plants in the wild.13 6 In
other words, the underlying science of transgenic plant agricultural
technology would range from understanding plant recombinant
deoxyribonucleic acid (rDNA); the technique of gene transfer
from a donor plant or micro-organism to the cell or genome of a
host plant;137 to safety issues, such as the management of
transgenic plant food allergens and toxins, as well as the stemming
of gene flow between transgenic and non-transgenic plants. A
fortiori, the science of transgenic plant agricultural technology is
divisible into two broad categories: the scientific knowledge that
underpins the production process for transgenic plant crops and
that which underpins environmental and public health safety. The
following section, will consider the theoretical and conceptual
distinctions between science and technology. Then, the Article
will further explore the interactive dynamics between the science
and technology of transgenic plant agriculture, focusing on how
the former ultimately impacts the regulatory and policy framework
of the latter.
B. Theorising Science and Technology: A Separate,
Separable, and Symbiotic Relationship
Deconstructing the interactive dynamic between "science" and
its resultant "technology" is imperative to unraveling how the
underlying science of a technology ultimately informs the
regulatory and policy framework for that technology. Thus, in
order to understand how the current governance systems for
transgenic plant technology work, it is imperative to examine the
nature of its underlying science, which is far from settled and often
contested by scientists working in the field.'38 Even so, the
method" involving "biolistic or particle acceleration." Id.
136 See Carol Mallory-Smith & Maria Zapiola, Gene Flow from Glyphosate-
Resistant Crops, 64 PEST MGMT. Sci. 428, 428 (2008) (discussing how one of the
challenges posed by transgenic plant agriculture to the environment is in preventing
adventitious commingling of genes between transgenic and non-transgenic plant in the
wild).
137 See KLOPPENBURG, supra note 15, at 193-94.
138 See infra Sec. II, pt. c (providing an analysis on the contested science of
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underlying science of transgenic plant technology continues to
trump possible non-scientific governance systems that include
ethical or cultural imperatives, as exemplified by Alliance for Bio-
integrity v. Donna Shalalal39 and the Commission of the European
Communities v. Republic of Poland.14 0 Thus, within the general
context of the discourse on science and technology scholarship,
this section seeks to highlight how the interactive dynamics of the
relationship between the science and technology of transgenic
plant ultimately informs the governance systems for the
technology.
Arguably, the relationship between science and technology is
at once separate, separable, and symbiotic. The symbiotic element
of the relationship is implicit in their definitions. "Science"
simultaneously connotes knowledge and the pursuit of knowledge
in a way that is "systematic and formulated" and is often used
synonymously with "natural and physical science."1 4 1  Thus,
scientific theories are markedly different from ethical, theological
or metaphysical claims because they are subject to controlled tests,
experiments, and observation.142  However, in contradistinction,
"technology" is defined as "the application of scientific knowledge
for practical purposes." 43  Therefore, science would appear to
embody the knowledge that ultimately finds practical expression
in technology. But then, technology historians have always
opined that technology transcends science "ontologically and
epistemologically" and that technology "is not merely applied
science. "l44 Even so, the distinction between science and
transgenic plant technology).
139 See Alliance for Bio-Integrity v. Donna Shalala, 116 F. Supp. 2d 166 (D. D.C.
2000) (granting deference to an agency policy that merely stated that genetically
engineered foods were presumptively not harmful, thereby denying any impingement on
plaintiff coalition's rights).
140 See Poland, supra note 72, at 220/10 (rejecting national legislation which
prohibited the marketing of genetically modified seed varieties).
141 THE OXFORD DICTIONARY AND THESAURUS 746 (American ed. 1996). Natural
sciences is defined as "sciences used in the study of the physical world." Id at 550.
Physical science is defined as "sciences used in the study of inanimate natural objects."
Id. at 621.
142 See PAPINEAU, supra note 71, at 98.
143 The Oxford Dictionary and Thesaurus, supra note 34, at 860 ("Study or use of
the mechanical arts and applied sciences.").
144 Thomas J. Misa, History of Technology, in A COMPANION To THE PHILOSOPHY
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technology often is not clear-cut, and overlap conceptually and
symbiotically, as demonstrated by the following definition of
"technology" by the United Nations Conference on Trade and
Development (UNCTAD): "[t]echnology is bought and sold as
capital goods including machinery and productive systems, human
labour usually skilled manpower, management and specialised
scientists. Information of both technical and commercial character,
including that which is readily available, and that subject to
proprietary rights and restrictions."' 4 5
Indeed, modem conception of technology now routinely uses
"technology interchangeably with know-how," especially in the
context of technology transfer discourse.14 6  This is again
exemplified by the term "techno-science," a hybrid concept
embodying science and technology, which is favored by
contemporary science and technology scholars.147 Perhaps these
scholars, such as Bruno Latour, who coined the concept
"technoscience," were persuaded by the ostensible symbiotic
relationship and overlapping concepts of science and
technology, 4 8 which is aptly framed by Martin Heidegger as
follows:
It is said that modem technology is something incomparably
different from all earlier technologies because it is based on
modem physics as an exact science. Meanwhile we have come
to understand more clearly that the reverse holds true as well:
[m]odem physics, as experimental, is dependent upon technical
apparatus and upon progress in the building of apparatus.149
Thus, while technology may have historically predated modem
science historically,' modem science, such as physics and
OF TECHNOLOGY, supra note 12, at 7.
145 Richard Li-Hua, Definitions of Technology, in A COMPANION To THE
PHILOSOPHY OF TECHNOLOGY, supra note 12, at 19.
146 Id
147 See Don lhde, Technology and Science, in A COMPANION To THE PHILOSOPHY
OF TECHNOLOGY, supra note 12, at 51.
148 See Kristian Hvidtfelt Nielsen, We Have Never Been Scientists, 67 ANNALS OF
Sci. 561, 561 (2010), available at http://www.tandfonline.com/doi/pdf/10.1080/0003
3790902788055.
149 HEIDEGGER, supra note 18, at 14.
150 See DON IHDE, Technology and Science, in A COMPANION To THE PHILOSOPHY
OF TECHNOLOGY, supra note 12, at 52 (noting that Homo sapiens, or our pre-modem
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genetics, are said to be "instrumentally embodied" or
technologically dependent."' For example, in the field of
biotechnology, geneticists are heavily reliant on "interventional"
microscopic instrumentations for key experiments such as "gene
splicing,"'5 2 without which it would be impossible to create
transgenic organisms, such as the Chakrabarty bacterium'53 or
transgenic crops, such as Bt. maize.'5 4 However, while the
relationship between science and technology may be symbiotic
and interdependent, the two concepts are arguably notionally and
theoretically separable. Thus, within the specific context of
transgenic plant agricultural technology for example, the
underlying science would be the knowledge of plant rDNA
techniques used in transference, recombination, or modification of
genes, while the technology would be the resultant transgenic
crops that are born out of the application of the knowledge of plant
rDNA techniques.'
Significantly, the underlying knowledge or science of
technology also informs best practices for optimal functionality
and safety, which is typically built into the technology with
accompanying operational manuals (i.e. washing machines) or
prescription medications that include instructions for prescribed
doses, drug interactions, and general usage.15 Even then, despite
rigorous pre-market trials for new medicine, safety is not always
guaranteed, as exemplified by the Thalidomide fiasco"' and the
ancestors, are believed to have used various technologies for more than a million years
prior to the advent of modern humans).
'51 Id
152 Id. at 53.
153 See Chakrabarty, supra note 59, at 305 (noting the significant value of this
genetically engineered bacterium because of its capability of breaking down components
of crude oil).
154 See KLOPPENBURG, supra note 15, at 193-94 (providing a brief overview on
biotechnology and how genetic engineers routinely transfer genes from one organism
into another organism).
155 See id It is important to note that "science" and "knowledge" are used
synonymously and interchangeably in this context.
156 See SALLY ROBINSON, ET AL., EMERGING SAFETY MEASURES: WORKSHOP
SUMMARY 1 (2008) (exploring the application of innovative technologies to the
assessment of drug safety), available at http://www.nap.edu/
openbook.php?record id= 11975.
157 In the early 1960s, pregnant women who took the Thalidomide drug to combat
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post-market withdrawal of ten new pharmaceutical drug products
between 2000 and 2006 by the FDA on safety concerns.'
Thus, as with pharmaceuticals, transgenic plant agricultural
technology products also have inbuilt safety science systems and
accompanying operational manuals on its manufacturing process,
cultivation, handling, and transportation in order to safeguard
public health and obviate in situ adventitious commingling with
non-transgenic crops in the wild.15 9 With regards to safety science,
for example, transgenic food crops are deemed to be substantially
equivalent to, and no different from, non-transgenic food crops. 160
According to the FDA policy statement on the substantial
equivalence doctrine, the methods of genetic engineering
technique in plant agriculture are "extensions at the molecular
level" of traditional plant breeding and should therefore be
regulated in an equivalent manner.161 The hotly contested
substantial equivalence doctrine 62 is ostensibly premised on the
assumption that the science underpinning the transfer of rDNA
between plant and non-plant species, and the production process of
transgenic crops, is no different from traditional or conventional
morning sickness gave birth to physically deformed children. Frederick Dove, What's
happened to the Thalidomide babies? BBC WORLD SERVICE (Nov. 3, 2011),
http://www.bbc.co.uk/news/magazine-15536544 (reporting on the physically deformed
children that were born to pregnant women in the early 1960's as a result of taking the
Thalidomide drug to combat morning sickness).
158 ROBINSON ET. AL., supra note 156, at 1.
159 See Field Testing of Plants Engineered to Produce Pharmaceutical and Industrial
Compounds, 68 Fed. Reg. 11337, 11337-40 (proposed Mar. 10, 2003) (to be codified at
7 C.F.R. pt. 340).
160 In the United States, the federal government regulates "biotechnology
products," including transgenic crops and foods, through a policy guidance known as the
Coordinated Framework for Regulation of Biotechnology, 51 Fed. Reg. 23302 (June 26,
1986). The policy was announced by the President's Office of Science and Technology
in 1986, and was subsequently amended in 1992. Michael Baram, Governance of GM
Crop and Food Safety in the United States, in GOVERNING RISK IN GM AGRICULTURE 15,
26 (Michael Baram & Mathilde Bourrier eds, 2011). Crucially, one of the policy
assumptions in the Coordinated Framework is the principle of substantial equivalence,
which posits that transgenic crops and products "should be subject to no greater degree
of oversight than was a comparable organism or product previously used in a past safe
introduction in a comparable target environment." Id at 28.
161 Statement of Policy: Foods Derived from New Plant Varieties, 57 Fed. Reg.
22987 (May 29, 1992).
162 See infra Part III.
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plant breeding techniques.163  Thus, arguably, the "substantial
equivalence" doctrine seeks to give safety assurances regarding
the science underpinning transgenic crops cultivation and
consumption respectively for the environment and public health.164
This again raises the question: How reliable, objective, or certain
is this science, which largely informs regulatory and policy
framework for transgenic plant technology? The following section
will assay an answer by exploring the contentious scientific
opinions on the safety science of transgenic plant technology with
respect to public health and the environment. It will also consider
how the underlying contested science has informed and continues
to shape the differing regulatory and policy regimes in the United
States and the European Union.
C. Transgenic Plant Agriculture: Contested Science,
Contested Technology
Transgenic plant agricultural technology is one of the most
hotly contested of contemporary technologies. Disagreements
amongst scientists are rife, typically polemical, and often
acrimonious, with opposing sides entrenched in their views."'
163 See Paul R. Billings & Peter Shorett, Coping with Uncertainty: The Human
Health Implications of GE Foods, in GENETICALLY ENGINEERED CROPS: INTERIM
POLICIES, UNCERTAIN LEGISLATION 75, 75-79 (lain E. P. Taylor ed., 2007) (noting how
the "substantial equivalence" doctrine was used to justify the launching of transgenic
foods into the market without long-term nutritional and toxicological testing on animals).
164 With regards to pre-empting adventitious commingling of transgenic and non-
transgenic crops for example, regulators had to draw on the science underpinning plant
pollination and reproduction processes. For example, the United States Department of
Agriculture policy guidelines on on-farm separation distances between transgenic crops
fields and non-transgenic crops and plants, is ostensibly premised on scientific
knowledge on plants' sexual reproduction systems and the behaviour of the pollinating
agencies of natural reproduction systems such as butterflies, birds, winds, etc. Field
Testing of Plants Engineered to Produce Pharmaceutical and Industrial Compounds,
supra note 159, at 11337-40. For example, the amended United States Department of
Agriculture's guidelines on experimental field testing for transgenic pharmaceutical corn
crop, inter alia requires that the size of the perimeter fallow zone around a trial field must
be fifty feet and that no corn should be grown within one mile (5,280 feet) of the trial
field throughout the duration of any field test, which involves open-pollinated corn. See
id
165 See Herring, supra note 23, at 2 (noting that some scientists are deeply troubled
by transgenic plant agriculture, due to "specifiable 'known unknowns' - horizontal gene
flow, allegenicity from novel proteins - and almost certainly unknown unknowns' as
well").
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Indeed, a cursory look at the literature since the 1996 commercial
debut of transgenic crops 6 6 reveals a dramatic and eclectic mix of
titles that are symptomatic of the charged and polemical discourse
on environmental and public health risks posed by transgenic plant
crops: Seeds of Destruction: The Hidden Agenda of Genetic
Manipulation;167 Genetic Roulette: The Documented Health Risks
of Genetically Engineered Foods;'6 1 Seeds of Contention: World
Hunger and the Global Controversy over GM Crops;'6 9 Seeds of
Deception: Exposing Corporate and Government Lies about the
Safety of Genetically Engineered Food;'0 Genetically Modified
Food: A Short Guide for the Confused;' GMO Free: Exposing
the Hazards of Biotechnology to Ensure the Integrity of Our Food
Supply;'7 2 and Genes, Trade, and Regulation: The Seeds of
Conflict in Food Biotechnology.'7 3  Notably, the palpable
polemics, contestations, tensions, and dissents inherent in the
literature, are generally reflective of the opinions in wider
society.' 74
Even academic researchers and scientists, who are routinely
caught up in the transgenic plant agriculture polemics, are neither
above the fray nor immune from the typically partisan and stifling
166 See PAARLBERG, supra note 31, at 10-11 (noting that genetically engineered
crops was first accomplished in a laboratory in 1973 and soon thereafter found
"commercial applications in medicine"); see also KLOPPENBURG, supra note 15, at 296.
167 See ENGDAHL, supra note 79, at 341.
168 See JEFFREY M. SMITH, GENETIC ROULETTE: THE DOCUMENTED HEALTH RISKS
OF GENETICALLY ENGINEERED FOODS 319 (2007).
169 See PINSTRUP-ANDERSEN & SCHIOLER, supra note 10, at 164.
170 See JEFFREY M. SMITH, SEEDS OF DECEPTION: EXPOSING CORPORATE AND
GOVERNMENT LIES ABOUT THE SAFETY OF GENETICALLY ENGINEERED FOOD 254 (2004).
171 See ANDY REES, GENETICALLY MODIFIED FOOD: A SHORT GUIDE FOR THE
CONFUSED 248 (2006).
172 See Ho, supra note 35, at 133.
173 See THOMAS BERNAUER, GENES, TRADE, AND REGULATION: THE SEEDS OF
CONFLICT IN FOOD BIOTECHNOLOGY 229 (Princeton Univ. Press ed., 2003).
174 Quite apart from the open hostility and resistance to transgenic plant agriculture
and foods in Europe, there are pockets of resistance even in the United States as
exemplified by the aborted transgenic plant food labelling law in the State of Oregon in
2003, and the failed judicial challenge to the governance systems for transgenic plant
agriculture and foods. Alliance for Bio-Integrity v. Donna Shalala, 116 F. Supp. 2d 166
(D. D.C. 2000); see also PAARLBERG, supra note 31, at 17-23 (discussing how ninety-
four percent of Americans polled in a 2003 survey showed preference for labelling of
transgenic plant food products).
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discourse. This is because unfavourable research outputs
perceived as "bad science" could effectively truncate a burgeoning
or promising academic career,17 1 or be retracted dramatically by
editors or publishers,'7 6 or be rebutted vigorously by opponents.'"
Also, there are abiding suspicions that research results are
routinely skewed in favor of the funding industry or agency; 7 1
research institutes have had their experimental transgenic plant
fields picketed, threatened and trashed,'7 9 and transgenic crops
scientists have succumbed to pressure to terminate open field
175 For example, Dr. Arpad Pusztai controversially lost his job due to an alleged
"premature release of flawed research data on the toxicity of GM potatoes," while
Ignacio Chapela of the University of California, Berkeley, allegedly forfeited his tenure
for "publishing a faulty paper on Bt maize." S. Shantharam, S. B. Sullia & G.
Shivakumara Swamy, Peer Review Contestations in the Era of Transgenic Crops, 95
CURRENT SCIENCE 167, 168 (2008).
176 Id
177 In 1999, for example, a report demonstrated that nearly half of the monarch
butterfly caterpillars that ate leaves dusted with transgenic Bt Maize pollen died within 4
days. John E. Losey, Linda S. Rayor, & Maureen E. Carter, Transgenic Pollen Harms
Monarch Larvae, 399 NATURE 214 (1999). The highly controversial report prompted
further research funded by industry and government, and by 2001, six papers were
published, which effectively neutered the 1999 report by concluding that most common
types of Bt maize pollen were not toxic to monarch larvae in concentrations that the
insects would encounter in the wild, and that Losey and colleagues had used higher
concentrations of Bt maize pollen. See id.; see also "Bt or not Bt: Is that the question?"
98 PROC. NAT'L ACAD. ScL. 12328, 12328-30 (2001).
178 For example, the strong pro-transgenic crops stance of The Royal Society of the
United Kingdom (founded in 1660 and thus the world's oldest scientific organisation)
has been attributed to the alleged millions of pounds in funding from major agricultural
biotechnology companies. The organisation's strong support for transgenic agriculture is
reputedly exemplified by numerous pro-transgenic crops publications, and particularly
the attacks on the unfavourable research outputs of Dr. Arpad Pusztai on the deleterious
effects of transgenic potatoes on rats. See REES, supra note 171, at 43-44. Also, there
are concerns that industry scientists who conduct safety assessments of new transgenic
crops for government on a voluntary basis, are usually unwilling to submit their research
for wider scientific review. See BILLINGS & SHORETr, Coping with Uncertainty: The
Human Health Implications of GE Foods, in GENETICALLY ENGINEERED CROPS: INTERIM
POLICIES, UNCERTAIN LEGISLATION, supra note 163, at 75.
179 See Clive Cookson, Food Battle Looms on Hertfordshire Fields, FINANCIAL
TIMES (May 25, 2012), http://www.ft.com/intl/cms/s/0/e69684d2-9cfl-1 lel-9327-
00144feabdcO.html#axzz2gH6MTrjF (describing how anti-transgenic crops activists
planned "mass action against genetically modified wheat" at Hertfordshire, where
scientists were experimenting genetically engineered wheat plants that could resist aphid
pests).
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trials of promising transgenic crops.'
Indeed, contemporary scientific research into transgenic plant
agriculture is so perilous that no active participant could be
guaranteed "a quiet life."'"' For example, David Schubert, a cell
biologist at the Salk Institute in La Jolla, California, was pilloried
for his 2002 commentary in Nature Biotechnology Journal,182
which opined that the potential unintended molecular effects and
implications of inserting novel genes into plant cells were not
given sufficient attention.'" David Schubert later reflected that
"[p]eople who look into safety issues and pollination and
contamination issues get seriously harassed."' 8 4  In a related
development, an attempt was made to suppress the publication of
Bruce Tabashnik's 2008 paper, which addressed how the
evolution of insect resistance threatened the success of transgenic
crops producing Bacillus thuringiensis toxins designed to combat
traditional pests, such as the European corn borer.' Prior to the
publication of the paper, Bruce Tabashnik had received an email
from William Moar, an entomologist at Auburn University,
warning that the paper would give anti-transgenic crops brigade
the ammunition to attack the technology.'86 However, following
the publication of Tabashnik's paper in Nature Biotechnology
Journal in February 2008, William Moar, criticized the paper at
conferences' and in a swift rejoinder in Nature Biotechnology
180 See Quirin Schiermeier, German Universities Bow to Public Pressure Over GM
Crops, 453 NATURE 263, 263 (2008) (discussing how two German universities pulled the
plug on field trials of transgenic maize crops due to aggressive picketing and threats
from anti-transgenic agriculture activists, who had the full support of the local
population).
181 Emily Waltz, GM Crops: Battlefield: Papers Suggesting that Biotech Crops
Might Harm the Environment Attract a Hail of Abuse From Other Scientists, 461
NATURE 27, 27 (Sept. 3, 2009).
182 See David Schubert, A Different Perspective on GM Food, 20 NATURE
BIOTECHNOLOGY 969, 969 (2002).
183 Id
184 Waltz, supra note 181, at 28.
185 See Bruce E. Tabashnik, Aaron G. Gasmann, David W. Crowder & Yves
Carriere, Insect Resistance to Bt Crops: Evidence Versus Theory, 26 NATURE
BIOTECHNOLOGY 199 (2008).
186 See Waltz, supra note 181, at 30.
187 Id. William Moar has since swapped academia for the laboratory of Monsanto,
a transgenic Bacillus thuringiensis crops manufacturer based in St. Louis, Missouri,
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Journal,'" challenged the methodology, validity, accuracy, and
reliability of Tabashnik's paper. Moar claimed that the
conclusions were scientifically unsound because they were based
on laboratory measurements, rather than on field studies, where
proof of insect resistance could be best measured and assessed.18 9
However, in his response to Moar's rejoinder, Tabashnik
contended that the "rigorous analysis in our paper was based on
systematic, objective analysis of all of the relevant data."' 90
Whilst constructive criticisms of scientific research are an
integral and validating feature of the peer-review system, the
scathing criticisms against research perceived as unfavourable,
often bordered on personal attacks, as exemplified by the hostile
reception and subsequent rebuttals to Rosi-Marshall's paper on the
negative effects of transgenic Bacillus thuringiensis maize on
caddis-fly larvae and the ecosystems.' 9' The Rosi-Marshall's
paper was critically panned by fellow scientists who branded her
two-year research as "bad science,"l 92 with accompanying, albeit
unfounded, insinuations of scientific misconduct.' 93  Rosi-
Marshall, who was then a stream ecologist at Loyola University
Chicago, Illinois, and her colleagues had spent two years studying
twelve streams in northern Indiana, where transgenic maize
designed to express insecticidal toxins from Bacillus thuringiensis,
was extensively cultivated.19 4 Rosi-Marshall et al. then discovered
that the twelve streams under study were strewn with leaves,
pollen, stalks, and cobs from transgenic Bacillus thuringiensis
maize.' 95 In subsequent laboratory studies, the researchers found
that caddis-fly larvae (herbivorous stream insects), which "fed
only on Bt maize debris[,] grew half as fast as those that ate debris
USA.
188 William Moar et al., Field-evolved Resistance to Bt Toxins, 26 NATURE
BIOTECHNOLOGY, 1072, 1072-74 (2008).
189 Id. at 1072.
190 See Waltz, supra note 181, at 30.
191 See E.J. Rosi-Marshall et al., Toxins in Transgenic Crop By-products May Affect
Headwater Stream Ecosystems, 104 PROC. NAT'L ACAD. SCI. 16204, 16204-08 (2007).
192 See Waltz, supra note 181, at 28.
193 Id. at 28-29.
194 See id. at 27.
195 See id.
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from conventional maize." 9 6 Furthermore, caddis flies that were
"fed high concentrations of Bt maize pollen died at more than
twice the rate of caddis flies fed non-Bt pollen."l97 Rosi-Marshall
et al. then concluded that transgenic Bt. maize "may have negative
effects on the biota of streams in agricultural areas," and that
"widespread planting of Bt. crops has unexpected ecosystem-scale
consequences."' 98
Even though the Rosi-Marshall et al. paper was not the first to
study the possible deleterious effects of transgenic Bt. crops on the
environment and the ecosystems,"' the ensuing negative
rejoinders and hostile rebuttals in six letters sent to the editor of
the Proceedings of the National Academy of Sciences of the United
States of America, by a dedicated alliance of pro-transgenic plant
agriculture academics and researchers, was simultaneously
predictable, hostile, and ad hominem.200 Amongst numerous
pejoratives deployed in the negative rebuttals, the Rosi-Marshall
paper was branded as a "sloppy experimental design" that was "so
bad that an undergrad would have done a better job."2 0 ' Also, the
piece was branded as "an idiotic experiment,"20 2 whilst its
conclusions were described as "dubious" and "arguably
amount[ing] to investigator misconduct." 20 3  In the Journal of
Current Science, the Rosi-Marshall paper was described as
"offen[sive]" and liable to be used by anti-transgenic plant
agriculture activists to "hamper the progress of science."2 04
But then, these hostile responses were predictable and
196 Id.
197 Id.; see also E.J. Rosi-Marshall et al., supra note 191, at 16204-08.
198 See E.J. Rosi-Marshall, et al., supra note 191, at 16204.
199 There are numerous previous studies on the possible negative effects of
transgenic crops on the environment, which include the 1999 German publication, based
on the first ever field study, and which provided prima facie evidence that transgenic
DNA had transferred from genetically modified sugar-beet plant debris into soil bacteria.
See Frank Gebhard & Kornelia Smalla, Monitoring Field Releases of Genetically
Modified Sugar Beets for Persistence of Transgenic Plant DNA and Horizontal Gene
Transfer, 28 FEMS MICROBIOLOGY ECOLOGY 261, 261- 72 (1999).
200 See Waltz, supra note 181, at 27.
201 Id. at 28.
202 Id. at 32.
203 Id. at 28-29.
204 See Shantharam et al., supra note 175, at 168.
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characteristic of the increasingly negative tactics by pro-transgenic
plant agriculture scientists and researchers, self-proclaiming
experts who would "forcefully present themselves as the ultimate
arbiters of truth." 205 The modus operandi of the characteristically
hostile rebuttals against research perceived as unfavourable to
transgenic plant agriculture is aptly summed up by Emily Waltz as
follows:
No one gets into research on genetically modified (GM) crops
looking for a quiet life.. . . But those who, like Rosi-Marshal
and her colleagues, suggest that biotech crops might have
harmful environmental effects are learning to expect attacks of a
different kind. These strikes are launched from within the
scientific community and can sometimes be emotional and
personal; heated rhetoric that dismisses papers and can even, as
in Rosi-Marshall's case, accuse scientists of misconduct. 2 06
Further, the increasingly acrimonious attacks by pro-transgenic
plant scientists and researchers elicited the following reflection
and response from an editor of Entomological Society of America:
I personally am in favour of GMOs in general, and think that
they are very beneficial for the environment. But I do have
problems with the tactics of the large block of scientists who
denigrate research by other legitimate scientists in a knee-jerk,
partisan, emotional way that is not helpful in advancing
knowledge and is outside the ideals of scientific inquiry.207
However, it has been noted that pre-emptive attacks against
unfavorable transgenic plant scientific research outputs with
perceived flaws are designed to neuter any possible influence on
policy makers.20 8  The motive and ultimate goal underlying the
strategic attacks is succinctly framed by Emily Waltz as follows:
"[w]hen a paper comes out in which they see problems, they react
quickly, criticize the work in public forums, write rebuttals letters,
and send them to policy-makers, funding agencies and journal
editors." 20 9 The strategy was however justified by Brian Federici,
205 See Waltz, supra note 181, at 31 (citing an "editor for the Entomological
Society of America who asked to remain anonymous").
206 Id. at 27.
207 Id. at 31.
208 See id at 27-28.
209 Id at 27.
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an insect pathologist at the University of California, Riverside, on
grounds that "bad science deserves more criticism than your
typical peer-reviewed paper."21 But then this raises a pertinent
question: whose prerogative is it to adjudge a peer-reviewed paper
"as bad science"? The Rosi-Marshall paper and similar others
certainly show a tendency for scientists to characterise
unfavourable research outputs as "bad science." However, this is
a needless attack, because a patently bad transgenic plant research
paper would become apparent in due course to the entire scientific
community, whether or not the research favours transgenic plant
agriculture. After all, numerous biomedical and life-science
research articles have been retracted over the past decades on
grounds such as error, plagiarism, fraud, and suspected fraud.2 1'
This seemingly would imply that a patently bad transgenic plant
research paper, irrespective of its take on transgenic plant
technology, could hardly survive long-term scrutiny of the entire
scientific community. Therefore, the characteristically partisan
and hostile rebuttals of unfavourable transgenic plant research
papers is hardly warranted, and would only serve to aggravate the
deepening divide between scientists and stifle beneficial
scholarship on transgenic plant agriculture.
However, despite the efforts by pro-transgenic plant
agriculture scholars to discredit the Rosi-Marshall paper in the
eyes of regulatory authorities, it nevertheless gained traction and
influenced policy makers in Europe. This was especially the case
in France, where the paper was referenced and relied upon by the
French authority as evidence of possible deleterious effects of Bt.
crops on wildlife, and used as justification for banning the
cultivation of Monsanto's Bt. maize (MON810) in France in
January 2008.212 Within the context of the significance of
regulatory science, the French government's reliance on the Rosi-
Marshall paper arguably underscores the visceral hold of "science"
over the policy framework for transgenic plant agricultural
technology governance, and the dramatic transformation of
2 10 Id. at 27.
211 Fang et al., supra note 42, at 1702 (discussing how a comprehensive search in
May 2012 of the PubMed database revealed a total of 2,047 biomedical and life-science
research articles retracted on grounds that ranged from error to misconduct).
212 Waltz, supra note 181, at 32.
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''science" into an unwitting battleground for the attention of
regulatory authorities across the world. Most significantly, the
differing scientific opinions on the proprieties of transgenic plant
agriculture and food respectively for the environment and public
health inevitably translate into differing regulatory and policy
frameworks for countries around the world.2 13 Further, the Rosi-
Marshall paper underscores the uncertainties that underpin the
safety science of transgenic plant agriculture. Thus, the foregoing
discourse aims to demonstrate how highly contentious and
uncertain the "science" is behind the regulation and policy of
transgenic plant agriculture, and how acrimonious the debates are
about the proprieties of transgenic plant agriculture and food.
Certainly, there is no denying the palpable sense of discord, and
the emotional cacophonies that continue to characterize and define
the scholarship and social discourse on the propriety of transgenic
plant agricultural technology. The following section will further
demonstrate how the uncertainty of the underlying "science" of
transgenic plant agriculture continues to shape different regulatory
regimes amongst countries.
III. The Limits of Regulatory Science in Transgenic Plant
Agriculture Governance
This section will explore the uncertainties and divisions that
have hindered the science of transgenic plant agriculture and
fueled the debates on the proprieties of the technology, as well as
the legitimacy of the current science-centric regulatory and policy
framework. In particular, this section examines the propriety of
the substantial equivalence doctrine, which is a science-based
regulatory tool for transgenic plant agriculture governance, by
using selected case studies that indicate scientific uncertainties and
conflicting results. The primary aim is to demonstrate the limits of
regulatory science in transgenic plant agriculture governance by
highlighting the dynamics of the uncertainties inherent in its
underlying science.
213 See id. (noting, for example, that despite the wide backlash against Rosi-
Marshall's paper, the French government announced a ban on cultivated maize after
France's watchdog on GM foods announced that "one of Monsanto's types of Bt maize,
known as MON810, may have an impact on wildlife" and citing the Rosi-Marshall's
paper as evidence for this assertion).
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A. The Propriety of the Substantial Equivalence Doctrine for
Transgenic Plant Agriculture Governance
The first bone of contention in the current regulatory and
policy framework for transgenic plant agriculture governance is
the substantial equivalence doctrine, which equates the science of
transgenic plant agriculture and its resultant technology with that
of conventional plant agriculture.2 14 As previously noted,215 the
substantial equivalence doctrine, which is rooted in the 1992 U.S.
FDA policy, posits that transgenic plant foods are similar in their
chemical composition to conventional plant foods and are
therefore "generally recognized as safe," as they "do not introduce
unique health risks to consumers." 216  Thus, there is a tacit
assumption that the genetic materials found in transgenic plant
crops "will likely be the same or substantially similar to
substances commonly found in foods, such as proteins, fats and
oils, and carbohydrates." 217 The doctrine also posits that similarity
between a transgenic food and its conventional counterpart could
be demonstrated by testing their chemical composition,2 18 and if
this comparative study could not resolve safety concerns, then
"feeding studies or other toxicological tests may be warranted." 2 19
The FDA has acknowledged the limitations of feeding studies and
toxicological tests, by noting that "feeding studies on whole foods
have limited sensitivity" since it would be relatively difficult "to
administer exaggerated doses."2 20
The 1992 policy on substantial equivalence sprang from the
1986 policy of the Office of Science and Technology Policy on
"coordinated framework for regulation of biotechnology," 221
which resolved that no new legislation would be necessary for the
214 See Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed. Reg.
22984, Part I (May 29, 1992).
215 See BILLINGS & SHORETT, supra note 163, at 75-79.
216 See id at 78-79.
217 Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed. Reg. at
22984-85.
218 See id. at 22987.
219 Id. at 23004.
220 Id.; see also Levidow, Murphy, & Carr, supra note 32, at 35.
221 Coordinated Framework for Regulation of Biotechnology, 51 Fed. Reg. 23302,
23302-93 (June 26, 1986).
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governance of transgenic plant agriculture and foods.2 22 Thus, by
extrapolation, in regulatory and governance terms, transgenic plant
agriculture and resultant crops would not be treated any differently
from conventional plant agriculture and crops, because the
methods of genetic engineering technique in plant agriculture are
deemed to be extensions at the molecular level of traditional plant
breeding. 2 23  As noted earlier in this article, this is arguably the
basis for the FDA's rejection of a labeling regime for transgenic
plant foods in the United States,2 24 even though some states, such
as Oregon, and most Americans polled in a 2005 survey expressed
their preference for the labeling of transgenic plant foods.225 But,
the United States government's official aversion for the labeling of
transgenic plant foods is understandable, given that a labeling
regime would tend to highlight the differences, if any, between
transgenic and conventional plant agriculture and foods. This
would inevitably undermine or negate the very essence of the
substantial equivalence doctrine.2 26
Also, and most significantly, the substantial equivalence
doctrine was given a fillip by its tacit international recognition and
222 See id. Part I, Sec. A.; see also Levidow, Murphy, & Carr, supra note 32, at 34.
223 See Coordinated Framework for Regulation of Biotechnology, 51 Fed. 23302-93
(June 26, 1996).
224 Obviously, labeling transgenic plant food products would run counter to, and
possibly undermine the doctrine of substantial equivalence. For what would be the
essence of labeling transgenic plant foods with a view to distinguishing them from
conventional plant foods if transgenic plant foods were really the same as conventional
plant foods? See Alliance for Bio-Integrity v. Donna Shalala, 116 F. Supp. 2d 166 (D.
D.C. 2000) (upholding the non-labeling rule of the Food and Drug Administration as
predicated upon on the substantial equivalence doctrine).
225 See PAARLBERG, supra note 31, at 22 ("In response to a Pew Initiative survey in
2005, half of a representative sample of Americans even said they would oppose the
introduction of genetically modified foods into the U.S. food supply, with 33% saying
they would oppose GM foods strongly (Pew Initiative 2005)."); see also Oriola, supra
note 123, at 570-71 (discussing the use of a referendum to assess the majority's view on
a labeling versus non-labeling policy by using the example of Oregon's aborted
transgenic food labeling rule in 2002).
226 See Alliance for Bio-integrity, 116 F. Supp. at 166. The United States District
Court for the District of Columbia observed the implications of labeling for transgenic
plant foods, as follows: "Plaintiffs fail to understand the limitation on the FDA's power
to consider consumer demand when making labeling decisions because they fail to
recognize that the determination that a product differs materially from the type of
product it purports to be is a factual predicate to the requirement of labeling." Id. at 179.
801
N.C. J. INT'L L. & COM. REG.
endorsement in a 1991 joint report by the Food and Agriculture
Organization and the World Health Organization (FAO/WHO),
which posited that "safety assessment should be based on sound,
scientific principles and data" and that transgenic plant food could
be compared with conventional food as part of safety assessment
measures. 227  Similarly in 1993, the Organization for Economic
Co-operation and Development (OECD) noted in their report that
transgenic plant food "does not necessitate a fundamental change
in established principles, nor does it require a different standard of
safety." 228  The 1993 OECD report explicitly endorsed the
substantial equivalence doctrine as follows:
[I]f a new food or food component is found to be substantially
equivalent to an existing food or food component, it can be
treated in the same manner with respect to safety. No additional
safety concerns would be expected. Where the substantial
equivalence is more difficult to establish because the food or
food component is either less well-known or totally new, then
the identified differences, or the new characteristics, should be
229the focus of further safety considerations.
Furthermore, in 1996, the FAO/WHO in a joint statement
explicitly and unconditionally endorsed the substantial
equivalence doctrine, and ostensibly drew on the doctrine to allay
any concerns on possible negative effects of transgenic plant
agriculture on the environment. 230  This support by cognate and
227 WORLD HEALTH ORGANIZATION, STRATEGIES FOR ASSESSING THE SAFETY OF
FOODS PRODUCED BY BIOTECHNOLOGY: REPORT OF A JOINT FAO/WHO CONSULTATION
Sec. 6.3.1(2) (1991), available at http://www.who.int/foodsafety/publications/biotech/
en/1990.pdf [hereinafter STRATEGIES]. The report noted inter alia that "comparative data
on the closest conventional counterpart are critically important in the evaluation of a new
food, including data on chemical composition and nutritional value." Id. at Sec. 7.1(6).
The report also noted that such data were not widely available at the time of consultation
and writing. Id.
228 ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT, SAFETY
EVALUATION OF FOODS DERIVED BY MODERN BIOTECHNOLOGY: CONCEPTS AND
PRINCIPLES 10 (1993).
229 Id. at 13.
230 Food and Agriculture Organization of the United Nations (FAO) & World
Health Organization (WHO), Joint FA 0/WHO Expert Consulation on Biotechnology and
Food Safety (Sept. 30 to Oct. 4, 1996), ftp://ftp.fao.org/es/esn/food/biotechnology.pdf
(last visited Oct. 7, 2013). This 1996 joint statement issued by FAO/WHO declared
inter alia that "the environmental issues related to biotechnology have been well
defined." Id. at 2. It is important to note this statement in comparison to the first
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reputable international organizations facilitated international
harmonization of mutually accepted "safety judgments" for
transgenic plant agriculture and foods, and it paved the way for the
liberalization of international trade in transgenic plant products
and food.23'
In light of international approval of the substantial equivalence
doctrine, it was inevitable that regulatory authorities in the
European Union 2 32 and other countries around the world233 would
draw upon this doctrine to assure the mass publics of the safety of
transgenic plant foods for public health, and the compatibility of
transgenic plant agriculture with the environment and
biodiversity. 234  Moreover, the official international consensus
amongst policy makers on the viability of the substantial
equivalence doctrine (which has been "variously called a concept,
a principle, a risk assessment tool, or all three at once"2 35) for the
FAO/WHO endorsement in 1991, which had cautiously noted that comparative data for
the assessment of transgenic and non-transgenic plant foods was not widely available at
the time. See STRATEGIES, supra note 227, at 7.1(6).
231 See Levidow, Murphy, & Carr, supra note 32, at 36.
232 Id. (noting that the European legislation's alignment with the substantial
equivalence doctrine in 1997 helped "harmonize product approval across the Atlantic").
In 1997, the European Union introduced Regulation 258/97 on Novel Rood, which
imposed a legal duty to seek approval before any novel food, such as GM food, is
introduced into the market. Id. This new law provided a simplified procedure that
essentially allowed companies to avoid a risk assessment if they could show that a
transgenic food was substantially equivalent to an existing safe food. Id. However, in
1998, EU Regulatory Committee adopted United Kingdom's more stringent criteria for
the simplified procedure and in June 1999, the EU Environment Council imposed an
"unofficial de facto moratorium on approval of any additional GM products". Id. at 41.
233 See Levidow, Murphy, & Carr, supra note 32, at 28 (noting that while in 1997,
the United Kingdom implemented EU Novel Food Regulation 258/97 on the substantial
equivalence doctrine, the United Kingdom Advisory Committee on Novel Foods
(ACNFP) then conditionally accepted the substantial equivalence doctrine for simplified
procedure "only in cases in which no intact transgenic DNA or protein remains after
processing).
234 See Billings & Shorett, supra note 163, at 79 (explaining that the substantial
equivalence doctrine has been used by regulatory authorities in Canada and the United
Kingdom to justify the introduction of transgenic plant agriculture and food products);
see also THE ROYAL SOCIETY, GENETICALLY MODIFIED PLANTS FOR FOOD USE AND
HUMAN HEALTH-AN UPDATE 5, (2002), available at http://royalsociety.org/uploaded
Files/RoyalSocietyContent/policy/publications/2002/9960.pdf (discussing the "use of
substantial equivalence in the safety assessment of GM food).
235 Levidow, Murphy, & Carr, supra note 32, at 27.
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regulation of transgenic plant agriculture and foods is indicative of
the transnational reach of the doctrine as a putative regulatory tool.
However, whilst the substantial equivalence doctrine enjoys
transnational supports, critics are quick to question its allegedly
dubious ideological basis by challenging its scientific propriety
and validity.23 6 For example, critics have characterised the
substantial equivalence doctrine as an ideologically driven policy
contrived by the U.S. federal government, primarily aimed at
promoting and expediting the adoption of biotechnology products
by "minimizing federal constraints on the advance of
commercially advantageous technology and preventing growth of
the federal bureaucracy."2 37 Indeed, securing a regime of minimal
regulation for transgenic plant agriculture would necessitate
circumventing the regulatory reach of the U.S. Congress. This
was precisely what the 1992 policy framework for biotechnology
products accomplished,23 8 when it vested oversight role of
transgenic plant agriculture and food in three Federal agencies: the
U.S. Department of Agriculture, the Environmental Protection
Agency, and the FDA-each was directly accountable to the Office
of the President of the United States, rather than to Congress.23 9
If the substantial equivalence doctrine succeeded in expediting
the approval of transgenic plant agriculture and food, it would be
at the expense of the Congress' total exclusion from transgenic
plant agriculture governance, a scheme that arguably could be
tantamount to denying transgenic plant technology governance
systems a comparably rigorous regulatory and concomitant safety
regime, which is the norm for new pharmaceuticals, as
demonstrated by legislatively-mandated rigorous clinical trials on
236 See generally Baram, supra note 160, at 53 (recognizing the limitations of a
relaxed regulatory system in the United States that currently govern the safety of GM
agriculture and food and the dangers of relying on the common law liability system
alone).
237 Id. at 27 (explaining that the substantial equivalence doctrine was in conformity
with the President Ronald Regan's political theme of light federal regulation of
businesses).
238 See id. at 26 (noting that the 1992 policy framework was an expanded version of
the 1986 United States policy framework for federal regulation of "biotechnology
products"); see also Coordinated Framework for Regulation of Biotechnology, supra
note 221, at 23302.
239 See Baram, supra note 160, at 26-27.
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animals and humans at both pre and post market debut phases.24 0
Inevitably, the palpable disparity in regulatory rigor for new
pharmaceuticals and transgenic plant products highlights the
inherent weakness of the substantial equivalence doctrine, given
that, like transgenic seed companies, drug companies now
routinely use rDNA in new pharmaceutical production, as
exemplified by transgenic human insulin, which was the first
commercial transgenic product produced in 1982, using
genetically modified bacterium.24' The pertinent question
therefore follows: why should pharmaceuticals undergo rigorous
safety checks via mandatory clinical trials,242 whilst transgenic
plant products literally breeze through safety checkpoints,
ostensibly piggybacking on the substantial equivalence doctrine.
In other words, why are transgenic plant products subject to a
relatively weaker safety oversight regime in the substantial
equivalence doctrine, vis-a-vis the stricter mandatory regulatory
clinical trials regime that is the norm for new pharmaceutical
products, given that rDNA technology is increasingly becoming an
integral feature of the production process for new
pharmaceuticals? 24 3
The above question, is particularly tangent, because pro-
transgenic plant agriculture scientists and scholars like Ronald J.
Herring and Robert Paarlberg are wont to bemoan the inherent
irony in the unquestioning acceptance by the general public, of the
240 Oriola, supra note 20, at 86-89 (discussing the expensive and extensive pre and
post market mandatory clinical trials of new pharmaceuticals, which could take several
years to ensure safety).
241 See PAARLBERG, supra note 31, at 11 (noting how transgenic human insulin was
the first commercial product of transgenic technology to be approved by the Food and
Drug Administration in the United States).
242 See Oriola, supra note 240, at 33 (noting that mandatory pre-clinical and clinical
trials for new pharmaceuticals can average 12 years prior to approval by the Food and
Drug Administration). Typically, clinical trials contain three phases: phase one studies
compare pharmacological effects in animal experimentation and those expressed in
human subjects; phase two studies seeks the amount of dosage required to achieve
anticipated therapeutic effects; and phase three studies seek to confirm therapeutic
efficacy and safety for the wider patient population at the dosage proposed for
marketing. Id. at 31-32.
243 It has been estimated that recombinant DNA technique now constitutes twenty-
five percent of all newly approved pharmaceutical products. See PAARLBERG, supra note
31, at 18.
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use of rDNA technology in medicine,24 4 and the paradoxical
disdain and scepticism of the general public for the use of rDNA
in plant agriculture and products, especially in Europe.2 45 Perhaps,
the general public's ready embrace and acceptance of transgenic
medicine, in contradistinction to their relative scepticism and
disdain for transgenic plant agriculture and foods, partly could be
explained by the perceived inadequacy of the regulatory
framework in the substantial equivalence doctrine in addressing
unresolved and outstanding safety and liability issues, relative to
the stringent regulatory standards required of comparable
pharmaceutical products? This is arguably exemplified by the
relative lack of public confidence in the federal regulatory
oversight regime for transgenic plant agriculture and food in the
United States, especially in the wake of national food scares
precipitated by the StarLink corn fiasco,24 6 the continuing
vulnerability of non-transgenic plant farmers to intellectual
property lawsuits,2 47 and possible economic damage from in situ
244 This is exemplified by transgenic human insulin. See Pandey Shivanand &
Suba Noopur, Recombinant DNA Technology: Applications in the Field of
Biotechnology and Crime Sciences, I INT'L J. OF PHARMACEUTICAL Sci. REV. & REs 43,
44 (2010), available at http://www.globalresearchonline.net/volumelissuel/Article
%20009.pdf (noting how transgenic human insulin, albeit from animal protein, is
structurally identical to naturally produced insulin in humans).
245 Herring, supra note 107, at 614-15 (noting how rDNA techniques were widely
accepted in pharmaceuticals, medicine, and industry); see also PAARLBERG, supra note
31, at 18 (discussing the ready acceptance of genetic engineering techniques in medicine
by rich countries and the relative opposition to the use of genetic engineering techniques
in agriculture).
246 See David Winickoff et al., Adjudicating the GM Food Wars: Science, Risk, and
Democracy in World Trade Law, 30 YALE J. INT'L L. 81, 102-03 (2005) (discussing the
StarLink case as an example of a regulatory reversal which resulted from "human
behaviors that the initial risk assessments had failed to anticipate"). StarLink was a
maize hybrid that was labeled as "a crop, a food, and a pesticide, [thereby] requiring risk
assessments by three separate agencies" under U.S. law. Id. at 102. Due to StarLink's
"potential allergenicity in humans . . . all three agencies determined that a 'split
registration' would be granted: the maize was to be used in animal feed but not in human
food." Id. at 103. Nonetheless, StarLink DNA was found in food products in September
2000 and caused a "massive and costly recall." Id.
247 See, e.g., Monsanto Co. v. McFarling, 302 F.3d 1291, 1291 (Fed. Cir. 2002)
(affirming a preliminary injunction against farmer McFarling's saving of transgenic
seeds because there was a reasonable likelihood of success on the intellectual property
infringement claim against McFarling); Schmeiser v. Monsanto Canada Inc., 2002 FCA
309, available at http://www.ariplex.com/percyschmeiser/Appeal%20Decision.pdf
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gene flow and adventitious commingling of transgenic and non-
transgenic plant materials.24 8
Most significantly, the general public disaffection with the
minimal federal regulatory system overseeing transgenic plant
agriculture in the United States ostensibly precipitated numerous
abortive legislative initiatives by county and state authorities.2 49
These abortive initiatives include labeling rules by the State of
Oregon in the fall of 2002,250 California's 2008 transgenic plant
liability law designed for the protection of non-transgenic plant
farmers from intellectual property infringement lawsuits,
concomitant economic loss or damage arising from adventitious
commingling of transgenic and non-transgenic crops. 251 Thus,
(granting Monsanto an injunction after finding that some claims of Monsanto's Canadian
patent for the invention of a genetic insert was infringed upon); see also Maria Lee &
Robert Burrell, Liability for the Escape of GM Seeds: Pursuing the 'Victim'? 65 MOD. L.
REV. 517, 519-27 (2002) (discussing the implications of the enforcement of intellectual
property rights in transgenic seeds against farmers in circumstances of adventitious
commingling).
248 See Yarui Li, Eric J. Wailes, Andrew McKenzie, & Michael Thomsen, LL601
Contamination and Its Impact on U.S. Rice Prices, 42 J. OF AGRIC. & APPLIED ECON. 1,
31 (2010) (exploring the impact of LL601, a genetically modified rice variety that was
unapproved for commercial use, and its effect on the prices and volume in the U.S. and
Thailand market); see also Sample v. Monsanto, 283 F. Supp. 2d 1088, 1090 (E.D. Mo.
2003) (involving farmer's class action lawsuit against Monsanto for alleged economic
loss stemming from the sale of genetically modified soybeans and corn in the market).
249 Attempts by numerous county authorities, including four California counties
and numerous New England towns, to restrict the cultivation of transgenic crops locally
were stifled by state legislatures via pre-emption laws which curbed the ability of local
authorities to regulate seeds and plants. See Britt Bailey, States Introduce Numerous
Bills to Regulate Genetically Modified Foods, ENVIRONMENTAL COMMONS,
http://environmentalcommons.org/gmo-regulation-2007.html (last visited Feb. 28, 2013).
Between 2004 and 2006, nearly twenty state legislatures attempted to suppress
legislative measures by county authorities to restrict cultivation of transgenic crops. Id.
250 Oriola, supra note 123, at 519-20 (discussing Oregon's aborted transgenic foods
labeling rule when in the fall of 2002, a coalition of consumer advocates and
environmental activists initiated a proposal for the labeling of transgenic food sold in the
state); see also Patricia Callahan, Oregon May Require Labels on Genetic Food, WALL
ST. J., Sept. 30, 2002, at B.1.
251 AB 541 (Cal. 2007), http://www.leginfo.ca.gov/pub/07-08/bill/asm/ab 0501-
0550/ab 541_bill_20080927 chaptered.html (adding to the Food and Agricultural Code
in California with regards to liability when concerning genetically engineered plants);
see also California's First Law Protecting Farmers From Threats of Genetic
Engineering Signed by Governor, GENETIC ENGINEERING POLICY ALLIANCE
http://www.gepolicyalliance.org/action-alert-support-ab541.htm (last visited on Feb.
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arguably, the substantial equivalence doctrine is no more than a
fait accompli for shoehorning transgenic plant agricultural
products into the global food systems. This point is aptly
summed-up by Michael Baram as follows:
Among developed nations, the United States is the leading
proponent and most permissive regulator of GM crops and
foods . . . The executive branch, led by the President's Office,
has promoted the commercialization and export of GM seeds,
crops, and food, and discouraged regulation that would treat
these products differently than their conventional, non-GM
counterparts. The regulatory agencies, which are subject to
presidential direction, have acted accordingly by lessening test
requirements, creating regulatory exemptions, and approving
commercialization despite scientific uncertainties about risks to
public health and the environment. They have steadfastly
resisted petitions for more stringent safety reviews and
precautionary policies, and rejected proposals for labeling GM
products that would enable informed choice by consumers.252
Most significantly, the voluntary consultation process for the
implementation of the substantial equivalence doctrine by the
FDA would appear to give a short shrift to the safety and risks
inherent in transgenic plant agriculture.25 3 According to Sheldon
Krimksy et al., rather than new regulations, the FDA introduced a
discretionary and voluntary consultation process for companies
planning to introduce transgenic foods into the market.254 Under
the voluntary consultation regime, transgenic seed developers "are
provided a flow chart indicating when consultation with the
agency is desirable." 25 5  According to the 1996 FDA guidance
document for industry on the procedures for consultation:
Under the process a developer who intends to commercialize a
bioengineered food meets with the agency to identify and
discuss relevant safety, nutritional, and other regulatory issues
28, 2013) (noting that on Sept. 27, 2008, Governor Schwarzenegger signed AB 541, the
"landmark piece of legislation protecting California's farmers from liability").
252 Baram, supra note 160, at 16.
253 See Krimsky & Murphy, supra note 53, at 80 (2002) (examining the "FDA's
policies on genetically modified foods including its voluntary consultation program and
its proposed rule on market notification and data submission").
254 Id. at 82.
255 Id.
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regarding the bioengineered food prior to marketing it .... A
developer may initiate such a consultation early or late in the
development of the food.256
However, the consultation process appears largely voluntary or
discretionary, as there is no legal obligation for a transgenic plant
foods developer to initiate a consultation with the FDA prior to its
products market debut. 25 7 Thus, it would be logical to infer from
the FDA consultation procedures for introducing new transgenic
plant foods, that there could be occasions when the FDA would
not deem consultation procedures desirable at all. This is in stark
contrast to the production process for new pharmaceuticals, for
which the U.S. Congress has mandated rigorous clinical trials on
animals and humans prior to market debut. 258  Even when
consultation might be deemed desirable by the FDA, Sheldon
Krimksy et al., noted that the FDA might not "usually conduct a
comprehensive scientific review of the data produced by the
developer for products that are classified as generally regarded as
safe." 25 9 Instead, the agency would only review the information
provided by the developer and then decide "whether any
unresolved issues exist regarding the food derived from the new
plant variety that could necessitate legal action by the agency if
the product were introduced into commerce." 2 60 While there is no
specific time frame for the completion of consultation procedures,
the estimated median and average time for completion of
consultation review by the FDA was 155 days and 175 days
respectively. 26' Again, this is in stark contrast to the FDA's
approval process for new pharmaceuticals, which could take up to
256 Id.
257 This conclusion could be inferred from the wording of the FDA guidance
document, which is apparently couched in non-obligatory terms, and gives the developer
leeway not to initiate any consultation process: "A developer may initiate a consultation
early or late in the development of the food." See id. It should be noted, however, that
there was a formal agency proposal in January 2001 to require premarket notifications of
bioengineered foods and that the proposal was expected to be finalized in 2002. Id. at
83.
258 See Oriola, supra note 240, at 31 ("In the United States as in Europe, pre-
clinical and clinical trials are legally mandated by law, and are often drawn out over a
period of years, adding considerably to the costs of drug development.").
259 See Krimsky & Murphy, supra note 53, at 82.
260 Id.
261 See id. at 83.
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12 years prior to the product's commercial debut. 26 2
Unsurprisingly, the FDA's voluntary and discretionary
consultation procedures for new transgenic plant foods approval
was criticized by stakeholders for its apparently inadequate
safeguards for public health protection.2 63 This led to
recommendations by an FDA Advisory Committee that transgenic
foods producers should submit safety and nutritional assessments
to the agency, prior to new transgenic plant products market
debut.264  The FDA published a proposal on January 18, 2001,
which mandated premarket notifications of new transgenic plant
foods by developers. 265 Amongst other things, the proposed rule
required transgenic plant foods manufacturers to submit a
scientific and regulatory assessment of transgenic foods to the
FDA 120 days prior to transgenic plant foods market debut.266
Furthermore, the mandatory scientific data submitted prior to
transgenic plant foods market debut, must compare the
composition and characteristics of the transgenic plant food in
question to that of comparable conventional food.2 67 According to
Sheldon Krimsky et al., the mandatory scientific data required
must also include the following five categories of information:
First, "characterization of the parent plant, mode of reproduction,
and history of development." 2 68  Second, the method of
development of the transgenic plant in question, detailing "the
construction of the vector used in the transformation of the parent
plant and a thorough characterization of the introduced genetic
material, [etc.]" 2 69 Third, analysis of newly inserted genes with
antibiotic properties. Fourth, "substances introduced into or
modified (present at an increased level relative to comparative
food)." 271' And fifth, a comparison of the composition and
262 See Oriola, supra note 240, at 33.
263 See Krimsky & Murphy, supra note 53, at 83.
264 See id.
265 Premarket Notice Concerning Bioengineered Foods, 66 Fed. Reg. 4706, 4713
(Jan. 18, 2001) (to be codified at 21 C.F.R. pts. 192 and 592).
266 Id
267 Id.; see also Krimsky & Murphy, supra note 53, at 84.
268 Krimsky & Murphy, supra note 53, at 84.
269 Id
270 Id
271 Id.
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characteristics of the transgenic food to comparable conventional
foods, as well as an analysis of how the transgenic food is as safe
as comparable non-transgenic food.272 Sheldon Krimsky et al.,
succinctly summarized the consultation procedure as follows:
The FDA's written consultation reports are approximately four
to five pages in length. They discuss the data provided by the
developer and summarize the developer's argument regarding
the safety of the expressed proteins and any changes in the
compositional analysis of the foods. The consultation reports
contain a final sentence indicating whether the FDA considers it
consultation complete. By reporting that the consultation is
complete, the agency is implicitly stating that it has no questions
or reservations about the science, that it is satisfied with the
company's comparative risk statement and that voluntary
compliance has been met.273
However, whilst the requirement of the submission of
mandatory scientific data on the nature and safety of transgenic
plant foods to the FDA prior to market debut is a welcome
improvement on the hitherto voluntary consultation process, the
research is entirely industry-led and generated, and it is doubtful
whether the FDA, which suffers from dwindling personnel,
funding, and "deficient scientific base," would have the necessary
wherewithal to vet or verify the accuracy and validity of every
piece of self-generated scientific data submitted by applicants.274
Yet, verifying the accuracy of industry-generated scientific data by
regulatory agencies is crucial to an effective science-based
regulatory regime, as the industry is historically notorious for
suppressing unfavourable scientific data.275
Even in the unlikely event that an unfavourable scientific data
was submitted by a transgenic plant developer to the FDA,276 the
272 Id.
273 Id.
274 LEBOVITZ ET AL., supra note 33, at 25.
275 See Gerald Markowitz & David Rosner, Corporate Responsibility for Toxins,
284 ANNALS AM. ACAD. POL. & Soc. SCI. 1, 159-74 (2002) (discussing how corporations
deliberately suppressed the knowledge of dangerous industrial toxins that were a threat
to public health in furtherance of corporate benefits and interests).
276 See Press Release, Friends of the Earth, GM Safety Tests Flawed: New
Research (Nov. 16, 2004) (on file with author), available at http://www.foe.co.uk/
resource/press releases/gm safety testsflawed new 24112004 (noting that companies
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transgenic plant in question might still pass the FDA's regulatory
muster, if risk analysis of potential danger to the environment and
public health was deemed reasonable, minimal, or too costly to
manage. 277  According to Michael Baram, designated Federal
agencies were required "to employ risk analysis to determine if
there is a sufficient factual basis for regulatory action, and apply
cost-benefit analysis to determine on economic grounds the extent
to which a risk is 'unreasonable' and worthy of regulation." 27 8 In
that circumstance, a risk would only be worthy of regulation
"when the value of the reduction in risk obtained by additional
oversight is greater than the cost thereby imposed." 27 9 A fortiori, a
potential food risk might still pass the FDA's regulatory muster on
the premise that the associated risk is minimal or reasonable
relative to the costs of regulation. Furthermore, according to
Michael Baram, regulators "are directed to minimize regulatory
burdens on product developers, accommodate rapid advances in
product development and commercialization, and use flexible
performance-based standards rather than rigid prescriptive or
design standards to deal with end products risks."28 0
Thus, it is theoretically possible for the FDA to countenance
unfavourable scientific data on an outstanding or unresolved risk,
if the risk is adjudged "reasonable" or "minimal," and if regulating
the risk would be economically inefficient. However, the framing
of transgenic plant foods risks governance purely in terms of
economic efficiency, rather than a zero tolerance approach to
eliminating every conceivable risk that new toxins and allergens
might pose to the consuming public, could arguably smack of
regulatory recklessness. Moreover, since risk is relative, it is
unclear what might constitute reasonable or minimal risk in the
transgenic plant foods context, and whether the general public,
who would ultimately consume transgenic plant foods, would have
the same level of tolerance to the permissible reasonable or
routinely ignored the Food and Drug Administration requests for additional information
and that the Food and Drug Administration would often review summaries of industry-
generated data, rather than the full contents of the studies on which industry data were
predicated).
277 BARAM, supra note 160, at 27.
278 Id.
279 Id.
280 Id
Vol. XXXIX812
2014 REGULATION AND TRANSGENIC PLANT AGRICULTURE
minimal risk that some cost-benefit analysts have deemed too
costly to regulate. Moreover, unlike new pharmaceuticals, 28 1 the
FDA has no post-market oversight over transgenic plant foods,
and therefore cannot check industry records for evidence of harm
or recall unsafe transgenic plant foods.282
It is therefore unsurprising that critics like Paul R. Billings et
al., have characterized the substantial equivalence doctrine as no
more than a ruse "to justify introducing GE foods into the market
without long-term nutritional and toxicological testing on
animals." 28 3  According to Paul R. Billings et al., without long
term nutritional and toxicological testing of transgenic plant
products on animals, "we have few ways of assessing the full
effects of foreign gene insertion."284 However, as previously
noted, the FDA has acknowledged the limitations of feeding
studies and toxicological tests, by noting that "feeding studies on
whole foods have limited sensitivity" since it would be relatively
difficult "to administer exaggerated doses."2 85 In the same vein,
David Schubert expressed concerns on the lack of sufficient study
on the potential unintended molecular effects and implications of
inserting novel genes into plant cell,286 thus underscoring the limits
of the substantial equivalence doctrine as a regulatory tool for
transgenic plant foods. Even Consumers International, an
independent and authoritative global voice for consumers, did
voice their reservations and concerns on the propriety of the
substantial equivalence doctrine for transgenic plant foods safety
and quality assurance:
Consumer experts are concerned that this concept has only
limited value. First of all, it is very difficult to assess substantial
281 See ROBINSON ET AL., supra note 156, at I (noting that the United States Food
and Drug Administration withdrew ten pharmaceutical drug products between 2000 and
2006 following their market debut because of safety concerns).
282 BARAM, supra note 160, at 42 (noting that the FDA has never carried out any
systematic post-market oversight of transgenic plant foods, and would typically expect
the United States Department of Agriculture's Animal and Plant Health Inspection
Service (APHIS) to handle post-market contamination issues).
283 See Billings & Shorett, supra note 163, at 79.
284 Id
285 Statement of Policy: Foods Derived from New Plant Varieties, 57 Fed. Reg
22988, Part VII, sec. G (May 29, 1992).
286 See Schubert, supra note 182, at 969.
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equivalence doctrine ... . Too much importance is attached to
digestibility tests for assessing safety. Finally, there is a lack of
available scientific data on safety of traditional foodstuffs used
for comparison with GEFs [genetically engineered foods .... In
a field of science in which many of the mechanisms are still a
mystery, great caution is needed.287
Moreover, the United States District Court for the District of
Columbia in its ruling on the essence of substantial equivalence
doctrine noted inter alia that "ultimately, it is the food producer
who is responsible for assuring safety."28 8 This underscores the
limits of the FDA's oversight regime for assuring transgenic foods
safety via the substantial equivalence doctrine. It is a limitation
that even the FDA has tacitly acknowledged, by noting that
transgenic plant foods "are likely in some cases to present more
complex safety and regulatory issues than seen to date." 289
It was perhaps the perceived inadequacy of the manner in
which the United States implemented the substantial equivalence
doctrine that influenced a relatively stricter variant of the concept
in the United Kingdom and the European Union.2 90 In the United
Kingdom, for example, the United States' variant of the
substantial equivalence doctrine was perceived by experts as a
"simplified procedure" for transgenic plant foods regulation,
which was suitable only for fully processed foods that no longer
contained "intact DNA or protein."291 According to the United
Kingdom Advisory Committee on Novel Foods Processes, there
should be additional mandatory tests on the stability of the novel
or foreign nucleic acid proteins inserted into plant genome:
If we must use that criterion alone, [substantial equivalence]
then we will tighten its definition ... a food cannot be regarded
as substantially equivalent if it contains any intact GM DNA, so
the product must be highly refined to ensure that all the DNA
has been denatured. Moreover, we will specify what tests are
287 Les Levidow et al., supra note 32, at 37.
288 See Alliance for Bio-Integrity v. Donna Shalala, 116 F. Supp. 2d 166, 177 (D.
D.C. 2000).
289 Premarket Notice Concerning Bio-engineered Foods, 66 Fed. Reg. at 4709.
290 Les Levidow et al., supra note 32, at 38-39.
291 See MINISTRY OF AGRICULTURE FISHERIES & FOOD, ADVISORY COMMITTEE ON
NOVEL FOODS AND PROCESSES (ACNFP) 1998 ANNUAL REPORT 1, available at
http://www.food.gov.uk/multimedia/pdfs/acnfpl998.pdf.
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required; the company must monitor generations of the crop
over two years at six sites.2 9 2
The European Union subsequently adopted and incorporated
the United Kingdom's more stringent variant interpretation,293 by
noting that "whilst substantial equivalence is a key step in the
procedure for assessment of the safety of genetically modified
foods, it is not a safety assessment in itself."2 94 However, the
pertinent question is whether the United Kingdom and member
countries of the European Union could use their stringent and
variant interpretation of the substantial equivalence doctrine to bar
the import of approved transgenic plant foods and products from
the United States, Canada, or Argentina? Arguably, the answer is
no, in light of the World Trade Organization Dispute Settlement
Board's Panel decision in the European Communities Biotech
Products case,295 in which certain pre-emptive safeguard measures
taken by the European Union were held in breach of the risk
assessment criteria of the Sanitary and Phytosanitary Measures of
the Uruguay Round (SPS Agreement).2 96 The European Union
was held to have breached, amongst others, Articles 5(1) and 5(2)
of the SPS Agreement, which provide inter alia that all food safety
measures must be based on a risk assessment and scientific
evidence.2 97 Thus, unless the European Union could prove the
scientific merit of their stringent interpretation or variant of the
substantial equivalence doctrine, they could hardly use it to bar the
importation of transgenic plant foods and products from the
United States, Canada, Argentina, or other countries who utilize a
looser interpretation of the substantial equivalence doctrine.
Against the background of the European Communities Biotech
Products case, it is certainly a probable scenario that the European
Union could again deadlock with the United States and countries
292 Les Levidow et al., supra note 32, at 39.
293 Id.
294 European Parliament & Council on Genetically Modified Food and Feed, (EC)
No.1829/2003 of 22 Sept. 2003, art. 2(12) at 2-3.
295 See Panel Report, European Communities- Measures Affecting the Approval
and Marketing of Biotech Products, WTIDS291R, WT/DS292R, WT/DS293R (Sept. 29,
2006), available at http://www.worldtradelaw.net/reports/wtopanels/ec-biotech(panel).
pdf.
296 See id.
297 See id.
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with varied interpretation of the substantial equivalence doctrine,
thus reinforcing the disparate, differing, and divergent approaches
to the interpretation of the "science" that underpins the regulatory
and policy framework for transgenic plant agriculture and foods.
B. Science on Trial: Alliance for Bio-integrity and the Legal
Challenge to the Substantial Equivalence Doctrine
The validity and legality of the substantial equivalence
doctrine was challenged before the United States District Court for
the District of Columbia in Alliance for Bio-integrity v. Donna
Shalala,2 98 by plaintiffs comprising a coalition of groups,
individuals, scientists, and religious leaders. The plaintiffs
contended inter alia that transgenic plant foods should be labeled,
and that the FDA's substantial equivalence policy presumption
that transgenic plant foods, as a class, were generally recognized
as safe (GRAS), and therefore not subject to regulation as food
additives, should be discountenanced. The plaintiffs further
contended that FDA non-labeling policy violated the GRAS
requirements of the Federal Food, Drug, and Cosmetic Act, 21
U.S.C. § 321(s), and therefore arbitrary and capricious.2 99
According to the provisions of § 321(s), a producer of food
additive must submit food additive petition to the FDA for
approval, unless the FDA determines that the additive "is
generally recognized [by qualified experts] ... as having been
adequately shown through scientific procedures ... to be safe
under the conditions of its intended use."300
The plaintiffs' claim did raise a pertinent question before the
298 See Alliance for Bio-Integrity v. Donna Shalala, 116 F. Supp. 2d 166, 166-81
(D. D.C. 2000).
299 Id. at 175.
300 See Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 387(1) (2010) (defining
"food additive" as "any substance the intended use of which results or may reasonably be
expected to result, directly or indirectly, in its becoming a component or otherwise
affecting the characteristics of any tobacco product (including any substance intended for
use in producing, manufacturing, packing, processing, preparing, treating, packaging,
transporting, or holding)"). Additives may not include: (1) a pesticide chemical residue
in or on a raw agricultural commodity or processed food; or (2) a pesticide chemical; or
(3) a color additive, among other things. Id. For a comparable law in the European
Union, see Council Directive on Approximation of the Laws of the Member States
Concerning Food Additives Authorised for Use in Foodstuffs Intended for Human
Consumption, 89/107/EEC, art. 1.2, 1988-1989 O.J. (L40) 32. .
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court: why did the FDA not characterize nucleic acid proteins used
in the genetic modifications of transgenic plant foods as "food
additives," in order to allow for automatic submission of
transgenic plant foods to the FDA approval process prior to market
debut? The court reasoned that it was because "nucleic acid
proteins," were not only generally recognized as safe, but also
deemed crucial for the survival of plant and animal organisms."'o
According to the court:
Nucleic acids are present in the cells of every living organism,
including every plant and animal used for food by humans or
animals, and do not raise a safety concern as a component of
food. Therefore FDA concluded that rDNA engineered foods
should be presumed to be GRAS unless evidence arises to the
contrary. 302
The court further noted that whilst the plaintiffs did not dispute
the FDA's claim that nucleic acid proteins were generally
recognized as safe per se, the plaintiffs did argue that there were
significant disagreements among scientific experts as to whether
or not nucleic acid proteins were generally recognized as safe
when used to alter organisms genetically.303 In other words, while
nucleic acid proteins might be safe in their natural environment as
such, scientists do disagree on the safety implications of using
nucleic acid proteins to genetically alter or modify a plant's
genome. Nevertheless, the court went on to hold that the "FDA's
decision to accord genetically modified foods a presumption of
GRAS status" was not "arbitrary and capricious" as claimed by the
plaintiffs. 304 The court rationalized the premise for deferring to the
FDA's judgment in awarding GRAS status to transgenic plants
foods as follows:
The rationale for deference is particularly strong when the
[agency] is evaluating scientific data within its technical
expertise ... in an atea characterized by scientific and
technological uncertainty .. . this court must proceed with
particular caution, avoiding all temptation to direct the agency in
301 See Alliancefor Bio-Integrity, 116 F. Supp. at 176.
302 Id at 176-77.
303 Id. at 177.
304 Id.
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a choice between rational alternatives.305
However, the court's reluctance to pick and choose between
conflicting scientific opinions or "rational alternatives" on whether
or not nucleic acid proteins are generally recognized as safe when
used in the alteration of the genome of transgenic plant foods is
understandable in the context of the court's lack of relevant
scientific expertise. This is especially so as the court did
acknowledge that the area was "characterized by scientific and
technological uncertainty,"306 and picking between alternative
scientific opinions is almost always a judicial dilemma for judges
who often rely on expert witnesses due to a general lack relevant
scientific expertise.30 But then, it is arguably an avoidable
dilemma that perhaps could have been (partly) pre-empted had the
FDA subjected transgenic plant foods to rigorous nutritional,
toxicological, and allergenic tests on animals and humans, prior to
market debut, instead of blindly drawing on industry-generated
data and studies to affirm the rebuttable presumption that nucleic
acid proteins are generally recognized as safe when used in the
modifications of transgenic plant foods and should therefore be
exempt from food additive petitions.308 Moreover, the FDA's
excuse that rigorous toxicological tests could be hamstrung by the
relative difficulty of administering "exaggerated doses" in
"feeding studies" 309 is no justification for not making it an.integral
305 See id. The Court drew on the decisions in Int'l Fabricare Inst. v. EPA, 972
F.2d 384, 389 (D.C. Cir. 1992) and Envtl. Def. Fund, Inc. v. Costle, 578 F.2d 337, 339
(D.C. Cir. 1978).
306 See Alliance for Bio-Integrity, 116 F. Supp. at 177.
307 See Daubert v. Merrell Dow Pharm., 509 U.S. 579 (1993) (discussing the nature
of expert testimony and the criteria for picking and choosing between conflicting
scientific evidence by judges); see also Taiwo A. Oriola, The Propriety of Expert Ethics
Testimony in the Courtroom: A Discourse, 6 J. PHIL. Scl. & L. 1, 1-25 (2006).
308 Alliance for Bio-Integrity, 116 F. Supp. at 175-76 (noting that the Food and
Drug Administration's presumption that the nucleic acid proteins used in genetic
engineering of plants genome was generally recognised as safe, was rebuttable).
Moreover, despite the FDA presumption of GRAS for transgenic plant foods, "certain
genetically modified substances might trigger application of the food additives
petitioning process." Id. The FDA recognised that "the intended expression product in a
food could be a protein, carbohydrate, fat, or oil, or other substance that differs
significantly in structure, function, or composition from substances found currently in
food" and that "such substances may not be GRAS and may require regulation as a food
additive." Id. at 176.
309 See Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed. Reg.
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feature of the approval process for transgenic plant foods. For it is
only by mandating rigorous nutritional, toxicological, and
allergenic tests on transgenic plant foods that novel nucleic acid
proteins used in the alteration of plant genome could automatically
be subjected to food additive petition processes under § 321 (s)310
Furthermore, the plaintiffs in Alliance for Bio-integrity
claimed that transgenic plant food ought to be labeled and that
failure to do so by the FDA was tantamount to denying consumers
with genuine religious concerns and transgenic food allergens a
means of exercising their food preferences.3 ' The FDA had
rejected labeling on grounds that transgenic plant foods were
substantially equivalent to conventional plant foods, and that they
were not legally obliged to label transgenic plant foods under §
321(n).3 12 The court agreed with the FDA, and held that the
agency had limited authority to require labelling of foods under §
321(n),3 13 and that they could only do so where non-labelling
would lead to food misbranding, which would occur where there
was a failure to reveal facts that were material to the consequences
associated with consuming the foods.3 14
The court further noted that since Congress had not "squarely
addressed whether materiality pertains only to safety concerns or
whether it also includes consumer interest,"315 then the FDA must
be allowed to interpret the provisions of § 321(n).3 16 The court
then went on to defer to the FDA's interpretation of the provisions
of § 321(n) to the effect that "no material change" under § 321(n)
at 24.
310 See Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 321(s) (2010)
(discussing what would constitute "food additive" and the circumstances under which a
food additive could be subject to the FDA's approval process).
311 See Alliance for Bio-Integrity, 116 F. Supp. at 177.
312 21 U.S.C. § 321(n) (granting the Food and Drug Administration limited
authority to require food labelling if non-labelling would lead to mis-branding of foods,
which would occur if food labelling "fails to reveal facts . . . material with respect to
consequences which may result from the use of the article to which the labelling ...
relates under conditions of use prescribed in the labelling . .. or under such conditions of
use as are customary or usual"); see also Alliance for Bio-Integrity, 116 F. Supp. at 178.
313 See 21 U.S.C. § 321(n).
314 Alliance for Bio-Integrity, 116 F. Supp. at 178 (emphasis added).
315 Id.
316 JI.
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had occurred "in the rDNA derived foods at issue," and that the
FDA's "exclusion of consumer interest from factors which
determine whether a change is 'material' constitutes a reasonable
interpretation of the statute."317 The court further noted that it was
doubtful whether the FDA had the power under § 32 1(n) to require
labelling in circumstances where the sole basis was consumer
demands.318 The court finally emphasized the virtual
implausibility of labelling under § 321(n) as follows:
Plaintiffs fail to understand the limitation on the FDA's power to
consider consumer demand when making labeling decisions
because they fail to recognize that the determination that a
product differs materially from the type of product it purports to
be is a factual predicate to the requirement of labeling. Only
once materiality has been established may the FDA consider
consumer opinion to determine whether a label is required to
disclose a material fact. Thus if there is a material difference,
and consumers would likely want to know about the difference
then labelling is appropriate. If however, the product does not
differ in any significant way from what it purports to be, then it
would be misbranding to label the product as different .... The
FDA has already determined that, in general, rDNA
modification does not "materially" alter foods, and . .. this
determination is entitled to deference . . . the FDA lacks a basis
upon which it can legally mandate labelling, regardless of
consumer demand.
It is thus clear that the substantial equivalence doctrine was the
basis for the court's rejection of plaintiffs' claims for the labelling
of transgenic plant foods and refusal to automatically subject
transgenic plant foods to "food additive" scrutiny.3 20
However, it is submitted that the court was wrong to have
discountenanced and excluded "consumer interest" or "consumer
demand" from its interpretation of what constitutes "material
facts" for the purposes of determining whether or not "foods
317 Id. at 179.
318 Id.; see also Stauber v. Shalala, 895 F. Supp. 1178, 1193 (W.D. Wis. 1995)
(holding that "in the absence of evidence of a material difference between [milk cows
treated with a synthetic hormone] and ordinary milk, the use of consumer demand as the
rationale for labelling would violate the Food, Drug, and Cosmetic Act").
319 Alliancefor Bio-Integrity, 116 F. Supp. at 179.
320 See 21 U.S.C. § 321(s) (defining "food additive").
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misbranding" had occurred to warrant labelling of transgenic plant
foods under § 321(n). 3 2' This is especially so since Congress did
not expressly make any distinction between "safety concerns" and
"consumer interest" in the determination of what constitutes
"material facts" for the purposes of establishing whether "foods
misbranding" had occurred to justify labeling of transgenic plant
foods under § 321(n).3 22 But then, by narrowly conceptualising
"material facts" solely in safety terms for the purposes of labelling
of transgenic plant foods, the court was able to focus entirely on
scientific considerations, which were easily explained by the
doctrine of substantial equivalence that posits that transgenic plant
foods were substantially equivalent to conventional plant foods.323
However, whilst this interpretation of § 321(n) rendered the
labeling debates moot and nugatory, it completely glossed over
genuine consumer interest in being able to make a free choice
between transgenic and non-transgenic plant foods, as exemplified
by the ninety-four percent support for labeling of transgenic plant
foods in a 2003 survey in the United States.324
However, even the use of substantial equivalence doctrine
would not quell safety concerns, as it is no magic wand that would
automatically assuage concerns or resolve conflicting science on
the possible risks posed by new transgenic plant foods toxins and
allergens for humans. For instance, as previously noted, the
European Union holds the view that "whilst substantial
equivalence is a key step in the procedure for assessment of the
safety of genetically modified foods, it is not a safety assessment
in itself."3 25 This view was re-echoed by Esther J. Kok and Harry
A. Kuiper, who opined that the substantial equivalence doctrine
was no more than "a tool to identify potential differences"
between conventional and transgenic plant crops and should not
321 Alliance for Bio-Integrity, 116 F. Supp. at 178.
322 See id. (recognizing that Congress did not expressly define what would
constitute "material facts" for the purposes of determining whether food misbranding
had occurred to warrant labelling of transgenic plant foods under the Federal Food,
Drug, and Cosmetic Act).
323 See Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed. Reg.
22984, 24 (May 29, 1992).
324 See PAARLBERG, supra note 31, at 17-23.
325 See European Parliament & Council on Genetically Modified Food and Feed,
(EC)No.1829/2003 of 22 Sept. 2003, art. 2(12) T 6.
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displace or override toxicological and nutritional studies, which
were key to assessing the safety and nutritional impacts of
transgenic plant foods on humans and animals.3 26 The authors
then suggested rephrasing of the substantial equivalence principle
as the "Comparative Safety Assessment" approach, which "better
outlines the comparative nature of the assessment, while avoiding
the idea that it is a safety assessment in itself."3 27 Indeed, both the
FDA and the court in Alliance for Bio-integrity seemed cognizant
of the limits of the substantial equivalence doctrine. The former
noted that transgenic plant foods "are likely in some cases to
present more complex safety and regulatory issues than seen to
date,"3 28 and the latter reasoned that the subject "is characterized
by scientific and technological uncertainty,"3 29  and that
"ultimately, it is the food producer who is responsible for assuring
safety."3 30 Arguably, these assertions by the FDA and the court
are no more than tacit disclaimers on the presumed viability or
reliability of the substantial equivalence doctrine and, by
extrapolation, a tacit acknowledgement of the uncertainty of its
underlying science, inevitably raising questions on its propriety for
transgenic plant foods governance.
In the following section, the article will examine the
conflicting scientific studies and opinions on transgenic plant
foods allergens and toxins, and further aims to demonstrate the
weakness of the substantial equivalence doctrine, as well as
underscore the limits of the "science" that underpins the regulatory
science systems for the governance of transgenic plant agriculture
and foods.
326 See Esther J. Kok & Harry A. Kuiper, Comparative Safety Assessment for
Biotech Crops, 21 TRENDS BIOTECHNOLOGY 439, 440 (2003).
327 Id. at 443.
328 See Premarket Notice Concerning Bio-engineered Foods, 66 Fed. Reg. 4706,
4709.
329 See Alliance for Bio-Integrity v. Donna Shalala, 116 F. Supp. 2d 166, 177 (D.
D.C. 2000).
330 Id
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C. Conflicting and Conflicted Science on New Allergens and
Toxins in Transgenic Plant Foods
The transfer of desirable nucleic acid proteins (DNA) from one
organism into another, irrespective of speciation, is the critical
mass of genetic engineering techniques. 331' DNA is found in all
living things. DNA transmits, encodes, and expresses genetic
information.3 32 In the context of plant genetic engineering
techniques, desirable DNA from Bt bacterium with pest resistance
properties are routinely transferred into plant crops that range from
maize, soybeans, canola, to cotton, with concomitant acronyms
like Bt maize, Bt soybeans, and Bt cotton.3 33
However, there are proven possible and numerous side-effects
to the alteration of plant genome via the insertion of novel or
foreign DNA. For example, it has been established that genetic
alteration or modification of plant crops via novel DNA could
affect the expression of non-target genes in the plant's genome.33 4
Indeed, the FDA acknowledged that the insertions of rDNA into a
genetically active chromosomal location in plant genome could
disrupt or hamstring important genes or regulatory sequences that
underpin the expression of one or several genes.33 The FDA also
acknowledged that transgenic plant developers using rDNA
technology could not control with precision the ultimate location
at which the inserted nucleic acid proteins would settle in the plant
genome.336 Furthermore, the FDA acknowledged that the insertion
of multiple foreign or novel genes into plant genome "to generate
new metabolic pathways" could precipitate unpredictable changes
or mutations in plant genome,3 37 and dramatically alter the
331 See KLOPPENBURG JR., supra note 15, at 2-4; see also REISs & STRAUGHAM,
supra note 14, at 1-2.
332 See Alliance for Bio-Integrity, 116 F. Supp. at 176-77 (expressing views worthy
of note).
333 See Madhuri Kota et al., supra note 105, at 1840-45 (discussing Bacillus
thuringiensis).
334 See Krimsky & Murphy, supra note 53, at 84.
335 See Prernarket Notice Concerning Bio-engineered Foods, 66 Fed. Reg. 4706,
4706-38 (Jan. 18, 2001).
336 Id. at 4710.
337 Id. at 4709.
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composition of transgenic plant crops significantly, with
concomitant nutritional, toxicity, and safety issues."'
Yet, while the full ramifications of the numerous possible side-
effects of the alteration of plant genome on food toxicity and
nutrition quality are currently unknown,33 9 and despite the
reservations of some scientists,3 40 and that of the FDA on the
nutritional, toxicity, and allergenic implications of the introduction
of novel or foreign genes into a food crop, transgenic plant foods
and products are not automatically treated as additive by the FDA
due largely to the substantial equivalence doctrine, unless there is
evidence of health risk for humans stemming from the expression
of novel proteins in transgenic plant foods.3 4 ' For example, due to
the possible presence of antibiotic resistance properties in its
delayed-ripening Flavr Savr tomato, Calgene filed for a food
additive petition with the FDA during the consultation procedure
for the approval of the transgenic tomato.3 42  The food additive
petition was necessary because the company had "introduced
genes into the cells of the tomato that made them resistant to
kanamycin and neomycin, two clinically used antibiotics."34 3
338 Id. at 4710; see also Mathilde Bourrier, Applying Safety Science to Genetically
Modified Agriculture, in GOVERNING RISK IN GM AGRICULTURE 236, 236 (discussing
how transgenic agriculture has added new safety issues that ranged from adventitious
commingling of transgenic and non-transgenic crops, environmental safety concerns to
"new food safety issues").
339 See Schubert, supra note 182, at 969.
340 See Kok & Kuiper, supra note 326, at 441 (noting concerns expressed by
scientific and public groups on the "unintended and unexpected side effects" of
transgenic plant food consumption on human and animal health); see also Billings &
Shorett, supra note 163, at 79-80 (discussing 1999 studies conducted by Marc Lappe and
colleagues and published in the Journal of Medicinal Food, which indicated that
soybeans "genetically modified for herbicide tolerance contained significantly lower
levels of phyto-estrogens than their conventional counterparts"). Authors also cited
industry studies of soybeans showing "heightened Trypsin inhibitor levels in defatted
non-toasted soybean meal," and limited experiments on transgenic herbicide-resistant
maize, which showed "unexpected changes in fat and carbohydrate content." Id.
341 See Krimsky & Murphy, supra note 53, at 83 (describing the principle of the
substantial equivalence doctrine); see also Alliance for Bio-Integrity v. Donna Shalala,
116 F. Supp. 2d 166, 176 (D. D.C. 2000) (dismissing plaintiffs' request that transgenic
foods be regarded as containing additives due to the presence of novel or foreign nucleic
acid proteins, on grounds that nucleic acid proteins were generally recognised as safe
given its integral part of all living organisms).
342 See Krimsky & Murphy, supra note 53, at 86-87.
343 Id
824 Vol. XXXIX
2014 REGULATION AND TRANSGENIC PLANT AGRICULTURE
Even where food additive petitions are not filed by transgenic
plant crop developers, on the assumption that their transgenic
crops are comparably similar to conventional crops, scientists are
still divided on the nutritional, toxicity, and allergenic implications
of transgenic plant foods for human consumption.3"
In the following paragraphs, the article will consider in
seriatim, the conflicting scientific literature on the degree to which
transgenic plant foods for human consumption are susceptible or
prone to new allergens and toxins. The primary aim is again to
underscore the frailty of the science underlying the regulatory and
policy framework for transgenic plant agriculture and foods and,
by extrapolation, to concomitantly challenge the basis for
science's exclusive prerogative on the governance systems for
transgenic plant agriculture and foods.
i. Conflicting Scientific Views on Transgenic Plant
Food Allergens
According to Samuel B. Lehrer et al., food allergens are
mostly proteins or glycol-proteins.3 45  Food allergies are said to
occur from "adverse immunology reactions to proteins" and other
components in food.3 46 The most common type of food allergies
are "immediate hypersensitivity reactions, which occur when
immunoglobulin E (IgE) antibodies bind to an allergen, causing
symptoms that range from mild itching and diarrheal to life-
threatening anaphylactic shock."3 47  However, scientists believe
that the percentage of allergenic proteins is small, and that only
approximately two hundred of the thousands of proteins that are
344 See Trish Malarkey, Human Health Concerns with GM Crops, 544 MUTATION
RESEARCH 217, 221 (2003) (discussing the potential allergenicity and toxicity of
transgenic plant foods and noting how the safeguard measures in place are sufficient to
ensure that transgenic plant foods "are as safe and nutritious as conventional
counterparts" and that "the changes in the composition of existing foods produced
through biotechnology are limited and have no adverse nutritional or safety
consequence"). This conclusion is sharply contradicted by a 1996 publication that
demonstrated that a major Brazil nut allergen had been transferred into Pioneer Hi-Bred
transgenic soybeans; see also Billings & Shorett, supra note 163, at 83.
345 See Samuel B. Lehrer et al., Why Are Some Proteins Allergenic? Implications
for Biotechnology, 36 CRITICAL REV. FOOD SCI. & NUTRITION 553, 553-564 (discussing
allergenic proteins).
346 See Billings & Shorett, supra note 163, at 82.
347 Id.
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consumed in foods are allergens.34 8 It is also estimated that two
percent of adults and eight percent of children in industrialized
countries suffer from food allergies, and that ninety percent of
food allergies ranging from moderate to severe are due to "a
narrow range of nuts, cereal grains, seafood, soybeans, and dairy
products,"34 9 demonstrating that food allergies are common to both
transgenic and conventional plant foods.3"o However, unlike
transgenic plant foods, conventionally cultivated crops have "a
well-established history of safe use,"35 while categories of
allergenic foods such as Brazil nuts, are relatively well defined
and fairly established, albeit "difficult to detect."3 52
With regards to allergens in transgenic plant foods, Samuel B.
Lehrer et al. noted that while most transgenic plant foods were
considered safe, biotechnology manipulation could affect crop
allergenicity.353 The authors suggested that it would be relatively
easy to evaluate and minimize allergens in transgenic plant foods,
if the sources of the genes responsible for the allergens were
known.3 54 The authors further observed that the greatest challenge
posed by allergens in transgenic plant foods was in determining
whether or not a particular protein was allergenic, and then
discovering the source of that protein." The authors also noted
that whilst there was no generally, established procedure for
defining or predicting a protein's allergenicity, methods ranging
348 Malarkey, supra note 344, at 219.
349 See Billings & Shorett, supra note 163, at 82.
350 See Kok & Kuiper, supra note 326, at 443 (noting that "traditional plant
breeding practices such as chemical mutagenesis might lead to higher rate of mutations
compared with genetic changes induced by recombinant DNA technology").
351 European Parliament & Council on Genetically Modified Food and Feed, (EC)
No.1829/2003 of 22 Sept. 2003, art. 2(12) (defining conventional plant crops as "food or
feed produced without the help of genetic modification and for which there is a well-
established history of safe use").
352 See PINSTRUP-ANDERSEN & SCHIOLER, supra note 10, at 42-43 (citing Samuel B.
Lehrer's view on how complex and extensive allergy tests were and how most foodstuffs
would never pass the tests); see also Billings & Shorett, supra note 163, at 82 (noting
that "food allergies are difficult to detect, measure objectively and assess in terms of
their impact on human health generally").
353 Lehrer et al., supra note 345, at 554.
354 Id. at 554 (discussing how scientists used traditional in vitro inhibition assays to
reduce allergen contents in transgenic rice).
355 Id.
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from the comparison of the structures of the novel protein with
known allergens, to Th-2 cell simulation, to IgE antibody
induction in animal models, could be useful in identifying and
reducing allergenic proteins in transgenic plant foods. 6 In the
same vein, a joint consultation policy statement by the FAO/WHO
formulated a "decision-tree" methodology for assessing potential
allergens in transgenic plant foods."' According to the
FAO/WHO report, the "decision-tree" approach:
is a strategy which focuses on the source of the gene, the
sequence homology of the newly introduced protein to known
allergens, the immunochemical binding of the newly introduced
protein with IgE from the blood serum of individuals with
known allergies to the transferred genetic material, and the
physicochemical properties of the newly introduced protein.358
Significantly, whilst Samuel B. Lehrer et al. conceded that
transgenic plant foods could be allergenic, they concluded that
there was no evidence that rDNA in transgenic plant foods were
more allergenic than traditional proteins in conventionally grown
plant foods." 9 Notably, this view is shared by several scientists,
including E.J. Kok et al., who argued that transgenic plant foods
were no less safe and no more allergenic than conventional plant
foods, and that instead of merely relying on history of safe usage,
conventionally grown plant foods should be subjected to
comparative safety, allergenic, and toxicity tests that were the
norms for transgenic plant foods.3 60 However, albeit ingenious, it
is doubtful that justifying transgenic plant foods on grounds that
they are no more allergenic than conventionally cultivated plant
foods would persuade skeptics to renounce their entrenched bias
against transgenic plant foods. Furthermore, the hypothesis that
356 Id. at 558.
357 See Food and Agriculture Organization & World Health Organization, Jan. 22-
Jan. 25, 2001, Evaluation of Allergenicity of Genetically Modified Foods, available at
http://www.who.int/foodsafety/publications/biotech/en/ecjan2001.pdf.
358 Id. at 5.
359 See Lehrer et al., supra note 345, at 563-64 (discussing allergenic proteins).
360 See E.J. Kok et al., Comparative Safety Assessment of Plant-Derived Foods, 50
REG. TOXICOLOGY & PHARMACOLOGY 98, 98-113 (2008); see also Kok & Kuiper, supra
note 326, at 439-44; Malarkey, supra note 344, at 217-21; A Konig et al., Assessment of
the Safety of Foods Derived from Genetically Modified (GM) Crops, 42 FOOD &
CHEMICAL TOXICOLOGY 1047, 1047-88 (2004).
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transgenic plant foods are no more allergenic than conventional
plant foods arguably smacks of classic "mudslinging" no-food-
types-are-allergens-free retort, which fails to offer any evidence of
superior or comparative advantages of transgenic plant foods over
conventionally grown foods in allergens reduction terms, and
thereby dispels safety concerns on transgenic plant foods
allergens, especially in Europe.36 1
Also, and most significantly, the hypothesis that transgenic
plant foods are no less allergenic than conventional plant foods
could further alienate the generally skeptical public, and reinforce
their preference for conventionally grown plant foods, which are
familiar, have been around for ages, and do enjoy a long history of
safe usage relative to novel or transgenic plant foods.3 62  Thus,
given the reality that both transgenic and conventional plant foods
are susceptible to allergens, the choice between transgenic and
conventional plant foods for the skeptical public could ultimately
be framed in terms of "better the devil you know than the devil
you do not know." Therefore, for the informed consumers who
are enabled by labeling law to choose between transgenic and
conventional plant foods,3 63 nothing short of proven evidence of
superior safety records for transgenic plant foods in allergens
reduction terms, could likely detract from their preference for the
familiar conventionally grown plant foods with concomitant
advantage of a long history of safe use.364
However, the pertinent question, which is central to the theme
of this article, is: if transgenic plant foods were no less safe and no
361 See Lee, GM Resistant: Europe and the WTO Panel Dispute on Biotech, in
ETHICS, LAW, AND SOCIETY, supra note 29, at 131-39 (discussing safety concerns for
transgenic plant foods in Europe).
362 See, e.g., European Parliament & Council on Genetically Modified Food and
Feed, (EC) No. 1829/2003 of 22 Sept. 2003, art. 2(12) (noting that conventional crops
are defined by the European Union as "food or feed produced without the help of genetic
modification and for which there is a well-established history of safe use").
363 Oriola, supra note 123, at 535 (discussing the legal and ethical imperatives for
transgenic plant food labeling, and discussing inter alia the State of Oregon's abortive
transgenic plant food labeling initiatives). It goes without saying that the choice between
transgenic and conventional foods is only plausible under a labeling regime, which is the
norm in Europe, but shunned in the United States. Id.
364 See European Parliament & Council on Genetically Modified Food and Feed,
(EC) No. 1829/2003 of 22 Sept. 2003, art. 2(12) (describing conventional plant crops as
having "a well-established history of safe use").
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more allergenic than conventionally grown plant foods, why the
abiding concerns about transgenic plant foods allergens amongst
certain scientists?36 5  For there are scientists who passionately
disagree with the scientific stance espoused by Samuel B. Lehrer
et al., that transgenic plant foods are no less allergenic or no less
prone to allergens than conventional plant foods.366 For example,
Mae-Wan Ho and Lim Li Ching colleague argued that studies such
as that of Samuel B. Lehrer et al., are unreliable due to "paucity of
published data."3 67  According to Ho and Ching: "There is a
distinct scarcity of published data relevant to the safety of GM
foods. Not only that, the scientific quality of what has been
published is, in most instances, not up to the usually expected
standards of good science."3 68
Moreover, Ho and Ching further buttressed their criticisms of
the safety science of transgenic plant foods by drawing on the
evidence of cancer expert, Stanley Ewen, regarding the safety of
transgenic plant crops before the Scottish Parliament as follows:
"It is unfortunate that very few animal trials of GM human food
are available in the public domain in scientific literature. It
follows that GM foods have not been shown to be without risk
and, indeed, the available scientific experimental results
demonstrate cause for concern."'
However, it is certainly not sufficient to disprove the validity
or reliability of the scientific literature on the safety science of
transgenic plant foods merely on grounds of paucity of published
scientific data. Surely, concrete scientific data should be proffered
to counter the hypothesis that transgenic plant foods are no more
allergenic and therefore no less safe than conventional plant
foods?370 Notably, those scientists, who believe that transgenic
365 See SMITH, supra note 168, at 51 (citing medical personnel and scientists who
claimed that transgenic soybeans could be highly susceptible to allergens, and a
physician allergy specialist, John Boyle, who claimed that transgenic soybeans "is so
dangerous that I tell people never to eat it").
366 See Ho & CHING, supra note 101, at 21-23.
367 Id. at 21. Mae-Wan Ho is a prominent opponent of transgenic plant agriculture
and foods.
368 Id
369 Id.
370 See PAPINEAU, supra note 71, at 98 (noting that scientific knowledge and
theories are grounded on deductions or data derived from observations and controlled
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plant foods are prone to food allergens, often tend to seek evidence
in the weakness of the safety science that underpins the production
process of transgenic plant foods. For instance, some scientists
contend that not only are transgenic plant foods more prone to
allergens than conventional plant foods, but that such allergens
could be more difficult to tackle because they: "[i]nclude gene
transfer from biological sources with known allergenicity and the
unanticipated creation of novel allergens through gene inactivation
or over expression of genes that code for a minor allergen.""'
In other words, while the categories of conventional plant
foods with allergens, such as Brazil nuts,3 72 are fairly and
relatively known, transgenic plant foods potentially could create
unknown or novel allergens. This is exemplified by the
acknowledgement of the FDA that the insertion of multiple
foreign genes into plant genome "to generate new metabolic
pathways," could dramatically alter the composition of transgenic
plants crops significantly with concomitant nutritional, toxicity,
and safety implications.3 73 Furthermore, transgenic plant foods are
said to be more susceptible to allergens because they not only
incorporate proteins into the food systems "from known source[s]
of common allergens," but many transgenic plants in development
also embody allergenic proteins from "organisms never previously
consumed as food." 37 4
Scientists have also argued that whilst it was difficult enough
to predict and tackle transgenic crops allergens using the
FAO\WHO criteria,375 the task has been further exacerbated by
experiments conducted on the physical and natural world, and not mere assumptions or
wild speculations); see also PIELKE, JR., supra note 74, at 43-44 (discussing how the
grounding of scientific knowledge on observable facts led to the ascription of high value
to scientific information by the society, vis-a-vis non-scientific information, which the
society tended to perceive negatively).
371 Billings & Shorett, supra note 163, at 83.
372 See Marion Nestle, Allergies to Transgenic Foods: Questions of Policy, 334
NEW ENG. J. MED. 722, 726 (1996) (noting that nuts are among the most common food
allergies).
373 See Premarket Notice Concerning Bioengineered Foods, 66 Fed. Reg. 4706,
4710 (Jan. 18, 2001).
374 Billings & Shorett, supra note 163, at 84.
375 Id. at 83 (noting that even the FAO\WHO reports acknowledged that current
criteria for predicting the allergenicity of crops were unreliable).
830 Vol. XXXIX
2014 REGULATION AND TRANSGENIC PLANT AGRICULTURE
biotechnology companies' increasing use of microorganisms
rather than food plants as gene donors."' Furthermore, critics
have noted how biotechnology companies routinely design and
customize proteins "even though the allergenic potential of these
newly introduced microbial proteins is uncertain, unpredictable[,]
and untestable."37 7 Even studies conducted by Monsanto scientists
revealed that Monsanto's "glycophosate-tolerant soybeans showed
a 28 percent increase in Kunitz trypsin inhibitor, a known anti-
nutrient and allergen." 378
Scientists who believe that transgenic plant foods are more
susceptible to allergens often reference a 1996 study published in
New England Journal of Medicine,3 79 which found a major Brazil-
nut allergen in Pioneer Hi-Bred transgenic soybeans.38" The
Brazil-nut allergen had found its way into the Pioneer Hi-Bred
transgenic soybeans when Pioneer Hi-Bred scientists inserted
Brazil-nut gene, 2S albumin, into soybeans genome in order to
increase the amount of sulphur-containing amino acids methionine
and cysteine in soy-based animal feed. 3 8' The Brazil-nut's 2S
albumin is especially rich in methionine and cysteine, and "its
gene was a logical choice as a donor." 38 2 Whilst the primary aim
of the experiment was to enrich the constituent protein of the
Pioneer Hi-Bred's transgenic soybeans with beneficial amino acid
(methionine),3 83 IGE immunoreactivity tests on the blood samples
of volunteers revealed that those who were allergic to Brazil-nut
were also allergic to the Pioneer Hi-Bred transgenic soybeans. 3 84
According to Julie A. Nordlee et al, the study firmly established
376 See Nestle, supra note 372, at 726.
377 Id.
378 Billings & Shorett, supra note 163, at 84.
379 See Julie A. Nordlee et al., Identification of a Brazil-nut Allergen in Transgenic
Soybeans, 334 NEw ENG. J. MED. 688, 688-93 (1996).
380 Id.
381 Id. at 688.
382 Nestle, supra note 372, at 726.
383 See Nordlee et al., supra note 379, at 688 (discussing the nutritional quality of
legumes). Legumes, such as soybeans, for humans and animals, are compromised by the
deficiency of methionine in the "protein faction of the seeds." Id. Consequently,
domestic animals fed on soybeans must have their feed fortified "with methionine or
protein sources of this essential amino acid." Id.
384 Id.
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that "an allergen from a food known to be allergenic can be
transferred into another food by genetic engineering."
However, whilst it would appear relatively easy to determine
that a natural or known allergenic food crop could retain its
allergenic properties when genetically transferred into another
food crop, such a determination is not always as easy to make
from experimental studies. This is exemplified by an experimental
animal study, in which the Brazil-nut transgenic soybeans failed to
induce an immunoglobulin response. This led the authors of the
study to conclude that the Pioneer Hi-Bred transgenic soybeans
infused with Brazil-nut genes were non-allergenic.38 6 Thus,
without the subsequent human study, the transgenic soybeans in
question could have slipped through scientific and regulatory net
virtually undetected.38 7 Therefore, the discrepancies in the results
between the prior animal study and the subsequent human study
led scientists to conclude that the subsequent positive allergenic
results of Brazil-nut transgenic soybeans on humans had been
fortuitous, as responses in animals could not reasonably predict
responses in humans.388 However, since Pioneer Hi-Bred
transgenic soybeans were designed primarily for animal feeds and
not human consumption, it should not have mattered much that it
was allergenic. But then, given the increasing incidences of
adventitious commingling of unapproved transgenic crops with
food crops, as exemplified by the StarLink corn fiasco,38 9 there
385 Id.
386 See Mitchell Berger, Public Health and Agricultural Biotechnology: A Review
of the Legal, Ethical, and Scientific Controversies Presented by Genetically Altered
Foods (Mar. 22, 2000) (unpublished dissertation, Emory University) (on file with Rollins
School of Public Health, Emory University).
387 Id. at 126.
388 See Nestle, supra note 372, at 727 (discussing how the general public was
fortunate in that the donor species (Brazil-nut) was known to be allergenic, serum
samples from persons allergic to Brazil-nut were available for testing, and the product
was subsequently withdrawn). He noted that the public might be less fortunate in the
future, and emphasized "the pressing need to expand basic and clinical research on food
allergies" and the need for more information on the "incidence, prevalence, dietary
exposure, antigenicity, immune responses, diagnosis, and treatment that would help
researchers, regulators, and biotechnology company predict whether transgenic proteins
are likely to cause harm." Id.
389 See infra Part II, sec. A (discussing the StarLink corn as an experimental
transgenic corn that was infused with Trypsin, an insulin precursor, especially designed
to combat diarrheal in piglets by Prodigene Corporation). Although the transgenic corn
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was no sure way of keeping Pioneer Hi-Bred transgenic soybeans
out of the food chain,39 0 underscoring the imperatives for basic and
clinical testing of all transgenic plant food crops on humans for
possible allergens, whether or not they were designed for animal
feeds or human consumption.3 9'
It has been established that food allergens such as those from
Brazil-nut could cause health problems that range from mild-
itching to death.392  However, food allergies are common to both
transgenic and conventional plant foods and are relatively difficult
to detect. 393 On the other hand, conventionally grown plant foods
enjoy a long history of safe usage,394 and the categories of
allergenic foods that are conventionally grown are clearly known
and relatively established. 395  However, as shown under this
section, scientists are clearly divided on whether transgenic plant
foods are no less safe and allergenic than conventional plant
foods.396
was never approved for human consumption, its adventitious entry into the global food
chain caused national and international furor, and underscored the challenges of
segregating transgenic plant crops from non-transgenic crops. Winickoff et al., supra
note 389, at 103.
390 See Berger, supra note 386, at 126.
391 See Nestle, supra note 372, at 728 (recommending the "pressing need for basic
and clinical research on food allergies"). Note however the challenges and limitations of
conducting human feeding studies, which the United States Food and Drug
Administration acknowledged as follows: "feeding studies on whole foods have limited
sensitivity" since it would be relatively difficult "to administer exaggerated doses."
Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed. Reg. 23004
(May 29, 1992).
392 See Nestle, supra note 372 at 726.
393 See also Billings & Shorett, supra note 163, at 82 (noting that "food allergies
are difficult to detect, measure objectively and assess in terms of their impact on human
health generally").
394 See European Parliament & Council on Genetically Modified Food and Feed,
(EC) No. 1829/2003 of 22 Sept. 2003, art. 2(12).
395 See Nordlee, supra note 372, at 688 (noting that allergies to nuts are said to be
the most common food allergies, while allergies to Brazil-nut are well documented).
396 See Lehrer et al., supra note 345, at 563-64 (noting that while transgenic plant
foods are allergies prone, they are no more susceptible to allergies than conventional
plant foods). Contrast this argument with that in Billings & Shorett, supra note 163, at
83 (noting how transgenic plant foods were more susceptible to allergies via
"unanticipated creation of novel allergens through gene inactivation or over expression
of genes that code for a minor allergen"); see also Ho & CHING, supra note 101, at 21
(contending that the published data on the safety of transgenic plant foods were
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The conflicting and conflicted nature of the scientific evidence
on the allergenicity of transgenic plant foods inevitably feeds into
the central theme of this article on the propriety of science's
exclusive prerogative on the governance systems for transgenic
plant agricultural technology and foods. Implicit in this thesis is
the following recurring question: in light of the apparent lack of
unanimity of scientific literature and views as exemplified by the
discourse on transgenic plant foods allergens, should science or
scientific knowledge, which underpins the regulatory and policy
framework for transgenic plant technology, continue to exclude
alternative governance systems such as ethics, religious beliefs,
and conscience, as canvassed by the plaintiffs in Alliance for Bi-
integrity?3 97 The following paragraph will review the literature on
the scientific views on the toxicity of transgenic plant foods and its
relevance to the policy and regulatory framework for transgenic
plant agriculture and foods.
ii. Conflicting Scientific Views on the Toxicity of
Transgenic Plant Foods
Food toxicity is an enduring part of human dietary
experience.39 Like food allergies, toxins are said to be an integral
part of most food plants, and many common food plants are
known to comprise naturally occurring toxins that could be
dangerous to human health if consumed in excess.3 99 For example,
spinach and rhubarb, common vegetables routinely consumed by
the general public, are said to contain "oxalic acid, an anti-
nutritional compound that inhibits calcium and iron absorption"
and could be potentially poisonous if eaten in excess.400
Furthermore, onions are known to harbour sulphuric acid, which
could corrode "the upper gastrointestinal tract of humans" if eaten
in excess.4 0 1 Moreover, many mushrooms species are poisonous
and could be "lethal in small doses," and are often "difficult to
unreliable because the scientific quality were short of "the usual standards of good
science").
397 See Alliance for Bio-Integrity v. Donna Shalala, 116 F. Supp. 2d 166 (D. D.C.
2000); see also infra Part II, sec. B (detailing the facts of the case).
398 See Billings & Shorett, supra note 163, at 84.
399 Id
400 Id
401 Id.
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distinguish from their edible counterparts."402
Therefore, given the reality that some well-known
conventionally grown food plants have innate toxic properties, the
pertinent question is: why are some scientists especially concerned
about increased levels of toxins or the potential for new toxins in
transgenic plant foods relative to conventionally grown plant
foods? Is it because transgenic plant foods are more prone to
developing new toxins other than naturally occurring toxins? If
not, then why do some scientists readily dismiss such concerns?
The following paragraphs will briefly review the conflicting
scientific literature on the nature of transgenic plant foods toxins,
with a view to contextualising the discourse on the uncertainty that
underpins the science on which transgenic plant policy is
predicated, and the propriety of transgenic policy's continual
deference to science at the expense of ethics, culture, and religion-
based policy systems, as canvassed unsuccessfully by plaintiffs in
Alliance for Bio-integrity.403
According to Paul R. Billings and Peter Shorett, genetic
modifications of plant genome could "alter both existing and
unanticipated toxicological characteristics of foods." 40 4  Indeed,
scientific literature is indicative that gene insertion could generate
unexpected and unintended increases in the levels of naturally
occurring toxins.405 As noted previously, even the FDA, one of the
three regulatory bodies for transgenic plant agriculture and foods,
noted in one of its numerous policy papers that the insertion of
multiple foreign genes into plant genome "to generate new
metabolic pathways" could dramatically alter the composition of
transgenic plant crops significantly with concomitant nutritional,
toxicity, and safety implications.40 6
Furthermore, the uncertainties surrounding the implications of
transgenic plant foods for public health was alluded to by John
Godfrey, who noted in his letter to The Lancet that while there was
402 Id
403 See Alliance for Bio-Integrity v. Donna Shalala, 116 F. Supp. 2d 166, 166 (D.
D.C. 2000).
404 See Billings and Shorett, supra note 163, at 84.
405 Id
406 Premarket Notice Concerning Bioengineered Foods, 66 Fed. Reg. 4710 (Jan. 18,
2001) (to be codified at 21 C.F.R. pts 192 and 592).
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no current evidence that transgenic plant foods were inherently
harmful, one could not conclude that all applications would be
harmless due to the possibility of the evolution of new allergens
and toxins.40 7 He also cautioned that while criendotoxin
insecticide was not harmful when judiciously used as a spray, it
was possible for the public to consume "much larger quantities" of
the insecticide in transgenic food crops, such as soybeans and
maize that have been engineered to produce the inherently toxic
insecticide from the DNA of Bt bacterium.40 8
Moreover, as evidence of the prevailing uncertainties
beclouding the safety science of transgenic plant foods, John
Godfrey referenced a 1997 study conducted on mice, which found
that foreign DNA ingested by mice was not completely degraded
by the digestive systems, and that the undigested DNA could
"reach peripheral leucocytes, spleen, and liver via the intestinal-
wall."4 09 Whilst it could be premature to speculate on what could
be the public health implications of undigested toxic transgenic
DNA permanently lodged in the human gut, Susan Bardocz, a
biochemist and nutritionist at the University of Debrecen, offered
the following insights:
As shown in the human feeding experiment, a fully functional
transgenic construct rendering Roundup Ready soya resistant to
glysophate can partially survive in the human gut, it is possible
that functional Bt-toxin transgenes can survive, be taken up by
bacteria resident in alimentary tract and convert us and our
410
animals into pesticide factories.
If the prognosis of Susan Bardocz was correct, then the
digestive systems of half the world's population could potentially
morph "into pesticide factories" overtime, given that transgenic
plant feed and food products, from soybeans and maize, that are
407 See John Godfrey, Do Genetically Modified Foods Affect Human Health? THE
LANCET, Jan. 29, 2000, at 414.
408 Id
409 Id See also Rainer Schubert, Doris Renz, Birgit Schmitz, and Walter Doerfler,
Foreign (M13) DNA Ingested by Mice Reaches Peripheral Leukocytes, Spleen, and Liver
via the Intestinal Wall Mucosa and can be Covalently Linked to Mouse DNA,
PROCEEDINGS OF THE NAT'L ACAD. OF SCIENCES OF THE UNITED STATES OF AMERICA,
Feb. 4, 1997, at 961-966.
410 JEFFREY M. SMITH, GENETIC ROULETTE: THE DOCUMENTED HEALTH RISKS OF
GENETICALLY ENGINEERED FOODS, supra note 168, at 136.
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genetically modified to embody and express the inherently toxic
DNA of Bt bacterium have been commercially available globally
since 1996 for livestock and human consumption. Therefore, any
consequential health problems from indigestible Bt toxins in
human and animal guts would have global public health
ramifications and resonance.4 1'
However, the findings that toxins from transgenic Bt crops
could survive in the guts of humans and animals are routinely
denied by pro-transgenic plant agriculture scientists. For example,
Anthony Trewavas swiftly rebutted and debunked John Godfrey's
observations on the digestibility of Bt toxins in the human gut, in a
rejoinder that was published in The Lancet two months following
the publication of John Godfrey's letter.4 12 In his robust defence
of transgenic Bt plant foods, Anthony Trewavas argued that
transgenic Bt plant foods had been subjected to:
[T]housands of compositional analyses under different growth
conditions of all the major nutrients, anti-nutrients, toxic and
benign alkaloids, and phyto-oestrogens to establish precise
similarities to the parent. The new trait, in this case the Bt toxin,
is then examined separately for possible allergic properties by
tests in six different mammalian species and attempts are made
to establish pharmacological properties by estimating a toxicity
concentration from which safe consumption data can be
estimated. To date, no toxicity concentration has been achieved,
no doubt because like most proteins, Bt toxin is simply digested
in the gut.413
Anthony Trewavas noted further that whilst fragments of DNA
might be found in leucocytes and other cells following digestion,
the inclusion of Bt DNA should cause no concern because millions
of "qualitatively different genes" were ingested daily via plant
411 As noted previously, food and feed crops that incorporated Bt toxins, a naturally
occurring toxic chemical used in pesticide products, have been commercially available
world-wide since 1996. For discussion on the nature of Bt toxins, see Carrie Swadener,
supra note 104, at 13-20. For discussion on the advent of commercial transgenic Bt.
crops in 1996, see ROBERT PAARLBERG, STARVED FOR SCIENCE: How BIOTECHNOLOGY IS
BEING KEPT OUT OF AFRICA, supra, note 31, at 10-11.
412 See Anthony Trewavas, Toxins and Genetically Modified Food, THE LANCET,
Mar. 11, 2000, at 931.
413 Id.
837
N.C. J. INT'L L. & COM. REG.
foods by the general public.4 14 However, the problem with this
analysis is that while millions of "qualitatively different genes"
may be ingested daily via plant foods by the general public, DNA
from Bt bacterium toxins is a natural pesticide with toxic
properties that potentially could cause harm to the human body if
permanently lodged in the human gut.415 Besides, Bt toxin is not
the sort of toxin commonly found in edible plant foods such as
spinach and rhubarb, which could be managed by moderate
consumption.41 Rather, transgenic plant Bt toxin is from Bt
bacterium that is often used to manufacture industrial pesticide4 17
and was never a natural component of plant foods commonly
consumed by humans, until it was genetically incorporated into
commercial food crops globally in 1996.418
The uncertainties underlying the public health implications of
human consumption of Bt toxins in approved transgenic food
crops is further exemplified by a 2011 study by Canadian
scientists,4 19 which would appear to undermine Anthony
Trewavas' claim that "[Bt] toxin is simply digested in the gut."4 20
Scientists at the Department of Obstetrics and Gynaecology, the
University of Sherbrook Hospital Centre in Quebec, Canada,
tested blood samples of pregnant women and found traces of Bt
toxins in ninety-three percent of the pregnant mothers tested, as
414 Id.
415 Bacillus thuringiensis is a bacterium that is naturally imbued with insecticide
properties. As a microorganism, the bacterium is not part of our natural diets. However,
the incorporation of the bacterium's DNA into plant foods via genetic engineering
techniques has brought the bacterium into the food chain with as yet unknown
consequences. For discussion on Bacillus thuringiensis bacterium, see Carrie Swadener,
supra note 104, at 13-20; see also Madhuri Kota, Henry Daniell, Sam Varma, Stephen F.
Garczynski, Fred Gould, and William J. Major, supra note 105, at 1840-45.
416 See Billings & Shorett, supra note 163, at 84 (noting that spinach and rhubarb
contain "oxalic acid, an anti-nutritional compound that inhibits calcium and iron
absorption," which could be potentially poisonous if eaten in excess).
417 See Carrie Swadener, supra note 104, at 13-20.
418 Examples of food crops that have been genetically modified to incorporate the
DNA of Bacillus thuringiensis bacterium are transgenic maize and soybeans. See
ROBERT PAARLBERG, STARVED FOR SCIENCE: How BIOTECHNOLOGY IS BEING KEPT OUT
OF AFRICA, supra note 31, at 10-11.
419 See Aziz Aris and Samuel Leblanc, Maternal and Foetal Exposure to Pesticides
Associated to Genetically Modified Foods in Eastern Townships of Quebec,
REPRODUCTIVE ToxICOLOGY, May 2011, at 534-39.
420 Anthony Trewavas, supra note 412, at 931.
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well as in eighty percent of the umbilical cords studied.4 2 1 Most
significantly, the authors noted that the pregnant women and
umbilical cords in question might have been exposed to Bt toxins
indirectly through the consumption of meat from cattle fed on
transgenic Bt corn feed.4 22 If this were so, the implications would
be that transgenic toxins could not only survive an animal's gut
and digestive systems and ultimately be passed on to the animal's
meat, the toxins could also survive both the cooking process to
which the meat is subjected and the digestive systems of those
who ultimately consume the meat, as exemplified by the study on
Canadian pregnant women and their umbilical cords.4 23 Also, it is
perfectly reasonable and logical to conclude that if pregnant
women and their umbilical cords could be vulnerable to secondary
or indirect exposure to transgenic toxins merely by eating meat
from livestock fed on transgenic Bt corn feed, so could men.
Also, contrary to Anthony Trewavas' claim that "Bt toxin is
simply digested in the gut," 42 4 the scenario of indirect or secondary
exposure also makes it highly plausible that the public could be
directly and permanently exposed to Bt toxins by eating transgenic
Bt food crops such as soybeans and corn, thus corroborating
scientific opinions such as those expressed by John Godfrey in his
letter to The Lancet in January 2000,425 and Susan Bardocz. 426
However, unsurprisingly, the findings by Canadian scientists
Avis and Leblanc were characteristically and swiftly challenged
and disputed in a rejoinder by Bayer CropScience, the primary
registrant of glufosinate-ammonium, the active ingredient in
transgenic Bt. corn and soybeans that was the subject of Avis and
Leblanc's study.427 Bayer CropScience, who had a commercial
interest in the transgenic Bt corn feed in question, wrote a
421 See Aziz Aris and Samuel Leblanc, supra note 419, at 534-39.
422 See id.
423 See id.
424 Anthony Trewavas, supra note 412, at 931.
425 See John Godfrey, supra note 407, at 414.
426 See JEFFREY M. SMITH, GENETIC ROULETTE: THE DOCUMENTED HEALTH RISKS
OF GENETICALLY ENGINEERED FOODS, supra, note 168, at 136.
427 See Ann Blacker, Richard Breum, Stephen Dacus, Pat Kwiatkowski, Frank
Laporte, Bryan Mallyon, Kent Rupprecht, and Klaus Stumpf, Bayer CropScience's
Position on the Findings of Glufosinate and its Metabolite, REPRODUCTIVE TOXICOLOGY,
Dec. 2011, at 494-95.
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rejoinder in which they disputed and questioned "the accuracy and
credibility of the authors' findings and conclusions related to
glufosinate and metabolite 3-MPPA." 42 8 However, in his response
to Bayer CropScience's rejoinder, Aziz Aris, the lead researcher of
the Canadian study countered as follows:
[T]he comments of the authors of BCS remain speculation
derived from studies on animals. Our study is the first to
demonstrate in humans traces of pesticides, used especially in
crops genetically modified to tolerate them. Our study has the
merit to provide an order of magnitude of actual concentrations
in human serum. What is reassuring is that the concentrations
found are far below those in used in animal toxicology.
However, as pesticides are bioaccumulative, endocrine
disruptors at low doses and acting in the long-term, other human
studies must be conducted to develop guidelines. These studies
should involve all players, both private and public. 429
But then, scientists are not only divided on whether or not
DNA from the Bt bacterium toxins consumed in transgenic Bt
plant foods could accumulate overtime and be permanently lodged
in the guts of animals and humans. 430  There is also a lack of
unanimity of views amongst scientists on the possible health
effects of transgenic Bt plant toxins in mammals. This is
exemplified by a 2012 study by French scientists, which
demonstrated that mice fed on transgenic Bt maize developed
cancerous mammary tumours and severe liver and kidney
damage.43 1 In the study, mice were fed on a two-year diet of
transgenic Bt herbicide-tolerant maize that has been approved for
human consumption by authorities in the United States, Canada,
the European Union, and around the world.432 Prior to the two-
year feeding study on mice, there had been several biotechnology
428 Id. at 494.
429 Aziz Aris, Response to Bayer CropScience's Position on the Findings of
Glufosinate and its Metabolite, REPRODUCTIVE TOXICOLOGY, Dec. 2011, at 497.
430 See JEFFREY M. SMITH, GENETIC ROULETTE: THE DOCUMENTED HEALTH RISKS
OF GENETICALLY ENGINEERED FOODS, supra note, 168, at 136 (citing Susan Bardocz, a
biochemist and nutritionist).
431 See Gilles-Eric S6ralini et al., Long Term Toxicity of a Roundup Herbicide and
a Roundup-tolerant Genetically Modified Maize, FOOD AND CHEMICAL TOXICOLOGY,
Nov. 2012, at 4224-25.
432 See id. at 4221.
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industry studies comprising ninety day feeding trials on mice,
although there was no legally mandated chronic animal studies on
approved herbicide-tolerant transgenic plant foods.433 Moreover,
although there had been prior "long-term and multi-generational
animal feeding trials" with contrasting safety results,43 4 the French
study was the first of its kind to have conducted an investigation
on NK603 R-tolerant maize, and included evidence of "a detailed
follow-up of the animals with up to [eleven] blood and urine
samples over [two] years."435 Whilst the mice in the study
suffered debilitating ailments including cancerous mammary
tumours, liver damage, and kidney damage, approximately fifty
percent of males and seventy percent of females in the groups on
the diet containing transgenic NK603 glysophate maize died
prematurely.43 6
Although the French study was not the first to link the
consumption of transgenic crops to debilitating diseases in mice,437
characteristically, the study was swiftly rebutted and condemned
by the European Food Safety Authority (EFSA), Monsanto
Corporation, and scientists from the academia. For example, in its
October 2012 Press Release, the EFSA concluded that the French
study was "of insufficient scientific quality to be considered as
433 See id.
434 See id. at 4222 (noting that there had been previous "long-term and multi-
generational animal feeding trials" had produced contrasting results "with some possibly
providing evidence of safety, while others conclude on the necessity of further
investigations because of metabolic modifications.").
435 See id.
436 See Gilles-Eric S6ralini, supra note 431, at 4223.
437 For example, the study on transgenic potatoes conducted by Professor Arpad
Pusztai and colleagues at the Rowett Institute, under the auspices of the Scottish Office
of Agriculture, Environment and Fisheries Department, demonstrated that young rats
fed on diets from transgenic tomatoes had their vital organs and immune systems
compromised. For discussion, see Ho & CHING, supra note 101, at 21-22. Similarly, Dr.
Irina Ermakova of the Institute of Higher Nervous Activity and Neurophysiology of the
Russian Academy of Sciences, conducted a study, which showed that more than half of
rats' offspring fed on transgenic soybeans dies in the first week of life. The mortality
rate was six times that of offspring born to mothers fed on normal diets. The result was
characteristically disputed by Monsanto Corporation, but the United States National
Institute of Health was asked to conduct an independent study by the American
Academy of Environmental Medicine. For discussion, see F. WILLIAM ENGDAHL, SEEDS
OF DESTRUCTION: THE HIDDEN AGENDA OF GENETIC MANIPULATION, supra note 79, at
245-46.
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valid for risk assessment." 43 8 The Press Release noted further that:
EFSA's initial review found that the design, reporting and
analysis of the study, as outlined in the paper, are inadequate.
To enable the fullest understanding of the study the Authority
has invited authors Sdralini et al., to share key additional
information. Such shortcomings mean that EFSA is presently
unable to regard the authors' conclusions as scientifically sound.
The numerous issues relating to the design and methodology of
the study as described in the paper mean that no conclusions can
be made about occurrence of tumours in the rats tested.
Therefore, based on the information published by the authors,
EFSA does not see any need to re-examine its previous safety
evaluation of maize NK603 nor to consider these findings in the
ongoing assessment of glyphosate.43 9
However, while the EFSA sought further clarifications and
scientific data from the authors, other criticisms were withering
and less circumspect. For example, by the first week of November
2012, there had been at least seventeen rejoinders to the editors of
the Journal of Food and Chemical Toxicology, sixteen of which
were extremely critical of the study.440 The rejoinder written by
scientists at Monsanto Corporation concluded as follows:
As a result of methodological failures, incomplete data
presentation, and lack of proper statistical analysis, S6ralini et
al.'s conclusions regarding NK603 and or Roundup cannot be
supported by the present data. Indeed, the fundamental flaw in
regards to the number of animals employed makes it highly
unlikely that any of the purported findings can be statistically
supported using standard approaches to analysis even if more
data were to be provided by the authors.44 1
438 See Press Release, European Food Safety Authority, EFSA Publishes Initial
Review on GM Maize and Herbicide Study, (Oct. 4, 2012), http://www.efsa.europa.eu/
en/press/news/121004.htm (last visited Oct. 7, 2013).
439 Id.
440 As of November 12, 2012, a cursory look at the journal's website showed that
there were at least seventeen letters and rejoinders on the French study to the editors of
Food and Chemical Toxicology. See Science Direct in SC,
http://www.sciencedirect.com/science/article/pii/S0278691512005637 (last visited Oct.
7,2013).
441 See Bruce Hammond, Daniel A. Goldstein, and David Saltmiras, Letter to the
Editor, FOOD AND CHEMICAL TOXICOLOGY, (Nov. 7, 2012), http://dx.doi.org/
10.1016/j.fct.2012.10.044, (last visited Oct. 7, 2013).
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Some of the rejoinders wondered how the research conducted
by the French scientists managed to pass the peer review process
"in its current form and [taking into account] the impact of this for
the normally high standards adopted by your journal. 442  In the
same vein, Mark Tester criticized the French paper for being
"misleading and fundamentally flawed" and wondered how the
Journal of Food and Chemical Toxicology could reconcile its
reputation for quality research with the publication of "such poor
work".4 43 Mark Tester then proceeded systematically to debunk
the findings in the French paper as follows:
S6ralini's allegation of negative impacts on rat health as a result
of eating biotech corn and glyphosate have been refuted by
numerous studies, including long-term feeding studies, in the
peer-reviewed scientific literature . . . . A 2008 two-year rat
feeding study by Sakomoto et al. found that biotech soybeans
pose no health risks. A 2012 assessment by Snell et al.,
reviewed 12 long-term feeding studies of biotech maize, potato,
soybean, rice, and triticale and found that biotech crops are
nutritionally equivalent to their conventional counterparts and
can safely be used in food and feed. Previous peer-reviewed rat
feeding studies using the same products (NK603 and Roundup)
have not found any negative food safety impacts.444
Also, some of the rejoinders demanded for an immediate
withdrawal of the French article in the Journal of Food and
Chemical Toxicology.445 For instance, in his criticism of the
ethical propriety of the conditions of the mice used in the French
study, Anthony Trewavas noted that the accompanying pictures
depicting mice inflamed with tumours and diseases "was frankly
nothing more than propaganda.'1 46 He noted further that because
442 See Andrew Cockburn, Letter to the Editor, FOOD AND CHEMICAL TOXICOLOGY,
(Article in Press, Nov. 7, 2012), at http://dx.doi.org/10.1016/j.fct.2012.10.040 (last
visited Oct. 7, 2013).
443 Mark Tester, Letter to the Editor, FOOD AND CHEMICAL TOXICOLOGY, (Nov. 7,
2012), at http://dx.doi.org/10.1016/j.fct.2012.10.046 (last visited Oct. 7, 2013).
444 Id.; see also Wim Grunewald and Jo Bury, Comment on "Long term toxicity of
a Roundup Herbicide and Roundup-tolerant Genetically Modified Maize" by Sdralini et
al., FOOD AND CHEMICAL TOXICOLOGY, (Nov. 2012), http://dx.doi.org/10.1016/j.fct.2012.
10.051 (last visited Oct. 7, 2013).
445 See Anthony Trewavas, Letter to the Editor, FOOD AND CHEMICAL TOXICOLOGY,
(Nov. 2012), http://dx.doi.org/l0.1016/j.fct.2012.10.050 (last visited Oct. 7, 2013).
446 Id.
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"[s]cience requires the dispassionate presentation of information-
this paper and this journal have dealt the value of evidence-based
knowledge a serious blow and it can only be rectified if the paper
is withdrawn by the authors with an apology for misleading the
public and the scientific community alike."447
Unsurprisingly, the French study that linked Monsanto's
transgenic Bt maize to cancerous tumours and liver failure in mice
had an immediate impact on food regulators, especially in Europe,
which, despite its general apathy to transgenic plant foods,
remains a veritable market for approved transgenic plant food and
feed.448 For example, as noted earlier, the EFSA issued a Press
Release in which it demanded comprehensive data from the
authors, without which they could not rely on the study for risk
assessment purposes.44 9 Similarly, the Russian consumer rights
watchdog, Rospotrebnazor, promptly ordered Russia's Institute of
Nutrition to assess the validity of the French study, while
temporarily suspending import of Monsanto's transgenic maize
from the United States.450
Arguably, the political and regulatory responses to the French
study that links Monsanto's transgenic maize to cancerous
tumours and liver failures in mice validates the central hypothesis
in this article that the policy and governance systems for
transgenic plant agriculture and foods are largely underpinned by
"science.,"451 By extrapolation, the disputed French study also
highlights the state of uncertainty of the "science" that underpins
the regulatory and policy framework for the governance of
447 Id.
448 Approved transgenic plant food products are generally available in Europe
subject to labeling regulation. Ditto approved transgenic plant feed, which is
indispensable to the livestock industry. See Margret Rosso Grossman, European
Community Legislation for Traceability and Labeling of Genetically Modified Crops in
LABELING GENETICALLY MODIFIED FOOD: THE PHILOSOPHICAL AND LEGAL DEBATE, (Paul
Weirich, ed. 2007) at 32-62.
449 See Press Release, European Food Safety Authority, EFSA Publishes Initial
Review on GM Maize and Herbicide Study, supra note 438.
450 See Sean Poulter, Russia Suspends Import and use of American GM Corn after
Study Revealed Cancer Risk, MAILONLINE, (Sept. 26, 2012), http://www.dailymail.co.
uk/news/article-2208452/Russia-suspends-import-use-American-GM-com-study-
revealed-cancer-risk.html (last visited Oct. 7, 2013).
451 The word "science" is defined as "an organised body of knowledge on any
subject." See OXFORD DICTIONARY AND THESAURUS, supra note 34, at 802.
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transgenic plant agriculture and foods, and arguably legitimizes
one of the central questions in this Article, on the propriety of
excluding possible parallel governance systems for transgenic
plant agriculture and foods that are rooted in ethics, culture, and
religious beliefs, as canvassed by plaintiffs in Alliance for Bio-
integrity.4 52 Although ethical, cultural, and religious beliefs might
lack the agnosticism, coherence, homogeneity, and certainty
required of credible governance systems for transgenic plant
technology, it is submitted that the current science-centric
governance system for transgenic plant agriculture and foods is
not as agnostic, coherent, or certain as it could possibly be, in light
of conflicting scientific knowledge that underpins current policy
and regulations for transgenic plant technology.
D. The Challenge ofAdventitious Gene Flow and
Implications for the Environment and Biodiversity
Scientists are divided on the merits of transgenic plant
agriculture for the environment and biodiversity. 453 This section
will revisit this debate with a view to highlighting the contrasting
and conflicting scientific evidence on the effects of transgenic
plant agriculture on the environment. It also will address how
these uncertainties continue to reinforce differing regulatory and
policy frameworks for transgenic plant agriculture around the
world.454 Indeed, it is this conflicted science fueling disparate
regulatory policies that prompts one of the key questions in this
article regarding the propriety of sidelining possible parallel
governance systems such as ethical and cultural imperatives.455
The question is especially pertinent since the science on which the
current regulatory framework is predicated is not as coherent,
452 See Alliance for Bio-Integrity v. Donna Shalala, 116 F. Supp. 2d 166, 166 (D.
D.C. 2000).
453 See REECE WALTERS, Eco CRIME AND GENETICALLY MODIFIED FOOD, (Oxford:
Routledge, 2011) at 38 (discussing "the weight of evidence that points to greater
environmental risks and concerns through GM crops and ecological contamination").
454 This is exemplified by the differences in regulatory approaches between the
United States and countries of the European Union. See Armin Sp6k, Biotechnology
Policy in the European Union, in, GENETICALLY ENGINEERED CROPS: INTERIM POLICIES,
UNCERTAIN LEGISLATION, (lain E.P. Taylor ed.) supra, note 163, at 229-63.
455 See Alliance for Bio-Integrity, 116 F. Supp. 2d at 166.
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certain, stable, objective, or agnostic as it should, or could, be.456
However, it is clear that as the science of transgenic plant
agriculture continues to evolve, so would the yet unknown
implications of the advent of the technology.457  After all,
commercial transgenic plant agriculture is still less than two
decades old,458 and whilst scientists might disagree on specific
findings, there appears to be a general consensus that there could
"be no proof that all risks are known or that current knowledge
will not be determined by new findings."459
The world population is in a spiral climb with concomitant
concerns about food security, as well as the capability and
sustainability of the agrochemical-dependent conventional plant
agriculture to meet the world's growing food needs.4 60
"Agrochemical" is a generic term for a range of chemical products
used in plant agriculture, which include pesticides, insecticides,
herbicides, fungicides, and synthetic fertilizers. However, these
products are not without downsides. For example, nitrogen-based
synthetic fertilizer has been linked to the proliferation of nitrous
oxide in the atmosphere, a principal contributor to Greenhouse
gases and global warming.4 6 1 Moreover, in the 1960s, American
456 This hypothesis is predicated on the evidence of contested and conflicting
science on the full ramifications of transgenic plant agriculture and food respectively for
the environment and public health, as amply demonstrated in part III of this essay. Thus,
the image of an unsettled and highly contested science arguably detracts from science's
perceived agnosticism, neutrality, objectivity, and relative certitude that intrinsically set
science apart from culture, religion, and ethics. See Hans Radder, Science and
Technology: Positivism and Critique, in A COMPANION TO THE PHILOSOPHY OF
TECHNOLOGY (Jan Kyrre Berg Olsen, Stig Andur Pedersen, and Vincent F. Hendricks,
eds.), supra note 73, at 61-62.
457 This is exemplified by a 2012 study, which showed for the first time that
transgenic Bt. Maize, which was designed to curb traditional maize foes such as the
European corn borer, could be deleterious to the populations of non-target soil organisms
such as arbuscular mycorrhizal fungi that are crucial for soil enrichments. See Tanya E.
Cheeke, Todd N. Rosentiel, and Mitchell B. Cruzan, supra note 95, at 700-07.
458 Transgenic plant crops were first commercially grown in 1996. See Jack Ralph
Kloppenburg Jr., supra note 15, at 296.
459 Ronald J. Herring, supra note 107, at 4.
460 See PER PINSTRUP-ANDERSEN AND EBBE SCHOLER, SEEDS OF CONTENTION:
WORLD HUNGER AND THE GLOBAL CONTROVERSY OVER GM CROPS, supra note 169, at I-
6 (discussing how plant genetic engineering techniques could be used to ameliorate food
security problems especially in Africa).
461 See VANDANA SHIVA, THE VIOLENCE OF THE GREEN REVOLUTION, 114-19
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marine biologist, Rachel Carson, highlighted the steep
environmental and public health costs of the rampant use and
misuse of synthetic chemical insecticides in commercial
agriculture in her landmark and seminal work: Silent Spring.462
Also, it has been well-documented that synthetic chemical
pesticides that are routinely used in conventional plant agriculture
have corrosive and poisonous effects on the environment and
biodiversity.4 63 Therefore, given the adverse effects that agro-
chemical dependency in conventional agriculture has on the
environment, any technology that could ameliorate the problems
posed by synthetic chemicals for the environment should be
welcome.
Biotechnology corporations such as Monsanto, Du Pont,
Novartis, etc., claimed to have such a technology in the form of
herbicide resistant crops and the Bt engineered insect-resistance
crops, which they believed could benefit the environment by
significantly reducing the use of agrochemicals in plant
agriculture.4 " Most significantly, the development of drought-
tolerant transgenic corn and soybeans by biotechnology companies
such as Monsanto, Pioneer-Dupont, and Syngenta have been
touted as a panacea for diminishing crop yields amongst forty
percent of world farmers who plough "arid and semi-arid regions
marked by long dry seasons and scant rainfall even in the wet
season." 465  Advocates of drought-tolerant transgenic plant
technology also believed that it could ameliorate drought-induced
famine in Africa, costly irrigation systems, and dwindling water
supply for commercial plant agriculture due largely to the effects
of global warming.4 66
(London & New York: Zed Books Limited, 2002).
462 See RACHEL CARSON, SILENT SPRING, (London & New York: Penguin Classics,
2000).
463 See Pamela Ronald, Plant Genetics, Sustainable Agriculture and Global Food
Security, 188 GENETICS 11, 11-12 (May 2011).
464 See Miguel A. Altieri, Transgenic Crops: Agro-biodiversity and Agro-
ecosystem Function, in GENETICALLY ENGINEERED CROPS: INTERIM POLICIES, UNCERTAIN
LEGISLATION, (lain E. P. Taylor, ed.) supra note 163, at 37-38. See also REECE
WALTERS, Eco CRIME AND GENETICALLY MODIFIED FOOD, supra, note 453, at 38.
465 See ROBERT PAARLBERG, STARVED FOR SCIENCE: How BIOTECHNOLOGY IS
BEING KEPT OUT OF AFRICA, supra note 31, at 149.
466 See id. at 149-77.
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However, despite the promising benefits of transgenic plant
agriculture for the environment, there are scientific indications and
concerns that gene flow from transgenic crops could result in
adventitious presence of transgene in non-transgenic crops and the
environment.4 67  But gene flow is not unique to transgenic plant
agriculture. Rather it is a natural phenomenon through which
genes from plant species could be disseminated to other plant
species in the wild via pollen, seeds, and in some cases,
"vegetative propagules." 4 68 However, most transgenic plants, such
as those encoded with genes from Bt bacteria, bear DNA from
micro-organisms and non-plant species that could easily be
transmitted into other plant species in the wild through gene flow.
Thus, there is a risk that Monsanto's Roundup Ready glyphosate-
resistant transgenic soybeans and maize plants,469 which enable
farmers to kill weeds without harming their crops, could pass on
their gene to non-transgenic conventional or organic soybeans or
maize as well as weeds in the wild.470 Indeed, a 2004 study
conducted by the Union of Concerned Scientists in the United
States showed evidence of an adventitious presence of glyphosate
resistant genes in samples of six conventional, non-transgenic
soybeans cultivars at the levels of 0.0.5 and 1% in 50%.471 Whilst
this could have significant economic and intellectual property
rights implications for non-transgenic plant farmers,472 it is the
467 See Mary A. Rieger et al., Pollen-Mediated Movement of Herbicide Resistance
Between Commercial Canola Fields, Sci., (June 28, 2002), at 2386-88.
468 See Carol Mallory-Smith & Maria Zapiola, Gene Flow from Glyphosate-
resistant Crops, PEST MANAGEMENT SCIENCE, (Apr. 2008), at 428, 430.
469 Glyphosate is a type of herbicide traditionally used to manage and control
weeds that compete with commercial crops for soil nutrients. See Stephen 0. Duke &
Stephen B. Powles, Glyphosate: A Once-in-a-century Herbicide: Mini Review, PEST
MANAGEMENT SCI., (Apr. 2008), at 319-25.
470 See Carol Mallory-Smith & Maria Zapiola, supra note 468, at 428-40.
471 See id. at 431 (citing Mellon M. & Rissler J., Gone to Seed: Transgenic
Contaminants in the Traditional Seed Supply 28, 40-42, UCS Publications, 2004).
472 Notably, organic and conventional farmers who trade in non-transgenic markets
could lose their markets if their crops tested positive for transgenes. For example, a
Western Australian organic farmer, Steven Marsh, sued his neighbouring farmer,
Michael Baxter for economic damaged arising from the loss of his organic certification.
Mr Marsh attributed the loss of his organic certification to the transgenic canola
materials, which escaped from his neighbour's farm into his farm. See Organic Farmer
to Sue Over GM Contamination, ABC NEWS, (Jan. 13, 2011), http://www.abc.net.aul
news/2011-01-13/organic-farmer-to-sue-over-gm-contamination/1904328, (last visited
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prospect that gene flow could create stubborn "super-weeds" that
most scientists and farmers find troublesome.47 3
Evidence of weeds' resistance to Monsanto's glyphosate
herbicide was first discovered in Australia, 47 4 whilst herbicide-
resistant volunteer canola is now a major weed problem in
Canada.475 In the United States, farmers are said to be coping with
resurgence in glyphosate Roundup resistant weeds that, as of
2010, have plagued approximately seven to ten million acres of
arable farmland.4 76 In order to combat super weed resurgence,
farmers in the East, Midwest, and South of the United States have
had "to spray fields with more toxic herbicides, pull weeds by
hand and return to more labor-intensive methods like regular
plowing." 477 For instance, Mr. Anderson, a Tennessee farmer, had
to wrestle with a notoriously tenacious species of glyphosate
resistant weed known as "Palmer amaranth" or "Pigweed." 4 7 8
According to William Newman and Andrew Pollack, Pigweed
could grow up to three inches daily and reach seven-feet or more,
Oct. 8, 2013). Moreover, seed companies such as Monsanto have filed numerous
lawsuits for intellectual property infringement against non-transgenic farmers, who
allegedly saved and cultivated their proprietary seeds without prior consent. See
MONSANTO, Saved Seed and Farmer Lawsuits, at http://www.monsanto.com/newsviews/
Pages/saved-seed-farmer-lawsuits.aspx, (last visited Oct. 8, 2013). For discussion on the
economic and intellectual property right implications of adventitious presence of
transgenic plant gene in conventional agriculture, see Schmeiser v. Monsanto Canada
Inc., 2002 FCA 309, available at http://www.ariplex.com/percyschmeiser/Appeal%
20Decision.pdf; Maria Lee & Burrell, supra note 247, at 517-37.
473 For example, the first documented case of weed resistance to glyphosate
involved rigid ryegrass (Lolium rigidum) and was found near Orange in New South
Wales, Australia. See Stephen B. Powles et al., Evolved Resistance to Glyphosate in
Rigid Ryegrass (Lolium rigidum) in Australia, 46 WEED Sci. 604, 604-07, (Sept.-Oct.
1998).
474 See id.
475 See Miguel A. Altieri, Transgenic Crops, Agro-biodiversity, and Agro-
ecosystem Function, in GENETICALLY ENGINEERED CROPS: INTERIM POLICIES, UNCERTAIN
LEGISLATION, (lain E.P. Taylor, ed.) supra note 163, at 43.
476 See William Newman and Andrew Pollack, U.S. Farmers Cope with Roundup-
Resistant Weeds, N. Y. TIMES, May 4, 2010), at BI (citing Ian Heap, director of the
International Survey of Herbicide Resistant Weeds, which is financed by the agricultural
chemical industry.). Across the United States, approximately one hundred and seventy
million acres are planted with corn, cotton, and soybeans, the crops most affected. See
id
477 See id
478 Id.
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with ability to choke out crops and damage harvesting
equipment.4 79 Thus, it is ironic that farmers had to resort to
herbicide in order to combat the emergence of super-weeds. This
is especially true since the herbicide resistant transgenic plant was
designed in part to reduce the use of toxic herbicide on arable
farmland.
The increased use of toxic herbicide would appear to belie the
claim by biotechnology companies that herbicide-resistant
transgenic plants were beneficial to the environment,480 a
sentiment shared by Bill Freese, a science policy analyst for the
Center for Food Safety in Washington, who stated: "The biotech
industry is taking us into a more pesticide-dependent agriculture
when they've always promised, and we need to be going in, the
opposite direction.' Even Monsanto Corporation, who is the
proprietary owner of glyphosate herbicide, has acknowledged that
weeds' resistance to the herbicide is "a serious issue."'48 2 In fact,
the company is so worried about the problem of weed-resistant
herbicide that they agreed to subsidize cotton farmers, who had to
purchase herbicide from Monsanto's competitors in order to
supplement Monsanto's glyphosate Roundup herbicide, in the
continuing fight against super-weeds in the United States.4 83
Furthermore, in what is set to be a perennial and daunting struggle
against super-weeds, Monsanto and other biotechnology
companies are busy developing transgenic crops that are resistant
to new types of herbicides.4 84 For example, Bayer has started
marketing transgenic cotton and soybeans that are resistant to
glufosinate herbicide, whilst Monsanto's new transgenic corn is
resistant both to glyphosate and glufosinate.48 5  Furthermore,
Monsanto is said to be developing transgenic crops that are
resistant to dicamba herbicide, whilst Syngenta is developing
479 See id
480 See Miguel A. Altieri, Transgenic Crops: Agro-biodiversity and Agro-
ecosystem Function, in GENETICALLY ENGINEERED CROPS: INTERIM POLICIES, UNCERTAIN
LEGISLATION, (lain E. P. Taylored.) supra note 163, at 37-38.
481 See William Newman & Andrew Pollack, supra note 476, at Bl.
482 See id (citing one Rick Cole, who managed weeds resistance issues for
Monsanto in the United States).
483 See id.
484 See id.
485 See id
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soybeans that are tolerant to its Callisto product, and Dow
Chemical is developing transgenic corn and soybeans that are
"resistant to 2,4-D, a component of Agent Orange, the defoliant
used in the Vietnam [W]ar." 8 6 It is however doubtful whether the
development of new herbicides would solve the challenge posed
by super weeds. If weeds could develop resistance to the current
variants of commercial herbicides, they could overtime develop
resistance to new varieties of herbicides, until there is no known
herbicide left with which to fight weeds. It is also clear that the
environment and biodiversity would be the worse for it, as weeds
continually evolve resistance to all known herbicides.
Apart from the weeds' resistance problem, scientists have
argued that targeted pests could, overtime, also become resistant to
the Bt toxins in transgenic Bt Maize or soybeans.48 7 According to
Miguel A. Altieri, over five-hundred species of pests have already
evolved resistance to conventional insecticides, and there was no
guarantee that pests such as the European corn borer could not
develop resistance to the Bt toxins in transgenic maize crops
overtime.488 Indeed, bioengineers regard insects' resistance to Bt
toxins as inevitable, and have therefore begun preparation for
"resistance management plans," which included building of
"refuges," and the provision of "susceptible insects for mating
with resistant insects," in order to delay the evolution of resistance
to Bt toxins in transgenic crops.489
Aside from possible evolution of resistance by targeted insects
to Bt toxins in transgenic crops, there is ample, albeit
controversial, evidence that Bt toxins in transgenic plant crops
could be deleterious to non-target organisms in the environment
and possibly deplete the biodiversity. 490 This is exemplified by the
Rosi-Marshall paper, which was based on the study of twelve
streams in northern Indiana.4 9 ' The paper found that caddis-fly
486 See William Newman & Andrew Pollack, supra note 476, at Bl.
487 See Miguel A. Altieri, Transgenic Crops, Agro-biodiversity, and Agro-
ecosystem Function, in GENETICALLY ENGINEERED CROPS: INTERIM POLICIES, UNCERTAIN
LEGISLATION, (lain E.P. Taylor ed.), supra note 163, at 46-48.
488 See id.
489 See id
490 See Rosi-Marshall, et al., supra note 191, at 16204-08.
491 See id.
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larvae that were "fed only on Bt maize debris grew half as fast as
those that ate debris from conventional maize."4 92 As previously
discussed, the Rosi-Marshall paper was criticized by fellow
scientists in numerous rejoinders and rebuttals that bordered on ad
hominem and insinuations of academic and scientific fraud.493
But then the Rosi-Marshall paper was neither the first nor the
last to link transgenic Bt crops to negative environmental
impacts.494 For example, as previously noted, a 2012 publication
in the American Journal of Botany found that transgenic Bt.
maize, which was designed to curb traditional maize foes such as
the European corn borer, could be deleterious to, or overtime
crash, the populations of non-target soil organisms, such as
arbuscular mycorrhizal fungi.495  However, the main problem is
that arbuscular mycorrhizal fungi are no ordinary fungi. Rather,
they exist in a mutually beneficial and symbiotic relationship with
land plants species, through which arbuscular mycorrhizal fungi
depend on land plants for carbon nutrition, and land plants depend
on arbuscular mycorrhizal for phosphorous intake from the soil.4 96
Thus, long term depletion in the populations of arbuscular
mycorrhizal fungi for land plants populations could dramatically
reduce the intake of natural phosphorous for land plants, with
predictable long term devastating effects on the environment and
the biodiversity.
It would appear that the full ramifications of the advent of
transgenic plant agriculture for the environment and biodiversity
are at best ambivalent. Also, given that the study on the effects of
transgenic Bt crops on arbuscular mycorrhizal fungi populations
was published for the first time in 2012, more revelatory findings,
whether positive or negative, could be expected in the years ahead,
492 Emily Waltz, supra note 181, at 27.
493 See generally supra Part IIC of the essay (discussing Rosi-Marshall paper). See
also Emily Waltz, supra note 181, at 27-30.
494 See Tanya E. Cheeke et al., Evidence of Reduced Arbuscular Mycorrhizal
Fungal Colonization in Multiple Lines of Bt Maize, AM. J. OF BOTANY, supra note 95, at
700-07.
495 See id
496 See N.S. Bolan, A Critical Review on the Role of Mycorrhizal Fungi in the
Uptake of Phosphorous by Plants, 134 PLANT AND SOIL 2, 189-207 (July, 1991); see also
Berta Bago, Putative Sites for Nutrient Uptake in Mycorrhizal Fungi, 226 PLANT AND
SOIL 2, 263-74 (Nov. 2000).
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as more arable farmlands are cultivated with transgenic plant crops
around the world, and more research studies are conducted on the
long term environmental impacts of transgenic agriculture. Thus,
to the extent that the full ramifications of the environmental
impacts of transgenic plant agriculture are yet unknown, the
hypothesis earlier posited in this article that the current science
that underpins the regulatory and policy framework for transgenic
plant agriculture is at best evolving or evolutionary in nature, has
arguably been validated.497  Furthermore, to the extent that the
current science on the full environmental impacts of transgenic
plant agriculture is ambivalent, ambiguous, and highly contested,
any regulatory and policy framework predicated on it would, of
necessity, reflect the differing scientific findings on the full
ramifications of transgenic plant agriculture for the environment.
This is exemplified by the fact that Austria is still opposed to
transgenic plant agriculture on grounds of its possible negative
impacts on public health and the environment. 498  However, the
governments of the United States and Canada, where commercial
plant agriculture has flourished since 1996, did not share the
concerns of the Austrian government that commercial transgenic
plant agriculture might be incompatible to a sustainable
agricultural environment.499 On the other hand, the government of
497 See supra Part I (analysis); see also notes 94, 95, 97, and accompanying text.
498 Under Regulation No. 45 of the Federal Ministry for Consumer Health
Protection of 13 February 1997, Austria prohibited the sale of Bt-176 maize in the
country on the basis of the safeguard clause contained in Article 16 of Directive
90/220/EC on Deliberate Release of Genetically Modified Organisms, which was
repealed by Directive 2001/18/EC on Deliberate Release of Genetically Modified
Organisms. Article 16 of the repealed Deliberate Release Directive 90/220/EC, which is
now Article 23 of Deliberate Release Directive 2001/18/EC, allowed national
governments to provisionally prohibit the use or sale of approved transgenic plant
products if human health and the environment were put at risk. When Austria's decision
was challenged by the United States, Canada, and Argentina in European Communities -
Measures Affecting the Approval and Marketing of Biotech Products (WTIDS291/R,
WT/DS292/R, and WT/293/R, Sept. 29, 2006), supra note 295, Austria argued inter alia
that "new scientific results have questioned the present scientific possibility of a
conclusive evaluation of the mechanism of gene transfer, as well as the development of
resistance to Bt toxin." The Panel concluded that Austria's safeguard measure on BT-
176 maize fell within the scope of Annex A (1) (b) and (c) of the Sanitary and
Phytosanitary (SPS) Agreement, an international treaty of the World Trade Organization.
See id. at 885-93.
499 Indeed, Canada and the United States successfully challenged the European
Union moratorium on the approval and sale of new transgenic plant organisms in
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the United Kingdom, where there is as of yet no locally managed
commercial transgenic plant agriculture,oo was recently urged by
members of Parliament to exercise caution and conduct
independent reports "on the potential impacts on the environment
of GM crops, and their impacts on farming and on the global food
system."so' This thus begs the recurring question: if the science
that underpins the differing national and transnational regulatory
and policy frameworks for transgenic plant agriculture is not
sacrosanct, what is the justification for the exclusion of possible
alternative governance systems premised on ethical, religious, and
cultural imperatives?
Therefore, within the context of relevant case law, Part IV of
the article will analyze the imperatives for the inclusion of ethical,
conscientious, religious, and cultural values in the governance of
transgenic plant agriculture, as unsuccessfully canvassed for by
plaintiffs in A lliance for Bio-integrity.50 2
IV. The Tyranny of Science: What Role for Ethical,
Conscientious, Religious, and Cultural Values in the
Governance of Transgenic Plant Agriculture and Food?
The national and transnational regulatory and policy
frameworks for transgenic plant agriculture and food range from
approval systems for new transgenic plant seeds,so' transgenic
European Communities-Measures Affecting the Approval and Marketing of Biotech
Products. Id. at 1. Moreover, commercial transgenic plant agriculture has flourished in
Canada and the United States since 1996, with millions of arable farmland under
cultivation, and millions of transgenic soybeans and corn sold annually on the domestic
and export markets. In the United States for example, it is estimated that approximately
170 million acres are planted with transgenic soybeans, corn and cotton crops. See
Newman & Pollack, supra note 476, at B 1.
500 Despite numerous field trials, which often face intense local opposition and
picketing, there is as yet no commercial transgenic plant agriculture in the United
Kingdom. For a report on local opposition to field trials for new transgenic crops, see
Telegraph View, Witless GM Vandalism, (May 21, 2012), http://www.telegraph.co.uk/
earth/agriculture/geneticmodification/9278916/Witless-GM-vandalism.html (last visited
Oct. 8, 2013).
501 See Alistair Driver, MPs Urge Government Caution on GM Crops, FARMERS
GUARDIAN, (May 14, 2012), http://www.farmersguardian.com/home/arable/mps-urge-
government-caution-on-gm-crops/46916.article, (last visited Oct. 8, 2013).
502 See Alliance for Bio-Integrity v. Donna Shalala, 116 F. Supp. 2d 166, 166 (D.
D.C. 2000).
503 See Directive 2001/18/EC, of the European Parliament and of the Council of 12
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plant seed cultivation rules," to marketing and labeling rules for
new transgenic plant seeds and food products.so5 The role of
science as the fulcrum anchoring the regulatory and governance
systems for transgenic plant agriculture and food has been
demonstrated in previous sections of this article. 0 ' For example, it
was noted how the guidance document of the EFSA on the
environmental risk assessment for transgenic plant is predicated on
"available scientific and technical data and on common
methodology for identification, gathering and interpretation of the
relevant data."507 Ditto the rules governing field testing or trials of
plants genetically engineered to produce pharmaceuticals and
industrial compounds by the U.S. Department of Agriculture,
which mandated on-farm separation distances between transgenic
pharmaceutical plant and non-transgenic plant, and the creation of
plants "refuges" or buffer zones between transgenic and non-
transgenic plants, as a bulwark against in situ gene flow and the
concomitant adventitious commingling of genes between
transgenic and non-transgenic plants.0
The regulatory and governance systems for transgenic plant
agriculture and food are science-dependent or science-centric.
However, whilst there is nothing wrong with a science-centric
regulatory and policy framework, the apparent exclusion of
possible parallel governance systems that range from ethics, to
religion, to culture, as exemplified by Alliance for Bio-integrity,50 9
Mar. 2001 on the Deliberate Release into the Environment of Genetically Modified
Organisms 90/220/EEC, 2001 O.J. (L 106) 1 (stipulating the conditions for approval for
the release into the environment of genetically modified organisms).
504 See id.
505 See, e.g., Regulation (EC) No. 1830/2003 of the European Parliament and of the
Council of 22 Sept. 2003, L268/24, O.J. (concerning the traceability and labeling of
genetically modified organisms and the traceability of food and feed products produced
from genetically modified organisms).
506 See generally supra Parts I, II, & III (discussing the role of science in transgenic
food governance).
507 See EFSA Panel on Genetically Modified Organisms, supra, note 54, at 3.
508 See Department of Agriculture, Animal and Plant Health Inspection Service,
Field Testing of Plants Engineered to Produce Pharmaceutical and Industrial
Compounds, 68 Fed. Reg. 11337-40 (Mar. 10, 2003).
509 See Alliance for Bio-Integrity v. Donna Shalala, 116 F. Supp. 2d 166, 166 (D.
D.C. 2000). See also, Jeffrey L. Fox, FDA, Activists Seeks Judgments in Food Policy
Lawsuit, 17 NATURE BIOTECHNOLOGY at 746-47 (Aug. 1999).
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smacks of science determinism and tyranny. This is especially so,
since the science that anchors the current regulatory and policy
framework for transgenic plant agriculture and food is at best
evolutionary, conflicted, and not as reliable, certain, or agnostic as
it should or could be. It is therefore undeserving of its ostensible
monopoly over the governance systems for transgenic plant
agriculture. 0o
The following paragraphs will review and analyze selected
case law in relative detail, with a view to ascertaining the
significance and extent to which non-scientific considerations are
excluded from the regulatory and policy framework for transgenic
plant agriculture and food. It will also examine the propriety of
the exclusion and how the current governance systems for
transgenic plant agriculture and food could benefit from a more
comprehensive, holistic, and inclusive regime that take cognizance
of ethical, religious, and cultural imperatives.
A. Alliance for Bio-integrity v. Donna Shalala: Religious
Belief Suppression Challenge to the Substantial
Equivalence Doctrine
As noted previously in this article,"'1 the plaintiffs in Alliance
for Bio-integrity12 were a coalition of scientists, chefs, civil
activists, and religious leaders who were opposed to transgenic
plant agriculture and food on grounds that it posed unacceptable
risks to public health and the environment.5 13 They contended that
the FDA's non-labeling regime for transgenic plant food unfairly
burdened their religious beliefs and violated their rights to free
exercise of religion as guaranteed by the First Amendment to the
United States Constitution and the provisions of the Religious
Freedom Restoration Act.5 14 This section of the article will focus
on the propriety of the plaintiffs' religious challenge to the FDA
policy statement on substantial equivalence doctrine and its
concomitant non-labeling regime for transgenic plant food, and the
510 See generally supra Part III C & D (discussing improvements in scientific
process).
511 See generally supra Part III B (addressing Alliance for Bio-Integrity).
512 See Alliancefor Bio-integrity, 116 F. Supp. 2d at 166.
513 See id. at 170.
514 See id at 180.
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legal imperatives for accommodating religious and cultural beliefs
alongside science in the regulatory and policy framework for
transgenic plant agriculture and food systems.
The plaintiffs in Alliance for Bio-integrity argued inter alia that
the FDA policy statement on substantial equivalence doctrine,
which endorsed and validated a non-labeling regime for transgenic
plant food, unconstitutionally violated their right to free exercise
of religion under the First Amendment to the Constitution of the
United States,"' which provides inter alia that "Congress shall
make no law respecting an establishment of religion, or
prohibiting the free exercise thereof."5 16 However, whilst drawing
on the United States Supreme Court decision in Employment
Division v. Smith,517 the Federal District Court in Alliance for Bio-
integrity rejected plaintiffs' argument on grounds that the FDA
statement of policy on the substantial equivalence doctrine, on
which the non-labeling rule for transgenic plant food was
predicated, was a neutral law of general application. The court
concluded that neutral laws of general application would not
violate the Free Exercise Clause of the First Amendment, "even if
the laws incidentally burden religion."' 18
The pertinent questions follow. First, what is a neutral law of
general application, and to what extent is the FDA statement of
policy on substantial equivalence doctrine, and its concomitant
non-labeling regime for transgenic plant food, a neutral law of
general application?"' Second, are all neutral laws of general
application automatically exempted from the Free Exercise Clause
of the First Amendment as opined by the Alliance for Bio-integrity
court?520 Third, was the court correct in holding that the statement
of policy on the substantial equivalence doctrine, on which the
non-labeling rule for transgenic plant food was premised, did not
violate plaintiffs' free exercise right of religion as guaranteed by
515 See id. at 179.
516 See U.S. CoNsT. Amend. I (regarding freedom of speech, freedom of the press,
religious freedom, freedom of assembly, and the right to petition).
517 See Employment Division v. Smith, 494 U.S. 872 (1990).
518 See Alliance for Bio-Integrity v. Donna Shalala, 116 F. Supp. 2d 166, 179-80
(D. D.C. 2000).
519 See id. at 180 (it is instructive to note that the parties never disputed that the
Statement of Policy was a neutral law of general applicability).
520 See id. at 179-80.
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the First Amendment to the United States Constitution on grounds
that it was a neutral law of general application?52 '
Answering these questions is paramount to a proper analysis of
the free exercise clause decision of the court in Alliance for Bio-
522 ,'a1;bintegrity, especially because the court appeared to gloss over
these questions when it presumptively found that the FDA
statement of policy on the substantial equivalence doctrine and its
non-labeling policy for transgenic plant food, was a neutral law of
general application that was automatically exempted from the Free
Exercise Clause of the First Amendment, notwithstanding its
apparent derogation from plaintiffs' religious beliefs.523 However,
answering the above questions would necessitate a brief but
thorough review of the decision of the Supreme Court of the
United States in Employment Division v. Smith.5 24
In Smith,5 25 the central issue for determination before the Court
was whether the Free Exercise Clause permitted Oregon to
penalize the religious use of peyote as a class B drug.526 Oregon
law prohibits the knowing or intentional possession of a
"controlled substance" unless the substance had been prescribed
by a medical practitioner.52 7 The respondents, Alfred Smith and
Galen Black, were dismissed from their jobs with a private drug
rehabilitation organization because they ingested peyote, a
hallucinogen class B drug for sacramental purposes at a religious
ceremony in a Native American Church, of which they were
members.5 28  The respondents subsequently applied to the
petitioner, the Employment Division of the State of Oregon, for
521 See id.
522 See Alliancefor Bio-integrity, 116 F. Supp. 2d, at 166.
523 The Federal District Court drew on Employment Division v. Smith, 494 U.S. 872
(1990), in support of the finding that the FDA statement of policy on substantial
equivalence and its non-labeling regime for transgenic plant food, was a neutral law of
generally applicability that was exempted from the free exercise clause of the First
Amendment to the Constitution of the United States. See Alliance for Bio-integrity, 116
F. Supp. 2d at 180.
524 See Employment Division v. Smith, 494 U.S. 872, 872 (1990).
525 See Smith, 494 U.S. at 872.
526 See id. at 874.
527 See id. at 874. See also Oregon Rev. Stat. § 475.992(4) (1987).
528 See Smith, 494 U.S. at 874.
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unemployment benefits. 5 29  However, the petitioner determined
that the respondents were ineligible for unemployment benefits
because they had been dismissed for a work-related
"misconduct."5 3 0  Nevertheless, the Oregon Court of Appeals
reversed the determination, on grounds that denial of
unemployment benefits to the respondents violated their "free
exercise rights under the First Amendment."5 1 In an appeal to the
Supreme Court of Oregon, the petitioner argued that the denial of
underlying benefits was permissible because respondents'
consumption of peyote a Class B drug, was a crime under the law
of the State of Oregon.53 2 However, the Supreme Court of Oregon
reasoned that the respondents' criminal use of peyote was
inadequate to justify the burden that the denial of unemployment
benefits "imposed on respondents' religious practice." 53 3  The
Supreme Court of Oregon then concluded that the respondents
were entitled to payment of unemployment benefits.53 4
The petitioner further appealed to the U.S. Supreme Court,
where the main question for determination was whether the
prohibition of religious use of peyote, a Class B drug, under the
State of Oregon's narcotics law was permissible under the Free
Exercise Clause of the First Amendment to the United States
Constitution.3 In their judgment, the Supreme Court of the
United States noted that the Free Exercise Clause not only
guaranteed the personal right to believe and profess whatever
religious doctrine one desired, 536 but also preserved and protected:
529 See id.
530 Id.
531 Id. at 874.
532 Id. at 875.
533 Id.
534 Smith, 494 U.S. at 875. For the Oregon Supreme Court decision, see Smith v.
Emp't Div. Dep't ofHuman Res., 301 Or. 209, 217-219 (1986). For a remanded decision
by the Oregon Supreme Court, see Smith v. Emp 't Div. Dep 't ofHuman Res., 308 Or. 68,
72-73 (1988). The U.S. Supreme Court had remanded the case to the Supreme Court of
Oregon to determine whether or not the Respondents' religious use of peyote was
prohibited by Oregon law. The Oregon Supreme Court held that there was no religious
use exemption for the use of peyote drug under Oregon law, but nevertheless went on to
affirm its previous ruling that the State of Oregon could not deny unemployment benefits
to the Respondents for their religious use of peyote drug. Id.
535 Smith, 494 U.S. at 876.
536 Id. at 877.
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"[t]he performance of (or abstention from) physical acts:
assembling with others for a worship service, participating in
sacramental use of bread and wine, proselytizing, abstaining from
certain foods or certain modes of transportation."53 7
However, the Court discountenanced the respondents' claim
that their religious use of peyote placed them beyond the reach of
the narcotics law of the State of Oregon that was not specifically
directed at their religious practice,' on grounds inter alia that the
claim was tantamount to taking the meaning of "'prohibiting the
free exercise [of religion]' one large step further."53 9 The U.S.
Supreme Court further noted that the Court had "never held that an
individual's religious beliefs excuse him from compliance with an
otherwise valid law prohibiting conduct that the State is free to
regulate."54 0 In support of its reasoning, the Supreme Court of the
United States then drew on its earlier decision in Minersville
School District Board ofEducation v. Gobitis5 4 ' as follows:
Conscientious scruples have not, in the course of the long
struggle for religious toleration, relieved the individual from
obedience to a general law not aimed at the promotion or
restriction of religious beliefs. The mere possession of religious
convictions which contradict the relevant concerns of a political
society does not relieve the citizen from the discharge of
political responsibilities.542
The Court further noted that in its previous decisions, it had
been consistent in the application of the principle that the right to
free exercise of religion did not relieve an individual of the
obligation to comply with a "valid and neutral law of general
applicability on the ground that the law proscribes (or prescribes)
conduct that his religion prescribes (or proscribes)." 4 3 One of
537 Id
538 This argument was solely geared towards enabling the respondents to claim
unemployment benefits, which was rejected by the petitioner on grounds that the
respondents' religious use of peyote, a class B drug, was a felony under the State of
Oregon's law. Id. at 877-878.
539 Smith, 494 U.S. at 878.
540 Id. at 878-879.
541 See Minersville School Dist. Bd. of Ed. v. Gobitis, 310 U.S. 586, 594-95 (1940).
542 Smith, 494 U.S. at 879.
543 Id. at 879.
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such decisions was Prince v. Massachusetts,544 in which the
Supreme Court of the United States held that a mother could be
prosecuted under the child labor laws for using her children to
disseminate religious literature on the street, notwithstanding her
own religious motivations.54 5 Yet another decision was Braunfeld
v. Brown,54 6 in which Sunday-closing laws were upheld against the
claim that the laws burdened the religious practices of persons
whose religions compelled them to refrain from work on other
days.547
However, the U.S. Supreme Court noted that there could be
exceptional circumstances under which the free exercise right of
religion could bar a valid and neutral law of general application.5 4 8
These would include a circumstance in which the free exercise
right was coupled with other constitutional rights such as the
freedom of speech and the freedom of the press.5 49 According to
the Supreme Court of the United States:
The only decisions in which we have held that the First
Amendment bars application of a neutral, generally applicable
law to religiously motivated action have involved not the Free
Exercise Clause alone, but the Free Exercise Clause in
conjunction with other constitutional protections, such as
freedom of speech and of the press. 5 o
As an example of exceptions to the general rule, the U.S.
Supreme Court referenced its previous judgment in Wisconsin v.
Yoder,"' in which a valid and neutral law of general application,
which mandated compulsory school attendance for pupils, was
invalidated for Amish parents who refused to send their children to
school on religious grounds. 552  Notably, the exemption to the
universal reach of neutral laws of general application by the Free
544 Prince v. Massachusetts, 321 U.S. 158, 171 (1944) (stating the United States
Supreme Court found no constitutional infirmity in "excluding [these children] from
doing there what no other children may do").
545 Id. (cited in Employment Div. v. Smith, 494 U.S. at 879-80).
546 Braunfeld v. Brown, 366 U.S. 599 (1961).
547 Id at 599; see also Smith, 494 U.S. at 880.
548 See id. at 881.
549 Id.
550 Id
551 Wisconsin v. Yoder, 406 U.S. 205 (1972).
552 Smith, 494 U.S. at 881 (citing Wisconsin v. Yoder, 406 U.S. at 205-06 (1972)).
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Exercise Clause in conjunction with other constitutional rights, as
exemplified by Wisconsin v. Yoder,5 53 and Murdock v.
Pennsylvania,5 54 was described by the U.S. Supreme Court in
Smith,"' as a hybrid situation, which the Court found inapplicable
to the respondents, whose claim to free exercise right of religious
use of peyote, a class B drug, was not coupled with any other
known constitutional rights.556
Yet another exemption to the general rule that the Free
Exercise Clause would not bar a neutral and valid law of general
application is the "compelling governmental interest" test
espoused by the U.S. Supreme Court in Sherbert v. Verner.5 7 The
test, which is otherwise known as the Sherbert test, posits that any
governmental actions that substantially burden a religious practice
must be justified by a compelling governmental interest.
Significantly, the respondents in Smith559 had additionally sought
refuge under the Sherbert test by arguing that their claim to
religious exemption from Oregon's narcotics law should be
evaluated under the Sherbert "compelling governmental interest"
test set forth by the U.S. Supreme Court in Sherbert.560 In Smith,
the respondents invoked the Sherbert test and called on the Court
to balance their alleged right to religious use of peyote against
Oregon's narcotics law, and then determine whether the State of
Oregon had a compelling interest that could justify the general
enforcement of its narcotics law, notwithstanding that such
enforcement would be prejudicial to respondents' religious use of
peyote. 56 1 However, the Court noted that it rarely applied the
Sherbert test beyond the realm of unemployment compensation
claims, 5 62 and then declined plaintiffs' request to apply the
553 Yoder, 406 U.S. at 205.
554 In Murdock v. Pennsylvania, 319 U.S. 105 (1943), the United States Supreme
Court invalidated a law that imposed a flat tax on solicitation for the dissemination of
religious ideas.
555 Smith, 494 U.S. at 881-82.
556 Id. at 882.
557 Sherbert v. Verner, 374 U.S. 398 (1963).
558 Id. at 402-03.
559 Smith, 494 U.S. at 882-83.
560 Id. at 883 (citing Sherbert v. Verner, 374 U.S. at 402-03).
561 See Smith, 494 U.S. at 882-83.
562 Id. at 883.
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Sherbert test "to require exemptions from a generally applicable
criminal law."5 63 Although the U.S. Supreme Court did
countenance the possibility of applying the Sherbert test beyond
the realm of unemployment compensation," it categorically
refused to apply the Sherbert test in Smith56 5 to exempt compliance
with a generally applicable criminal law:
Even if we were inclined to breathe into Sherbert some life
beyond the unemployment compensation field, we would not
apply it to require exemptions from a generally applicable
criminal law. The Sherbert test, it must be recalled, was
developed in a context that lent itself to individualized
governmental assessment of the reasons for the relevant
conduct ... our decisions in the unemployment cases stand for
the proposition that where the State has in place a system of
individual exemptions, it may not refuse to extend that system to
cases of "religious hardship" without compelling reasons. 56 6
Significantly, the impracticality of applying the "compelling
governmental interest" test in Sherbert to all religiously motivated
actions, and the imperative for a restrictive or narrow application
of the "compelling governmental interest" test was aptly summed
up by the Court as follows:
[P]recisely because we value and protect that religious
divergence, we cannot afford the luxury of deeming
presumptively invalid, as applied to the religious objector, every
regulation of conduct that does not protect an interest of the
highest order. The rule respondents favor would open the
prospect of constitutionally required religious exemptions from
civic obligations of almost every conceivable kind-ranging from
compulsory military service ... to payment of taxes ... and
child neglect laws.567
563 Id. at 884.
564 Id. at 884. Although it rarely did so, the United States Supreme Court had
indeed applied the Sherbert test beyond the realm of unemployment compensation in the
following cases: United States v. Lee, 445 U.S. 252 (1982), Gillette v. United States, 401
U.S. 437 (1971), and Sable v. Communications of California v. FCC, 492 U.S. 115, 126
(1989), where compelling governmental interest was invoked in the context of
governmental regulation of the content of speech.
565 See Smith, 494 U.S. at 884.
566 Id. at 884.
567 Id. at 888-89.
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The Supreme Court of the United States then concluded that
because respondents' ingestion of peyote was prohibited under
Oregon law, which was a generally applicable neutral law, and
because that prohibition was constitutional, Oregon could,
consistent with the Free Exercise Clause of the First Amendment,
deny respondents' unemployment compensation, primarily
because their dismissal from work was triggered by the criminal
use of peyote, a class B drug.568
The pertinent question is whether the district court in Alliance
for Bio-Integrity569 correctly applied the Supreme Court decision
in Smiths70 with regards to when neutral laws of general
application would be invalidated by the Free Exercise Clause. To
begin with, the court in Alliance for Bio-Integrity"' was certainly
correct in its determination that the FDA's statement of policy,
and its concomitant non-labeling rule for transgenic plant food
was a neutral law of general application,572 not least because it was
policy of the U.S. Government that was generally applicable to all
citizens and residents irrespective of religious affiliations.573 Most
importantly, it was in evidence that the parties in Alliance for Bio-
Integrity never disputed that the statement of policy of the FDA
that ground the non-labeling policy for transgenic plant food, was
a neutral law of general application.574 A fortiori, the
determination of the district court in this respect was no more than
an affirmation of a trite and undisputed point of law.
Moreover, the court in Alliance for Bio-Integrity was arguably
wrong in its sweeping generalization that "neutral laws of general
applicability do not violate the Free Exercise Clause, even if the
laws incidentally burden religion." 7  This reasoning patently
glossed over the determination by the Court in Smith that not all
568 Id. at 890.
569 See Alliance for Bio-Integrity v. Donna Shalala, 116 F. Supp. 2d 166, 179-81
(D. D.C. 2000).
570 Smith, 494 U.S. at 872.
571 Alliancefor Bio-Integrity, 116 F. Supp. 2d at 166.
572 Id. at 179-80.
573 Id. at 179-81.
574 Id. at 180 (containing the observation of the Federal District Court that the
parties never disputed that the statement of policy was neutral and generally applicable).
575 Id. at 179.
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neutral laws of general application would be automatically
exempted from the constitutional reach of the Free Exercise
Clause. 57 6 Thus, the court in Alliance for Bio-Integrity failed to
consider plaintiffs' claim to Free Exercise of Clause in the context
of exceptions to the general rule adumbrated in Smith.5 77
As noted previously, the first exception to the general rule on
the inviolability of neutral laws of general application by the Free
Exercise Clause, as espoused in Smith, is when the Free Exercise
Clause is coupled with other constitutional rights.' This
circumstance is exemplified by Yoder, in which a valid and neutral
law of general application, which mandated compulsory school
attendance for pupils, was invalidated for Amish parents who
refused to send their children to school on religious grounds. 79
Thus, in Alliance for Bio-Integrity the court ought to have
considered whether or not plaintiffs' claim to free exercise of
religion was coupled with other constitutional rights such as
freedom of speech. For it is arguable that the FDA's rejection of a
labeling regime for transgenic plant food is tantamount to
suppression or abridgement of freedom of speech, which also is
guaranteed by the First Amendment.8 o This proposition is legally
plausible because labeling of transgenic plant food essentially
pertains to the communication of information relating to food
contents or properties by farmers, the food industry and grocers to
the general public, and its suppression by the FDA's statement of
policy on substantial equivalence doctrine, could arguably be
tantamount to an infraction of the freedom of speech of a
576 See Employment Div. v. Smith, 494 U.S. 872, 881-90 (1990) (discussing the two
exemptions to the general rule on neutral laws of general application and the free
exercise of religion clause under the First Amendment: the first being where the free
exercise clause right is coupled with other constitutional rights; and the second being the
"compelling governmental interests" test in the Sherbert case).
577 Id.
578 Id. at 881-82.
579 See Wisconsin v. Yoder, 406 U.S. 205, 205 (1972).
580 The First Amendment prohibits Congress and state legislatures from passing
legislation that could abridge the freedom of speech, which is codified as a constitutional
right by the First Amendment to the Constitution of the United States. See the text of the
First Amendment, which provides "Congress shall make no law respecting an
establishment of religion, or prohibiting the free exercise thereof; or abridging the
freedom of speech, or of the press; or the right of the people peaceably to assemble, and
to petition the Government for a redress of grievances." U.S. CONST. amend. I.
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commercial or economic strand that is guaranteed by the First
Amendment."'
Although under the circumstances plaintiffs or the general
public would be no more than mere recipients of information
conveyed by labeling of transgenic plant food, this should by no
means derogate from its qualification for constitutional protection
as commercial speech, because, according to the Supreme Court of
the United States in Virginia State Pharmacy Board v. Virginia
Citizens Consumer Council, "freedom of speech 'necessarily
protects the right to receive."' 5 82 A fortiori, failure in Alliance for
Bio-Integrity to adopt the Supreme Court's approach in Smith,5 83
and consider whether or not plaintiffs' claim to free exercise of
religion was coupled with other constitutional rights (the obvious
right being freedom of speech), arguably deprived the judgment of
the necessary depth and quality it might otherwise have had, and
by extrapolation, deprived plaintiffs of the benefits of a material
point of law that could have swayed the decision of the district
court in their favor.
The second exception to the general rule on the inviolability of
neutral laws of general application by free exercise of religion is
the principle enunciated in Sherbert, which holds that any
governmental actions that substantially burden a religious practice
must be justified by a compelling governmental interest.58 4 The
"compelling governmental interest" test in Sherbert was again
revisited in Smith,"' and was subsequently enacted into law by the
U.S. Congress in the form of the Religious Freedom Restoration
Act. 58 6  According to this Act, "[g]overnment shall not
581 Being commercial or economic in nature, the information in question is
tantamount to "commercial speech" and is in principle protectable by the First
Amendment to the United States Constitution. See Va. State Pharmacy Bd. v. Va.
Citizens Consumer Council, 425 U.S. 748 (1976).
582 Id. at 757 (quoting Kleindienst v. Manel, 408 U.S. 753, 726-63 (1972); see also
Taiwo A. Oriola, Regulating Unsolicited Commercial Electronic Mail in the United
States and the European Union: Challenges and Prospects, 7 TULANE J. TECH. & INTELL.
PROP 113, 140-51 (2005).
583 See Employment Division v. Smith, 494 U.S. 872, 881-90 (1990).
584 See Sherbert v. Verner, 374 U.S. 398 402-03 (holding that any governmental
actions that substantially burden a religious practice must be justified by a compelling
governmental interest).
585 See Smith, 494 U.S. at 883-90.
586 Religious Freedom Restoration Act, 42 U.S.C. §2000bb-2000bb-4 (2003).
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substantially burden a person's exercise of religion even if the
burden results from a rule of general applicability."' However,
government may burden a person's exercise of religion if it can be
demonstrated that the burden would further a compelling
governmental interest, and that the burden is the least restrictive
means of furthering that compelling governmental interest.8
Moreover, the Religious Freedom Restoration Act further
stipulates that a person whose religious exercise has been
substantially burdened in violation of the provisions of the Act
could assert the violation as a claim or defense in a judicial
proceeding and obtain appropriate relief against a government.589
The plaintiffs in Alliance for Bio-Integrity had urged the court
to hold that the FDA's non-labeling policy for transgenic plant
food constituted a substantial burden on their religion, and thereby
violated the provisions of the Religious Freedom Restoration
Act.5 90 However, the court rejected plaintiffs' argument in the
following terms:
Assuming arguendo that Plaintiffs meet the RFRA requirement
that their beliefs are sincerely held and can demonstrate an
"honest conviction" desiring to avoid genetically engineered
foods, Plaintiffs still must establish that Defendants have
substantially burdened Plaintiffs' religion. A substantial burden
does not arise merely because "the government refuses to
conduct its own affairs in ways that comport with the religious
beliefs of particular citizens." The Free Exercise Clause (as
interpreted before Smith and incorporated into RFRA) does not
require the government to take action to further the practice of
individuals' religion. Indeed, were the government to take such
action, it might bring itself precariously close to violating the
First Amendment's Establishment Clause.
It could thus be inferred that the district court was not satisfied
that plaintiffs had discharged their burden of proof, a civil
procedural obligation, which required plaintiffs to establish on
587 Id. §2000bb (1) (a).
588 Id. §2000bb (1) (b) (1)-(2).
589 Id. §2000bb (1) (c).
590 Alliance for Bio-Integrity v. Donna Shalala, 116 F. Supp. 2d 166, 180 (D. D.C.
2000).
591 Id at 180.
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balance of probability and preponderance of credible evidence that
defendants' refusal to label transgenic plant food had substantially
burdened plaintiffs' religion. If this inference were correct, then
the district court ought not to have granted defendants' prayer for
summary judgment,592 which invariably denied plaintiffs the
benefits of a full trial that would have afforded plaintiffs a better
forum to prove their case than in summary judgment proceedings.
For, according to the Federal Rules of Civil Procedure, a summary
judgment could only be granted if the applicant litigant could
show that "there is no genuine dispute as to any material fact and
the movant is entitled to judgment as a matter of law."593
However, judging by the quality and diversity of the supporting
swom affidavit evidence from Rabbis, a member of the Christian
Clergy, a Buddhist, and a Hindu religious organization,59 4 contrary
to the reasoning in Alliance for Bio-Integrity, plaintiffs did show
that they had a "genuine dispute" and concerns regarding the
suppression of their religious practice by the defendants' policy
prohibiting the labeling of transgenic plant food. 9 A fortiori, the
district court ought to have refused defendants' prayer for
summary judgment and allowed plaintiffs' case to proceed to a full
trial.
However, assuming arguendo that the district court was correct
in granting defendants' order for summary judgment, arguably the
court was wrong in holding that plaintiffs had not established that
their religious belief had been substantially burdened by
defendants' non-labeling policy for transgenic plant food.596 This
proposition is supported by the relative cogency and strength of
plaintiffs' affidavit evidence in support of their religious belief
suppression claim, which was sworn to by an Orthodox Rabbi, a
592 The Federal District Court granted defendants' prayer for a summary judgment
on grounds that there was no genuine issue as to any material fact, and that defendants
were entitled to judgment as a matter of law. See id at 170-71.
593 See FED. R. Civ. P. 56(a).
594 For a full list of plaintiffs with religious objections to transgenic plant food in
the Alliance for Bio-Integrity case, see the webpage of Alliance for Bio-Integrity at
http://www.biointegrity.org/ReligiousPlaintiffs.htm, (accessed on Feb. 28, 2013). See
also Alliance for Bio-Integrity, 116 F. Supp. 2d at 179-81.
595 See Alliance for Bio-Integrity, 116 F. Supp. 2d at 179-81.
596 The court in Alliance for Bio-Integrity reasoned that plaintiffs failed to establish
that defendants had substantially burdened their religion. Id. at 180-81
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Christian Clergy member, a Buddhist, and a Hindu practitioner. 97
Arguably, the sworn affidavit evidence was, ex facie, sufficiently
cogent and weighty enough to establish plaintiffs' claim that their
religion had been substantially burdened; the court was wrong to
have held to the contrary.598
This proposition is buttressed by the sworn affidavit evidence
of the Reverend Samuel Kedala of the Orthodox Christian Laity5 99
and Rabbi Alan Green, a United States citizen of Beth Israel
Synagogue in Winnipeg, Canada.600 For example, Rabbi Green's
sworn affidavit evidence in support of plaintiffs' claim in Alliance
for Bio-Integrity reveals a practitioner of Conservative Judaism,
who was worried that transgenic plant food was inimical to
"kosher dietary laws, which are grounded in the Torah" that was
"a basic aspect" of his "religious life" to which he strictly
adhered.60 ' The importance of kosher dietary laws to Rabbi Alan
Green's food choices is aptly put in paragraph 5 of his sworn
affidavit evidence as follows:
These laws govern my choice, preparation[,] and consumption
of food. They specifically prohibit certain types of foods, food
additives and ingredients, including those containing substances
from insects and certain types of animals. I believe that
substances produced by genes from these prohibited species are
unacceptable. I further believe that when such genes are
inserted within the DNA of an otherwise permissible organism,
that organism and all products derived from it are made
unkosher and thus spiritually unacceptable. 602
Similarly, paragraphs sixteen and eighteen of plaintiffs'
supporting affidavit evidence in Alliance for Bio-integrity, which
597 See id. at 179-81.
598 See id. at 180.
599 See Reverend Samuel Kedala, Father Samuel Kedala: Bioengineering of Food
is an Expression of the Spiritual Dark Forces at Work in the World, ORTHODOX
CHRISTIAN LAITY (May 27, 1999), http://archive.ocl.org/?id=8175.
600 See plaintiffs' supporting affidavit evidence sworn to by Rabbi Alan Green, in
Court document filed in the United States District for the District of Columbia. See
Declaration of Rabbi Alan Green at 1, Alliance for Bio-Integrity v. Donna Shalala, 116
F. Supp. 2d 166 (D. D.C. 2000) (No. 98-1300), http://www.ogmdangers.org/
enjeu/philosophique/religion/greendeclaration.html.
601 See id 4.
602 See id. 5.
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was sworn to by Reverend Samuel Kedala of the Orthodox
Christian Laity in Wantage, New Jersey, aptly captured the alleged
burden imposed on members of Eastern Christian Orthodox
Religion in New Jersey by the FDA's non-labeling policy for
transgenic plant food as follows:
I believe that organisms that have been engineered to express
foreign genes by the use of viral vectors have in some
significant way been infected with a negative spiritual energy,
which adheres to any substances derived from them.
Accordingly, I feel strongly motivated on the basis of spiritual
principle to avoid all foods containing ingredients from such
organisms. However, it is currently extremely difficult for me to
act on my beliefs and avoid genetically engineered foods,
because the FDA permits them to be marketed without
identifying labels. Therefore, although there have been
fundamental structural changes made to these foods that have
major spiritual implications from a standpoint of the Eastern
Orthodox Christian religion, I and other members of this Church
who feel a strong religious reason to avoid the engineered foods
are being unduly inhibited in the free exercise of our religion. I
find this highly objectionable, and I demand a prompt change of
policy. 603
In light of the foregoing excerpts from plaintiffs' affidavit
evidence, which denote genuine disputes of material facts relating
to plaintiffs' alleged religious belief suppression claim, the district
court ought to have rejected defendants' order for summary
judgment and allowed plaintiffs the benefits of a full trial.604
Moreover, given the strength of plaintiffs' supporting affidavit
evidence, the district court ought not to have held that plaintiffs
failed to establish that their religious belief had been substantially
burdened by defendants' non-labeling policy for transgenic plant
food.os
603 See Kedala, supra note 599, T 16, 18.
604 See Alliancefor Bio-Inlegrity, 116 F. Supp. 2d at 170-171 (In which the Federal
District Court granted defendants' prayer for a summary judgment on grounds that there
was no genuine issue as to any material fact, and that defendants were entitled to
judgment as a matter of law. However, according to Rule 56(a) of the Federal Rules of
Civil Procedure, a summary judgment could only be granted in the absence of genuine
disputes on material fact, which, going by the strength of the supporting affidavit
evidence, was not the case in Alliance for Bio-Integrity).
605 See id at 180.
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Furthermore, the court failed to address the central question on
whether or not government had a compelling interest for rejecting
plaintiffs' demand for labeling of transgenic plant food, in line
with the "compelling governmental interest" requirement of the
Religious Freedom Restoration Act, which forbids government to
burden religious beliefs of citizens absent "compelling
governmental interests." 60 6  It is submitted that the federal
government had no compelling governmental interest to suppress
labeling of transgenic plant foods, since plaintiffs' claim for
labeling was not tantamount to an outright ban on transgenic plant
foods.607  Moreover, food labeling is ubiquitous and generally
legally mandated to establish nutritional and dietary contents.
There was no evidence from the FDA that labeling of transgenic
plant foods would denigrate the interest of the federal government.
For whilst the federal government might have compelling
economic or security interest for opposing an outright ban on
transgenic agriculture and food, it is hard to fathom any
"compelling governmental interest" justifications for refusing
plaintiffs' request for labeling of transgenic plant food.
Nevertheless, the district court chose to ignore plaintiffs'
affidavit evidence and indulge in a hypothetical reasoning that a
substantial burden would not arise merely because "the
government refuses to conduct its own affairs in ways that
comport with the religious beliefs of particular citizens." 6 08 For
had the district court specifically addressed plaintiffs' affidavit
evidence in the context of the provisions of the Religious Freedom
Restoration Act,609 the district court would have realized that the
only effective legal rebuttal to such weighty and cogent affidavit
evidence was a compelling governmental interest for refusing
labeling of transgenic plant food, a legal rebuttal that the
defendants patently failed to demonstrate in Alliance for Bio-
Integrity,610 even though the summary judgment proceeding was
606 Religious Freedom Restoration Act, 42 U.S.C. §2000bb (1) (a)-(b) (1993).
607 See Alliance for Bio-Integrity, 116 F. Supp. 2d at 180.
608 Id. at 180.
609 See Religious Freedom Restoration Act, 42 U.S.C. §2000bb-2000bb-4 (1993),
especially §2000bb (1) (a), which provides that "Government shall not substantially
burden a person's exercise of religion even if the burden results from a rule of general
applicability."
610 Alliance for Bio-Integrity, 116 F. Supp. 2d at 166.
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decided entirely on points of law."'
After all, the Religious Freedom Restoration Act was enacted
by the U.S. Congress to safeguard the Free Exercise Clause from
undue judicial limitations and constraints imposed by the Supreme
Court of the United States in Smith,6 12 and arguably, the district
court decision in Alliance for Bio-Integrity was nothing short of a
judicial limitation on the Free Exercise of Clause. Even the
Supreme Court in Smith opined that it could apply the compelling
governmental interest test outside of unemployment compensation
cases to exempt compliance with a generally applicable law,613 and
Alliance for Bio-Integrity exemplifies such a case.
But then the district court decision in Alliance for Bio-Integrity
is consistent with, and symptomatic of, undue judicial deference to
scientific imperatives at the expense of religious, cultural, or
ethical considerations.614 This is especially so since the substantial
equivalence doctrine is a scientific tool that posits that transgenic
and non-transgenic plant foods are equivalent, and by
extrapolation, labeling of transgenic plant foods is superfluous.
Indeed, the scientific nature of the substantial equivalence doctrine
was tacitly acknowledged by the district court in its decision
regarding the validity of substantial equivalence policy of the
FDA, when it held that the Court would defer to the expert
judgment of the Food and Drug Administration because the
subject in question was "characterised by scientific and
technological uncertainty."61 5 However, as previously noted, such
judicial decisions and the concomitant legislation constitute
regulatory science, which is extremely limited and constrained by
the uncertainties that continue to characterize the science of
transgenic plant agriculture and food.616 The following paragraphs
611 Whilst granting defendants' prayer for summary judgment, the Federal District
Court referenced the provision of Rule 56(a) of the Federal Rules of Civil Procedure that
a litigant was entitled to summary judgment when "there is no genuine issue as to any
material fact and the moving party is entitled to judgment as a matter of law." Id. at 170-
71.
612 Id. at 180.
613 See Employment Div. v. Smith, 494 U.S. 872, 884 (2011).
614 See Diamond v. Chakrabarty, 447 U.S. 303, 303; see also Onco-
mouse/Harvard, OJ EPO 1990, 476 at 1-4.
615 See Alliancefor Bio-Integrity, 116 F. Supp. 2d. at 177.
616 For discussion on the concept of regulatory science and its inherent limitations
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will discuss the primacy of regulatory science in the context of
cases showing similar judicial deference to scientific imperatives
at the expense of religious and cultural objections to transgenic
plant agriculture and food.
B. The European Communities Biotech Products Case: The
Triumph of Science Over Non-Scientific Objections to
Transgenic Plant Agriculture and Foods
Whilst the Alliance for Bio-Integrity case exemplifies the
primacy of regulatory science and its underlying "science" over
religious, cultural, and non-scientific considerations in the
governance of transgenic plant agriculture and food at the national
level, the European Communities Biotech Products case617
exemplifies the supremacy of science over non-scientific
considerations on a transnational scale amongst the 157 members
and twenty-seven observer governments of the World Trade
Organization (WTO),6 18 which was established by the 1994
signing of the Uruguay Round negotiations in Marrakesh,
Morocco.6 19
In the European Communities Biotech Products case, the
induced by the "science" on which regulatory science is premised, see infra Parts I, 11,
and III of the essay. See also Gareth Davies, Morality Clauses and Decision-Making in
Situations of Scientific Uncertainties 6-7 (The Hebrew University of Jerusalem Int'l Law
Forum's SSRN Research Paper Series, Research Paper No. 10-06, 2006), available at
www.ssrn.com/abstractid=920754 (discussing the uncertainties and inconclusiveness of
science in addressing environmental and public health issues posed by transgenic plant
agriculture and food).
617 See European Communities - Measures Affecting the Approval and Marketing
of Biotech Products, supra note 295.
618 As of 24 August 2012, the World Trade Organization has 157 members and 27
observer governments. For a list of membership, see Members and Observers, WORLD
TRADE ORGANIZATION, http://www.wto.org/english/thewtoe/whatis e/tif e/org6_e.htm.
619 See TIM JOSLING ET AL., FOOD REGULATION AND TRADE: TOWARDS A SAFE AND
OPEN GLOBAL SYSTEM 35-36 (2004). The World Trade Organization now administers
the 1994 General Agreement on Tariffs and Trade (GATT), which is a progeny of the
1947 General Agreement on Tariffs and Trade (GATT). See id. WTO also administers
the following trade agreements: the Agreement on Trade-Related Aspects of Intellectual
Property Rights, located in Annex IC, Article 8.1 of the Marrakesh Agreement
Establishing the World Trade Organization, Apr. 15, 1994, 1867 U.N.T.S. 154, 33 I.L.M.
1125, 1201; the WTO Agreement on the Application of Sanitary and Phytosanitary
Measures (SPS Agreement), Apr. 15, 1994, 1867 U.N.T.S. 493; and the Uruguay
Agreement on Technical Barriers to Trade, Apr. 15, 1994, 1868 U.N.T.S. 120.
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United States, Canada, and Argentina filed a complaint before the
WTO's Dispute Settlement Body, challenging the legality of the
de facto moratorium of the European Commission on the approval,
import, and sale of new transgenic plant products, on grounds inter
alia that it violated both the General Agreement on Tariffs and
Trade (GATT) and the Marrakesh Agreement on the Application
of Sanitary and Phytosanitary Measures (MAASPM). 62 0 The
European Commission had justified the moratorium on approval
of new transgenic plant materials on grounds of precautionary
principle, which authorized safeguard measures in the face of
scientific uncertainties.6 2' The Communication from the
Commission on the Precautionary Principle sums up the essence
of the precautionary principle of the European Union as follows:
The Community has consistently endeavoured to achieve a high
level of protection, among others in environment and human,
animal or plant health. In most cases, measures making it
possible to achieve this high level of protection can be
determined on a satisfactory scientific basis. However, when
there are reasonable grounds for concern that potential hazards
may affect the environment or human, animal or plant health,
and when at the same time the available data preclude a detailed
risk evaluation, the precautionary principle has been politically
accepted as a risk management strategy in several fields.622
However, the United States, Canada, and Argentina argued
that the European Commission lacked scientific evidence to justify
its concerns that transgenic plant materials were unsafe for the
environment and the public health and that the moratorium on
approval and imports of new transgenic plant materials was no
more than trade protectionism, in contravention of Article III (4)
of the GATT, which requires "national treatment" for "like
products," and prohibits countries from applying discriminatory
national taxes and regulations to imports. The WTO Dispute
Settlement Panel agreed with the complainants that the European
Commission moratorium on the approval of new transgenic plant
organisms had no scientific basis or justification as protective
620 See European Communities - Measures Affecting the Approval and Marketing
of Biotech Products, supra note 295, at 1-3.
621 See id at 3.
622 See Communication from the Commission on the Precautionary Principle, at 9,
COM (2001) 1 final (Feb. 2, 2000).
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measures under Article XX of GATT, which recognizes
governments' sovereign right to adopt restrictive trade measures
for public health, public moral, and environmental safeguards.62 3
The WTO Dispute Settlement Panel further noted that, with
regards to the safeguard measures, the European Commission
moratorium on the approval and importation of new transgenic
plant organisms contravened Articles V(l) and 11(2) of the
MAASPM, which requires that all food safety measures must be
based on risk assessment and scientific evidence. Whilst the
European Commission denied that its moratorium was tantamount
to trade protectionism as claimed by the complainants, the
objections from some member states of the European Union to
transgenic plant agriculture and foods clearly transcended socio-
economic issues and included "religious and ethical
considerations" going by the argument in the first written
submission of the European Commission to the WTO Dispute
Settlement Panel. 624 Again, this argument was dismissed by the
Dispute Settlement Panel as unscientific and illegal under the
combined provisions of the GATT and the MAASPM. 625 Thus,
the decision of the WTO Dispute Settlement Panel in the European
Communities Biotech Products case, like that of the Federal
District Court in Alliance for Bio-Integrity, 626 is indicative of the
triumph of science over non-scientific oppositional grounds to
transgenic plant organisms.
However, the question of morality or ethics is not as foreign to
the jurisprudence of the WTO as it might seem, in light of the
provision of Article XX (a) of the GATT, which allows for public
morality protection as a basis for derogation from compliance with
its non-discriminatory provisions.627 Moreover, albeit a non-
science-related case, the WTO case of U.S. measures affecting the
623 See European Communities-Measures Affecting the Approval and Marketing of
Biotech Products, supra note 295, at 1067-87.
624 See id. at 1067-1087.
625 See id. at 1067-87.
626 See Alliance for Bio-Integrity v. Donna Shalala, 116 F. Supp. 2d 166, 166 (D.
D.C. 2000).
627 Article XX on "General Exceptions" provides in Article XX (a) that contracting
parties may adopt measures that derogate from general compliance with non-
discriminatory trade measures if they are "necessary to protect public morals." General
Agreement on Tariffs and Trade art. XX (a), Oct. 30, 1947, 55 U.N.T.S. 194.
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cross-border supply of gambling and betting services, upheld the
measures taken by the United States to prohibit internet gambling
via offshore websites based in foreign jurisdictions, as consistent
with Article XIV (a) of the GATT.62 8 Interestingly, the WTO
Appellate Body Report held that the provisions of Article XIV(a)
of the GATT 629 were analogous to the provision of Article XX(a)
of the GATT on public morality preservation derogation from
general compliance with the non-discriminatory provisions of the
GATT.630
However, in the context of the regulation of new technologies,
the propensities for judicial inclinations to defer to science are
high and rife, as exemplified by the Supreme Court in Diomond v.
Chakrabarty, in which the Court refused to invalidate a patent on a
genetically modified bacterium invention that had been designed
to consume oil.' The Supreme Court dismissed the arguments
that the "invented" bacterium and similar genetic research could
"spread pollution and disease" or "result in a loss of genetic
diversity," or "depreciate the value of human life."632 Rather, the
Court held that only the United States Congress had the legislative
oversight to determine the conditions under which inventions
could be patented.63 3 Similarly, in Onco-mouse/Harvard,
European patents examiners drew on the benefits inherent in the
advancement of cancer research to hold that the Harvard Onco.-
mouse invention did not contravene the provisions of Article 53(a)
of the European Patent Convention, which excluded from
patentability inventions that were contrary to public policy, public
order, or morality.63 4 However, as noted earlier in this article,
628 See Appellate Body Report, US- Measures Affecting the Cross-Border Supply of
Gambling and Betting Services, T 299, WT/DS285/AB/R (Apr. 7, 2005).
629 Article XX on "General Exceptions," provides in Article XX (a) that members
may adopt discriminatory measures that are "necessary to protect public morals" or
maintain public order. See General Agreement on Tariffs and Trade, supra note 627, at
art. XX (a).
630 The Appellate Body Report concurred with the Panel's findings that the
protection of public morals "denotes standards of right and wrong conduct maintained by
or on behalf of a community or nation." See Appellate Body Report, supra note 628, T
296.
631 See Diamond v. Chakrabarty, 447 U.S. 303, 316-18 (1980).
632 Id. at 316.
633 Id. at 317-18.
634 See Onco-mouse/Harvard, at 1, 4; see also, Oriola, supra note 58, at 497-29
876 Vol. XXXIX
2014 REGULATION AND TRANSGENIC PLANT AGRICULTURE
scientific knowledge is not as agnostic, certain, or sacrosanct as it
could be, and in the context of transgenic plant agriculture
governance systems, even scientists have acknowledged that there
are 'known unknowns,' and scientific uncertainties on new
allergens, toxins, and environmental impacts that are yet to be
resolved by the current science of transgenic plant agriculture."'
C. The European Commission v. The Republic of Poland:
Science Trumps Cultural Objections to the Marketing and
Registration of Transgenic Plant Seeds
The case of the European Commission v. The Republic of
Poland again demonstrates the supremacy of science over
religious and cultural bases for the governance of transgenic plant
agriculture and food.636 The European Commission successfully
challenged Polish anti-transgenic seeds legislation, which
prohibited the marketing of seeds derived from genetically
modified varieties and the registration of such varieties in the
national catalogue of seeds varieties, on ethical and religious
grounds. 63 7  The Polish authorities had justified their anti-
transgenic plant legislation on ethical and religious grounds.638
However, the European Court of Justice held inter alia that the
Polish law contravened the provisions of Articles 22 and 23 of the
Deliberate Release Directive 2001/18/EC.639
Article 22 of the Deliberate Release Directive enjoins member
states of the European Union not to prohibit, restrict, or impede
the placing on the market of transgenic plant organisms, which
had complied with the requirements of the Deliberate Release
Directive.6 40 In the same vein, Article 23(1) provides that a
(discussing deliberative and public policy-induced legislative and juridical examples of
pro-biotechnology research policies).
635 See, e.g., Ronald J. Herring, supra note 23, at 2 (explaining the author
acknowledged, "there are scientists deeply troubled by genetically engineered organisms.
There are specifiable 'known unknowns'; - horizontal gene flow, allergenicity from
novel proteins - and almost certainly 'unknown unknowns' as well.")
636 Case C-165/08, Comm'n of the European Cmtys. v. Republic of Poland, OJ C
220 (2009).
637 Id. at 66.
638 Id. at 35.
639 Id. at 66.
640 See Deliberate Release Directive, supra note 72, art. 22.
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member state may only prohibit or restrict the use or sale of
transgenic plant organisms that had been approved under the
Deliberate Release Directive, if new or additional information
reveals that the transgenic plant organism in question constitutes a
risk to human health and the environment. 64 ' However, the Polish
authority did not have any new or additional information that
showed that the transgenic plant seeds in question constituted a
risk to public health and the environment. Therefore, the
European Union Court of Justice (Second Chamber), held that the
Polish law prohibiting the registration of transgenic plant seeds in
the national catalogue contravened the provisions of Article 22
and 23(1) of the Deliberate Release Directive. 4 2
However, it is instructive to note that the European Court of
Justice did not take into consideration the provision of paragraph 9
of the recitals to the Deliberate Release Directive, which provides
for an ethical basis for the governance of transgenic plant
organisms: "Respect for ethical principles recognised in a member
state is particularly important. Member states may take into
consideration ethical aspects when GMOs are deliberately released
or placed on the market as or in products.""
Therefore, the failure of the European Court of Justice to take
into consideration the provision of paragraph 9 of the recitals to
the Deliberate Release Directive on ethical bases for the
governance of transgenic plant organisms once again demonstrates
that, in the context of transgenic plant agriculture governance,
non-scientific imperatives, such as ethics and religious beliefs, are
easily trumped by scientific imperatives. This proposition is
furthered by the fact that the European Parliament and the Council
chose to place the provision of paragraph 9 relating to ethical
governance of transgenic plant organisms in the recitals, whilst the
provisions of Articles 22 and 23(1) relating to scientific
consideration are a part of the substantive text of the Deliberate
Release Directive.644 Recitals are no more than preliminary
641 See id. art. 23(l).
642 Case C-165/08, Comm'n of the European Cmtys. v. Republic of Poland, OJ C
220, at 66 (2009).
643 See Deliberate Release Directive, supra note 72, recital 119.
644 Recitals are preliminary parts of legislative documents, which explain their
purpose and provide other factual information. Thus, whilst recitals often help to explain
the reasons for legislations, they are not construed as part of legislative texts as such.
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explanations of the purpose, factual background, and essence of
legislative texts, and are not construed as part of the substantive
texts of legislative instruments." Thus, to the extent that the
paragraph 9 provision relating to ethical governance of transgenic
plant organisms is placed in the largely enforceable part of the
Deliberate Release Directive, it is indicative that it is inferior or
secondary to the provisions of Articles 22 and 23 of the Deliberate
Release Directive.6 46
However, the alienation of strong societal norms and values
that are rooted in morality, ethics, or religion from transgenic plant
agriculture governance systems risks further aggravating public
skepticism and disdain for transgenic plant agriculture, especially
when science, as the fulcrum on which the regulatory and policy
regime for transgenic plant agriculture is premised, is not as
agnostic or certain as it could or should be. Moreover, skepticism
and dislike for the current science-centric regulatory regime for
transgenic plant agriculture are bound to fester for as long as the
current governance systems fail to sufficiently address concerning
questions on public health and environmental safety, as well as
liability, and redress regime for inevitable economic or property
damage from adventitious admixture of transgenic and non-
transgenic plant materials.6 47 In the United States for example,
dissatisfaction with the status quo is exemplified by the 2008
transgenic agriculture liability law of the State of California,
which primarily protects non-transgenic plant farmers from
intellectual property rights and associated liabilities surrounding
For example, according to paragraph 10.5.1 of the Joint Practical Guide ofthe European
Parliament, the Council, and the Commission, "recitals should constitute a genuine
statement of reasons; they should not set out the legal bases (which must be in the
citations) nor should they repeat the passage in the provision already cited as the legal
basis which empowers the institution to act. Furthermore, recitals which do no more
than state the subject-matter of the act or reproduce or even paraphrase its provisions
without stating the reasons for them are superfluous or pointless." See Joint Practical
Guide: Guide of the European Parliament, the Council, and the Commission for Persons
Involved in the Drafting of Legislation Within the Community Institutions, EUR-LEX
(last visited Feb. 28, 2013), http://eur-lex.europa.eu/en/techleg/l0.htm.
645 See id.
646 See Deliberate Release Directive, supra note 72, art 22, 23 and recital 9.
647 For discussion on possible remedies for property and economic damage caused
by adventitious commingling of transgenic and non-transgenic plant materials see Lee,
supra note 247, at 517-37.
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transgenic plant agriculture.64 8 Similarly, the State of Oregon was
involved in an abortive initiative in 2002 to label transgenic plant
foods, whilst numerous county authorities across the United States
have been involved in abortive attempts to legislate against the
perceived threats posed by transgenic plant agriculture that Federal
authorities had sufficiently failed to address through the current
science-centric regulatory framework.64 9
V. Conclusion: The Imperatives for Reconciling Science and
Social Values in the Governance of Transgenic Plant
Agriculture and Food Systems
It is imperative to reconcile science and social values in the
governance of transgenic plant agriculture and food in order to
inspire public confidence in the technology. Indeed, rather than
being the prerogative of religious fundamentalists on the societal
margins, religious opposition to transgenic plant agriculture and
food could be mainstream and transcendental of religious faiths
and denominations, as exemplified by plaintiffs' claim in Alliance
for Bio-Integrity, whose affidavit evidence straddled Hindu,
Jewish, and Christian religions.5 o However, there is nothing to
suggest that all religious groups are unanimously opposed to
transgenic plant agriculture and food, as exemplified by the
budding literature on religion and transgenic plant agriculture,
which depicts variations in religious oppositional views that range
from subtle to critical."' Thus, religious, ethical, and cultural
perspectives on transgenic plant agriculture and food are
inherently fractious and far from unanimous, even for people of
similar faith. For example, while Rabbi Green, a plaintiff in
Alliance for Bio-Integrity was totally opposed to transgenic plant
648 See Cal. Civ. Code, B. No. 541 §7200 (2007) or Food; Agric. Code, Chapter 3
Part I Div. 1, .Art. 6 § 510 (2007).
649 See Bailey, supra note 250; Callahan, supra note 250, at Bl; Oriola, supra note
123, at 535 n.92.
650 See Alliance for Bio-Integrity v. Donna Shalala, 116 F. Supp. 2d, 166, 166 (D.
D.C. 2000).
651 See Carl Feit, Genetically Modified Food and Jewish Law (Halakhah), in
GENETICALLY MODIFIED FOODS: DEBATING BIOTECHNOLOGY 123, 123-29 (Michael Ruse
and David Castle eds., 2002) (discussing the flexibility of Talmudic thought on
transgenic plant foods).
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652agriculture and food as an adherent of Conservative Judaism, a
rational interpretation of the Torah according to rabbinic thought
that dated "back to Talmudic discussions on the questions of
mixtures of permitted and forbidden food," demonstrated an
ambivalent Jewish law that neither condemns or embraces
transgenic plant agriculture and food.6 53 Furthermore, whilst not
expressly condemning transgenic plant agriculture and food, there
was an unmistakable caution in the address of the late Pope John
Paul II to the agricultural community in November 2000, in which
he noted that "the Earth belongs to God" and that it "must
therefore be treated according to his law."654 The late Pope also
cautioned against "irresponsible culture of "dominion" over the
earth that was being fuelled by frenetic scramble for natural
resources "with devastating ecological consequences" that were
contrary to "God's plan."655 He further observed that the divine
strictures in Genesis chapter 1, verse 28 that men should "fill the
earth and subdue it; and have dominion over the fish of the sea and
over the birds of the air" merely entrusted "the earth to man's use,
not abuse." He noted further that the strictures in Genesis chapter
1, verse 28 did "not make man the absolute arbiter of the earth's
governance, but the Creator's "co-worker", and that man's mission
is "marked by precise boundaries that can never be transgressed
with impunity."6 5 6  He urged biotechnology companies to
remember this principle in agricultural production, whenever there
was a question that could not "be evaluated solely on the basis of
immediate economic interests," and that such question must be
subjected "to rigorous scientific and ethical examination to prevent
them from becoming disastrous for human health and the future of
the earth." 657
Thus, there are inherent challenges in relying on disparate
religious, ethical, and cultural values for transgenic plant
652 See Declaration of Rabbi Alan Green, supra note 600, at 4, 5.
653 See Carl Feit, supra note 651, at 123-29 (discussing the flexibility of Talmudic
thought on transgenic plant foods).
654 See Pope John Paul II, Jubilee of the Agricultural World, in GENETICALLY
MODIFIED FOODS: DEBATING BIOTECHNOLOGY 112 (Michael Ruse and David Castle eds.,
2002).
655 Id
656 Id
657 Id
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agriculture governance, given the lack of unanimity of religious,
ethical, and cultural views on transgenic plant agriculture and
food. But then, it is arguable that religious, ethical, and cultural
views on transgenic plant agriculture and food are no less
disparate, uncertain, and contradictory than scientific opinions and
knowledge on the propriety of transgenic plant agriculture and
food.658 Indeed, as this article has amply demonstrated, there are
plant scientists, food nutritionists, geneticists, and toxicologists
who are genuinely worried about the continuing scientific
uncertainty on the long term implications of transgenic plant
agriculture and food respectively for the environment and public
health. Such genuine concerns could never be simply wished
away by the presumed agnosticism and certainty of science, when
the reality is indeed very different.65 9
Most significantly, there are legal and ethical imperatives for
holistic governance systems that are sensitive to and cognizant of
deep-rooted socio-cultural and religious norms. For example, it
was argued in this article that religious belief was wrongly
excluded as a basis for labeling of transgenic plant foods in the
United States by the court in Alliance for Bio-Integrity.660 This
proposition is predicated on the argument that labelling is a
protected informational commercial speech under the First
Amendment to the Constitution of the United States.66 1 Moreover,
consumers do have a fundamental right and prerogative to choose
whether or not to eat transgenic plant foods, and it should not
matter whether consumer preference is predicated on cultural or
religious beliefs.6 62 Moreover, it is arguably unethical to deprive
consumers of the fundamental right to food preferences, or to foist
658 See supra Part II.C, on the contested nature of the science that underpins
transgenic plant technology, supra Part I.C, on the conflicting and conflicted science
on the potential for new allergens and toxins in transgenic plant food.
659 For discussion on the contested safety science of transgenic plant agriculture
and food, see supra Part I.C.
660 See generally Part IV.A of the Article on the religious belief suppression
challenge in Alliance for Bio-Integrity v. Donna Shalala, 116 F. Supp. 2d. 166, 166 (D.
D.C. 2000).
661 See supra Part IV.A, particularly with regards to the analysis on labelling as a
form of commercial speech protectable by the First Amendment, which lead up to
footnotes 584, 585, and 586.
662 For discussion on consumers' fundamental right to food preferences, see Oriola,
supra note 123, at 530.
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on entire populations the inevitability of transgenic plant
agriculture and food.6 63 Thus, addressing religious, cultural, and
ethical concerns of the public through holistic governance systems
that are sensitive to and cognizant of socio-cultural and religious
values could help in disarming the continuing resistance to
transgenic plant technology, especially in Europe.664
663 See id.
664 For discussion see Lee, supra note 29 at 131-39.
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